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ABSTRACT 
ANCA DANA DRAGOMIR: Uterine Location of Leiomyomata:  
Risk Factors and Relation to Stress Urinary Incontinence 
(Under the direction of Jane Schroeder) 
 
The first objective of this research was to compare risk factors for three uterine 
leiomyomata (UL) subtypes (submucosal UL, intramural/subserosal UL, and diffuse only) 
among African-American and Caucasian women. The second objective was to investigate the 
association between UL and self-reported SUI in premenopausal women. Data were from 35 
to 49 year old premenopausal African American and Caucasian women enrolled in the 
National Institute of Environmental Health Sciences Uterine Fibroid Study.  
The cross-sectional study of risk factors for UL subtypes included 986 premenopausal 
women (581 African-American, 405 Caucasian). For women in both ethnic groups, 
associations with age at ultrasound examination, age at menarche, body mass index, and 
current physical activity were similar for all three UL subtypes. Inverse associations 
estimated for pregnancies after age 24 were stronger for the submucosal UL subtype than the 
other two subtypes. Current smoking was positively associated with the diffuse only subtype, 
but was not associated with focal UL subtypes in either ethnic group.  
The study of UL and SUI included 798 premenopausal women (446 African-
American and 352 Caucasian). The estimated prevalence of SUI was higher among women 
with UL than among women without UL. Associations were slightly stronger for medium (2-
4cm) and large (≥ 4cm) UL, but anterior location was not associated with further increase in
iii 
prevalence. Women with very large uterine volume (above the 83rd percentile for the 
population) reported more SUI than those with small uterine volume (bellow the 33rd 
percentile). There was no clear evidence of effect modification by ethnicity or parity. 
The two studies have improved upon prior research by identifying and characterizing 
UL based on ultrasound examinations (instead of including diagnosed UL only), and by 
including both African American and Caucasian women. Results suggest that future studies 
of UL etiology should distinguish the focal UL subtypes from the diffuse only subtype to 
account for potential differences in etiologic mechanisms, and that treatment for larger UL 
might enhance SUI treatment in some women. 
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CHAPTER I 
REVIEW OF THE LITERATURE 
Introduction 
 
Uterine leiomyomata (UL) are the most prevalent tumors of women in the United 
States (Flake et al. 2003). Based on cross-sectional screening for UL done among women 
aged 35 to 49 years old without regard to the presence or absence of clinical symptoms, the 
National Institute of Environmental Health Sciences (NIEHS) Uterine Fibroid Study 
estimated that more than 80% of African-American women and about 70% of Caucasian 
women develop UL by age 50 (Baird et al. 2003). Although only about 20% to 50% of 
women with UL experience related symptoms (Stovall 2001), the economic impact of UL is 
considerable. Estimates for the direct cost of treating UL have been as high as $2.1 billion 
per year (Flynn et al. 2006). 
Epidemiological studies tend to investigate risk factors associated with the presence 
of UL without regard to anatomic location, whereas studies that have evaluated the 
association of characteristics of UL with reproductive outcomes have noted that anatomic 
location could be an important predictor of adverse effects. Thus there is a need to identify 
risk factors associated not only with the presence of UL in general, but also with their 
presence at specific location. 
No population-based epidemiological studies have investigated risk factors for the 
location of UL. The association of age at first birth with the location of UL has been 
examined only as a secondary analysis in a practice-based case-control study, in which the
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 results were limited by the small number of women with known location of UL (Faerstein et 
al. 2001 a). The proposed research will investigate risk factors for the location of UL using 
premenopausal African-American and Caucasian women from the baseline data of the 
NIEHS Uterine Fibroid Study for whom the location of their UL is known. 
Urinary incontinence is one of the most common types of lower urinary tract 
dysfunction, affecting about a third of adult women in the United States (DuBeau 2001). The 
annual direct cost of urinary incontinence for women in the US is estimated as $12.4 billion 
(in 1995 dollars) (Wilson et al. 2001).  
Stress urinary incontinence (SUI), i.e. the complaint of involuntary leakage of urine 
on effort or exertion, or on sneezing or coughing (Abrams et al. 2002), is the most common 
type of urinary incontinence in women, with about half of women with urinary incontinence 
suffering from SUI (Hampel et al. 1997). SUI accounts for 85% of treatment expenditures for 
urinary incontinence for women (Wilson et al. 2001), and also may have a substantial 
negative impact on the quality of life (Contreras-Ortiz 2004). 
Although it is often stated in the literature that UL and SUI are associated (Stovall 
2001, Nygaard and Heit 2004) there is little evidence to support it. No population-based 
observational studies have assessed the association between the size and location of UL and 
SUI. The proposed research will fill this research gap based on data from African-American 
and Caucasian premenopausal women from the first follow-up of the NIEHS Uterine Fibroid 
Study.  
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Epidemiology of Uterine Leiomyomata 
UL are the most prevalent tumors of women in the United States (Flake et al. 2003). 
These benign neoplasms are monoclonal, arise from the smooth-muscle cells of the uterus, 
and contain an increased amount of extracellular matrix proteins, such as collagen and elastin 
(Stewart 2001, Walker and Stewart 2005). Regarding their gross features, UL are firm, 
rubbery, and are characterized by a very sharp line of demarcation between them and the 
surrounding myometrium (Robboy et al. 2000).  
Although the prevalence of UL was estimated to be as high as 77% in hysterectomy 
specimens (Cramer and Patel 1990), perhaps only about 20% to 50% of women with UL 
experience related symptoms (Stovall 2001). Several epidemiological studies have found that 
African-American women are more likely than Caucasian women to have multiple UL, 
larger diameter UL, and greater uterine weight (Kjerulff et al. 1996, Marshall et al. 1997). 
Based on cross-sectional screening for UL done among women aged 35 to 49 years old 
without regard to the presence or absence of clinical symptoms, the National Institute of 
Environmental Health Sciences (NIEHS) Uterine Fibroid Study estimated that more than 
80% of African-American women and about 70% of Caucasian women develop UL by age 
50 (Baird et al. 2003). If attention is restricted to clinically relevant UL (defined as the 
presence of an enlarged uterus, or the presence of a tumor with a diameter of at least 4 cm, or 
the presence of submucous UL) approximately 50% of African-American and 35% of 
Caucasian premenopausal women will have clinically relevant UL by age 50.  
Although a large percentage of the women with UL are asymptomatic, the economic 
impact of UL is considerable. From 1988 to 1990 UL was one of the five most common 
hospital discharge diagnoses among all gynecologic disorders for reproductive-age women 
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(Velebil and al. 1995). From 1990 to 1997 about 40% of total abdominal hysterectomies, and 
about half of subtotal hysterectomies were performed for UL (Farquhar and Steiner 2002). 
From 1994 through 1999 UL was the most frequent diagnosis for the approximately 600,000 
hysterectomies performed annually in the United States (Keshavarz et al. 2002). Estimates 
for the direct cost of treating UL have been as high as $2.1 billion per year (Myers et al. 
2001). 
UL are heterogeneous with respect to their natural history. Etiology is believed to 
involve the combined effect of risk factors (such as ethnicity, parity, obesity) and genetic 
alterations (including hereditary susceptibilities and somatic alterations) acting through 
hormones (estrogen and progesterone) and growth factors (Walker and Stewart 2005). 
A recent comprehensive review on the epidemiology of UL (Schwartz 2001) 
summarized the results of 20 papers published between 1986 and 2001 that were based on 
data from 11 epidemiological studies. The review emphasizes that many of these studies have 
important methodological limitations, the most critical being limitations due to the presence 
of subclinical UL among women without established clinical disease, and the use of case 
identification via hysterectomy. Because of the latter, women who have not been treated for 
their UL often have not been included as cases, and even when case status is based on a 
clinical diagnosis of UL there may be substantial misclassification of case/control status 
because of undiagnosed UL. 
Of the 11 epidemiological studies cited only two were specifically designed to 
identify risk factors for UL, one in Thailand (Lumbiganon et al. 1996) and the other in the 
United States (Faerstein et al. 2001 a, Faerstein et al. 2001 b). Most of the studies were 
conducted as ancillary investigations within larger studies of women’s reproductive health, 
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such as the Oxford Family Planning Association Study (Ross et al. 1986), the Cancer and 
Steroid Hormone Study (Samadi et al. 1996), and the Nurses’ Health Study (Marshal et al. 
1997). Five of the studies were cohort studies, while the other six were case-control studies, 
including the two studies that focused on UL etiology. Overall most of the participants in 
these studies were Caucasian premenopausal women.  
Schwartz’s review underlines the consistency of results for ethnicity, age at 
menarche, postmenopausal status, parity, years since last birth, and cigarette smoking, while 
inconsistent results were noted for use of oral contraceptives, history of infertility, and BMI 
(Schwartz 2001). There were also risk factors that were investigated by too few studies to 
provide conclusive evidence, such as the use of an injectable progestin-only contraceptive 
(Lumbiganon et al. 1996), diet (Chiaffarino et al. 1999), family history (Lumbiganon et al. 
1996), perineal talc use (Faerstein et al. 2001 b), and use of antihypertensive medication 
(Faerstein et al. 2001 b). In addition there is also evidence that risk factors for UL may vary 
by ethnicity (Chen et al. 2001). 
Table 1.1 contains the 20 papers reviewed in Schwartz (2001) and nine more recent 
papers not included in that review. The nine epidemiological papers published since 2001 
include six based on the Black Women’s Health Study and the NIEHS Uterine Fibroid Study, 
two studies that included African-American women. The three papers that used prospective 
data from the Black Women’s Health Study provide evidence supporting the role of age at 
menarche, parity, years since last birth, BMI, age at first birth, current use of progestin-only 
injectables, and alcohol consumption, among African-American women (Wise et al. 2004 a, 
Wise et al. 2004 b, Wise et al. 2005). Without reporting estimates for the effect of smoking 
on UL, all three papers included adjustment for smoking. These data also suggest that among 
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African-American women the inverse association between parity and UL is attenuated by 
obesity, such that the inverse relationship was stronger among those with BMI < 27 (below 
the median) (Wise et al. 2004 a). The most recent paper (Wise et al. 2005) described different 
relationships between BMI and UL (self-reported, ultrasound or hysterectomy-diagnosed 
cases), one for the parous and the other for the nulliparous premenopausal African-American 
women.  
Based on cross-sectional data from the NIEHS Uterine Fibroid Study, which included 
both African-American and Caucasian women, it was shown that prenatal diethylstilbestrol 
exposure is associated with UL (Baird and Newbold 2005) and that luteinizing hormone may 
stimulate UL development in premenopausal women (Baird et al. 2006). Also the number of 
full-term pregnancies after age 24, physical activity, and alcohol consumption have been 
found to be associated with UL (D’Aloisio and Baird 2004, Baird et al. 2006). 
Prospective data from the Nurses’ Health Study (Boynton-Jarrett et al. 2005) suggest 
that hypertension is a risk factor for UL, consistent with previous results (Faerstein et al. 
2001 b). Maternal history of UL was strongly associated with UL in a small hospital-based 
case-control study involving mostly Caucasian women (Van Voorhis et al. 2002). The use of 
estrogen and progestogen therapy was associated with UL among perimenopausal and 
postmenopausal women with lower BMI (BMI < 24) in a recent case-control study of mostly 
Caucasian women (Reed et al. 2004). 
In summary, the reviewed literature underlines the importance of ethnicity, 
postmenopausal status, age at menarche, parity, cigarette smoking, BMI, physical activity, 
and alcohol consumption, as risk factors for UL.   
 
 7  
Location of Uterine Leiomyomata 
Based on their location, UL are classified as submucosal, intramural, and subserosal. 
Submucosal UL intrude in, or are contained in, the endometrial cavity; intramural UL are 
contained within the wall of the uterus; and subserosal UL extend the uterus into the 
peritoneal cavity (Stewart 2001). According to the literature, intramural UL are the most 
common (Robboy et al. 2000, Walker and Stewart 2005). For example, in an ultrasound 
study of UL in pregnancy involving 408 women aged 23 to 43 years old, 281 (69%) women 
were classified as having intramural UL, 75 (18%) women had subserosal UL, and only 52 
(13%) women had submucosal UL (Rosati et al 1989). 
There is available scientific evidence of differences between submucosal, intramural, 
and subserosal UL, that extend beyond their anatomic location. Pathophysiological data 
suggest that submucosal UL, which arise from the highly specialized structure of the 
junctional zone myometrium, are distinct clinical entities from other UL (Brosens 2003). A 
cytogenetic study that investigated the presence of chromosomal aberrations in 217 UL using 
cytogenetic karyotyping found that the prevalence of abnormal karyotypes among 
submucosal UL (12%) was significantly smaller than among intramural UL (35%) or 
subserosal UL (29%), after adjusting for the size of UL (Brosens et al. 1998). Using uteri 
obtained from 30 women undergoing hysterectomy for UL, a laboratory study found that 
during the proliferative phase of the menstrual cycle, estrogen receptor and progesterone 
receptor levels were significantly higher in submucosal UL (n=5) than in subserosal UL 
(n=5) (Marugo et al. 1989). Receptor levels were also significantly higher in submucosal UL 
(n=9) than in subserosal UL (n=9) in the secretive phase of the menstrual cycle. 
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The choice among various surgical techniques to deal with UL, and the outcome of 
various infertility treatment options, are strongly dependent on the anatomical location of 
UL. Pregnancy and implantation rates were significantly lower in patients with submucosal 
and intramural UL in a study of the effect of the location of UL on the outcome of assisted 
reproductive technology treatment (Eldar-Geva et al. 1998). In decreasing order of 
importance, submucosal, intramural, and subserosal UL, have been found to be associated 
with infertility and pregnancy wastage (Bajekal and Li 2000). A meta-analysis on the 
association of UL with infertility suggests that only submucosal UL are associated with 
adverse reproductive outcomes (Pritts 2001), although other studies suggest adverse effects 
associated with nonsubmucosal UL as well (Rackow and Arici 2005). 
Because the location of UL is important, there is a need to identify risk factors not 
only for the presence of UL in general, but for their specific location, e.g. submucosal versus 
nonsubmucosal, as well. To date only one epidemiological study has investigated risk factors 
associated with the location of UL, although results were limited by the small number of 
women with known location of UL (n = 111) (Faerstein et al. 2001 a). The authors 
categorized UL as “at least one submucosal” (n=40) and “nonsubmucosal only” (n=71), and 
used two separate logistic regression models to compare each case subtype group to the 
group of women without UL (n=394), as additional analyses in the practice-based case-
control study. The two logistic regression models were used to evaluate the association of 
age at first birth and age at first being detected infertile with the location of UL, adjusted for 
age, clinic, marital status, and ethnicity. Parity was found to be negatively associated with the 
presence of submucosal UL (versus no UL), and positively associated with the presence of 
only nonsubmucosal UL (versus no UL). Results for infertility were in the opposite direction. 
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The odds of having submucosal UL (versus no UL) among women first found to be infertile 
before age 25 were 7.2 times higher than the same odds among women never found to be 
infertile, 95% CI: (2.0, 26.0). This was the only statistically significant result found by these 
additional analyses. 
The only statistically significant result was found for the comparison of women first 
found to be infertile before 25 years old with women never found to be infertile  
It should be noted that the main goal of these additional analyses was not to identify 
risk factors for the location of UL, but rather to argue that infertility and consequent lower 
parity represent consequences of UL. An alternative hypothesis is that the association of 
parity with a reduced risk of UL may be due to a protective effect of postpartum involution 
of the uterus, which may clear small UL during the remodeling of the myometrial tissue 
(Baird and Dunson 2003). According to this hypothesis, the greatest protective effect of 
parity would occur for pregnancies during the mid-reproductive years. The Eker rat model 
for UL supports the latter hypothesis of a protective effect of pregnancy (Walker et al. 2001). 
Although there are proven differences between submucosal, intramural, and 
subserosal UL beyond their anatomic location, only one study to date has considered the 
location of UL as the outcome for an additional analysis.  
 
Epidemiology of Stress Urinary Incontinence 
Urinary incontinence is one of the most common types of lower urinary tract 
dysfunction, affecting about a third of adult women in the United States (DuBeau 2001). The 
annual direct cost of urinary incontinence for women in the US is estimated as $12.4 billion 
(in 1995 dollars) (Wilson et al. 2001). 
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The most recent report from the Standardization Sub-committee of the International 
Continence Society (Abrams et al. 2002) proposed uniform definitions of the symptoms, 
signs, urodynamic observations, and conditions associated with lower urinary tract 
dysfunction. The symptom of stress urinary incontinence (SUI), one of the lower urinary 
tract storage symptoms, is defined as the complaint of involuntary leakage on effort or 
exertion, or on sneezing or coughing. The sign of SUI is defined as the observation of 
involuntary leakage from the urethra, synchronous with exertion/effort, or sneezing or 
coughing. Urodynamic stress incontinence is defined as the involuntary leakage of urine 
during increased abdominal pressure, in the absence of a detrusor contraction, and it is noted 
during filling cystometry (the method by which the pressure/volume relationship of the 
bladder is measured during bladder filling) (Abrams et al. 2002). 
The focus of this review will be on SUI symptoms, not on the sign of SUI or 
urodynamic stress incontinence. SUI is one of the three most common subtypes of urinary 
incontinence symptoms; the others are urge urinary incontinence (associated with urgency, 
i.e. the sudden compelling desire to pass urine), and mixed urinary incontinence (associated 
with urgency, exertion, effort, coughing, or sneezing) (Fine et al. 2004).  
According to the literature SUI is the most common type of urinary incontinence in 
women (Miller 2005), occurring at least weekly in at least a third of adult women (Nygaard 
and Heit 2004). Nearly half of women with urinary incontinence suffer from SUI (Hampel et 
al. 1997). About half of all women report symptoms of SUI during pregnancy that in most 
cases disappear after delivery (Nygaard and Heit 2004). In addition to the pressure effect of 
the enlarged uterus and changes in renal, bladder and urethral function, the reproductive 
hormone relaxin may also play a role in SUI during pregnancy (Kristiansson et al. 2001). 
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A recent population-based postal survey of 6,000 women aged between 30 and 90 
years who were enrolled in a health maintenance organization (Group Health Cooperative) 
found that among women with urinary incontinence the prevalence of self-reported SUI (SUI 
in the absence of urge urinary incontinence, occurring at least monthly) decreased with age, 
from 45% for women aged 30 to 39 years old, to 16% for women aged 80 to 90 years old 
(Melville et al. 2005). The results are in agreement with a previous review that concluded 
that the proportion of women with SUI (and without urge urinary incontinence) among 
women with urinary incontinence is highest among younger women (Thom 1998).  
There is a higher prevalence of SUI symptoms among Caucasian women than among 
African-American women. A survey of 2,370 women attending a university gynecologic 
clinic noted that 39% of the Caucasian women reported SUI, compared with only 27% of 
African-American women (Sze et al. 2002). Parous Caucasian women between 30 and 50 
years of age were significantly more likely to have SUI symptoms than African-American 
women of similar age and parity (Sze et al. 2002). 
The estimated increase in the lifetime medical cost of treating a woman with SUI is 
$58,000 (in 2002 US dollars) resulting in total lifetime medical costs that are 1.8 times 
greater than the costs for a demographically similar woman without SUI (Birnbaum et al. 
2003). SUI accounts for 85% of treatment expenditures for urinary incontinence for women 
(Wilson et al. 2001). SUI also has a negative impact on the quality of life; women with SUI 
may be prevented from participating in sports activities, meeting people or shopping. They 
may feel less attractive, be less sexually active, and have low self-esteem and more anxiety 
and depression than other women (Contreras-Ortiz 2004). 
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Epidemiological studies on SUI differ with respect to outcome definitions, study 
populations, study designs, and data collection. Table 1.2 includes epidemiological studies on 
risk factors for SUI that included adjustment for potential confounders. These published 
studies were found through a careful review of the literature. Recognizing their role as 
established risk factors for SUI, the majority of the studies adjusted for age, BMI, and parity.  
Thirty-two papers investigated risk factors for SUI, including 21 cross-sectional 
studies, 6 prospective cohort studies, 3 retrospective cohort studies, 2 case-control studies, 
and one randomized clinical trial. One paper described both a cross-sectional study and a 
retrospective cohort study (Hojberg et al. 1999). Most of the studies were population-based. 
Outcome definitions included self-reported symptoms of SUI during the previous year (8), 
the previous month (4), the prior week (2), 4 years after the first delivery (1), 5 years after 
first delivery (1), and current (i.e. at the time of data collection) (2). Most of the studies 
considered the outcome defined as SUI vs. no SUI, regardless of the presence or absence of 
urge urinary incontinence. The other eleven studies defined the outcome as SUI only (i.e. 
SUI present, urge urinary incontinence absent) vs. no incontinence (i.e. both SUI and urge 
urinary incontinence absent). Participants were women from U.S.A. (8), Denmark (7), 
Norway (5), U.K. (3), France (2), Sweden (2), Italy (1), Taiwan (1), South Korea (1), 
Thailand (1), and China (1).  
Established risk factors for SUI include ethnicity, age, BMI, parity, and mode of 
delivery. Four studies examined the effect of ethnicity. Caucasian ethnicity (vs. African-
American) was associated with SUI during the previous week (Brown et al. 1999), SUI 
occurring weekly or more during the past year (Jackson et al. 2004), SUI some of the time or 
more (Handa et al. 2004), and at least weekly SUI during the last year (Thom et al. 2006). 
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Older age has been associated with current SUI (Peyrat et al. 2002, Goldberg et al. 
2003, Goldberg et al. 2005, Song et al. 2005), SUI during the last month (Rohr et al. 2005), 
SUI during the last week (Schytt et al. 2004), and SUI occurring monthly or more 
(McGrother et al. 2006). As noted before, all studies included age as a potential confounder, 
although they may not necessarily report on the association of age with SUI specifically. 
BMI was positively associated with the presence of SUI during the previous year 
(Mommsen and Foldspang 1994, Hojberg et al. 1999), once a week or more SUI (Nygaard 
1997), SUI during the previous month (Parazzini et al. 2003, Rohr et al. 2005), SUI during 
the previous week (Brown et al. 1999), current SUI (Goldberg et al. 2003, Goldberg et al. 
2005), SUI occurring weekly or more during the past year (Jackson et al. 2004), and SUI 
occurring some of the time or more during last month (Handa et al. 2004). Higher BMI was 
associated with an increased risk of SUI (Kuh et al. 1999), weekly or more SUI (Moller et al. 
2000), and SUI occurring monthly or more (McGrother et al. 2006). Obesity was associated 
with SUI (Hannestad et al. 2003, Song et al. 2005), SUI at least several times a month at 1-
year follow-up (Dallosso et al. 2003), sometimes or more SUI (Teleman et al. 2004), and SUI 
one year after childbirth (Schytt et al. 2004). Obesity was defined as BMI  > 40 (Hannestad 
et al. 2003), BMI > 30 (Dallosso et al. 2003, Teleman et al. 2004, Schytt et al. 2004) or as 
BMI > 75th percentile (Song et al. 2005). Elevated BMI since age 25 has also been associated 
with SUI (Teleman et al. 2004). 
Parity was associated with SUI during the previous year (Foldspang et al. 1992), 
current SUI (Nygaard 1997, Rortveit et al. 2001, Peyrat et al. 2002, Chen et al. 2003, 
Goldberg et al. 2005, Song et al. 2005), SUI during the last month (Rohr et al. 2005, 
Manonai et al. 2005), weekly or more SUI (Moller et al. 2000), SUI some of the time or more 
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(Handa et al. 2004), SUI during the last week (Schytt et al. 2004), and SUI occurring 
monthly or more (McGrother et al. 2006). The effects of parity seem to disappear with older 
age (Rortveit et al. 2001). 
Previous vaginal delivery has been associated with current SUI (Peyrat et al. 2002, 
Song et al. 2005). Having a history of four or more vaginal deliveries was associated with 
SUI during the past year (Han et al. 2005). A history of vaginal only deliveries (vs. Cesarean 
only) was associated with SUI (Rortveit et al. 2003 a). The history of at least one vaginal 
delivery (vs. Cesarean only) has been associated with SUI (Goldberg et al. 2003, Handa et al. 
2004, Goldberg et al. 2005). History of vaginal birth vs. nulliparous was associated with SUI 
during the last year (Hojberg et al. 1999). History of vaginal birth vs. nulliparous and history 
of Cesarean section vs. nulliparous were both associated with SUI during the last month 
(Parazzini et al. 2003). Among primiparous women, Cesarean at first delivery (vs. vaginal 
delivery) has been associated with a reduced risk of SUI 4 years after the first delivery (Fritel 
et al. 2004), and one year after the childbirth (Schytt et al. 2004). Among parous women, a 
history of vaginal delivery vs. Cesarean section was associated with SUI during the last 
month (Manonai et al. 2005). 
Conflicting results have been found regarding associations between SUI and HRT use 
(Parazzini et al. 2003, Teleman et al. 2004, Hendrix et al. 2005), postmenopausal status (Kuh 
et al. 1999, Manonai et al. 2005, Goldberg et al. 2005), alcohol consumption (Teleman et al. 
2004, Song et al. 2005), and occupation (Han et al. 2005, Manonai et al. 2005, Song et al. 
2005). 
Risk factors identified by at most two studies include use of diuretics (Moller et al. 
2000, Rohr et al. 2005), current oral estrogen use (Jackson et al. 2004), higher waist-to-hip 
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ratio (Brown et al. 1999), higher waist circumference (Han et al. 2005), higher level of 
education (Kuh et al. 1999), current cigarette smoking (Hannestad et al. 2003), and low 
impact physical activity (Hannestad et al. 2003). 
Other risk factors for SUI identified by only one study include several types of 
surgery (Mommsen et al. 1993, Moller et al. 2000, Peyrat et al. 2002, Chen et al. 2003, Song 
et al. 2005), delivery-related variables (Hojberg et al. 1999, Parazzini et al. 2003, Rortveit et 
al. 2003 b, Fritel et al. 2004), pregnancy and sports-related incontinence-type variables 
(Nygaard 1997, Viktrup and Lose 2001, Peyrat et al. 2002, Fritel et al. 2004, Schytt et al. 
2004), constipation variables (Schytt et al. 2004, Song et al. 2005, McGrother et al. 2006), 
health status variables (Kuh et al. 1999, McGrother et al. 2006), history of various medical 
conditions (Chen et al. 2003, Jackson et al. 2004, Song et al. 2005, Rohr et al. 2005, 
McGrother et al. 2006), family history of SUI (Hannestad et al. 2004), and diet variables 
(like bread consumption, carbonated drinks consumption, etc.) (Dallosso et al. 2003, 
Hannestad et al. 2003).  
 
Uterine Leiomyomata and Stress Urinary Incontinence 
Uterine enlargement due to the presence of UL, in particular large subserosal UL 
located in the anterior lower part of the uterus, is believed to cause urinary symptoms by 
compressing the urinary bladder, which is located in front of the uterus (Haney 2000). In 
particular, laughing, coughing, or sneezing, may push UL against the bladder and cause 
involuntary loss of urine (i.e. SUI). Several papers have stated that UL may be associated 
with SUI (Stovall 2001, Altman et al. 2003, Nygaard and Heit 2004). There is also a case 
report of a pedunculated UL causing acute SUI (Isherwood et Rane 1999). 
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One cross–sectional study involving 1,293 women scheduled for hysterectomy from 
the Maryland Women’s Health Study evaluated the association of UL (as the primary 
diagnosis for hysterectomy) with self-reported SUI during the previous month (Handa et al. 
2004). Women with UL as a primary diagnosis were as likely to report SUI as women who 
had other primary diagnoses, such as noninfectious conditions, cancer and premalignant 
conditions, adnexal conditions, and infections. It should be noted that the study did not 
compare the prevalence of SUI among women with UL to women without UL, and that the 
study was not population-based. 
The association between UL and urinary incontinence (not SUI) has been investigated 
in only one study to date (Sampselle et al. 2002). This study used baseline data from the 
longitudinal cohort of the Study of Women’s Health Across the Nation, a multiethnic study 
of the natural history of menopausal transition. Participants were 3,302 women aged 42 to 52 
years old, 47% of whom were Caucasian, 28% African-American, and the rest Chinese, 
Hispanic, and Japanese. Women were classified as having UL if they reported that a health 
care provider had ever told them that they had the condition. Among women without a 
history of UL, African-American women were less likely than Caucasian women to report 
urinary incontinence, OR = 0.31, 95% CI: (0.23, 0.40). However, among women with history 
of UL, African-American women were more likely than Caucasian women to report urinary 
incontinence, OR = 1.81, 95% CI: (1.22, 2.71). The authors did not report race-specific odds 
ratios for the association of history of UL with urinary incontinence. Results were adjusted 
for age, menopausal status, BMI, diabetes, and parity. To explain the finding the authors 
speculated that the propensity of African-American women to develop larger UL resulted in 
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an increased prevalence of SUI, and subsequently an increased prevalence of urinary 
incontinence. 
Research on changes in SUI symptoms before and after hysterectomy (or other 
treatments) may provide indirect information about the association between UL and SUI. 
In a small study including 14 patients with large UL treated with monthly injections of 
gonadotropin-releasing hormone analogues, the number of patients with SUI decreased from 
6 to 5. Based on this, the authors concluded that SUI is probably unrelated to uterine size; 
however the small numbers involved prevent any meaningful conclusion regarding the 
association of UL with SUI based on this study (Langer et al. 1990). 
A randomized double blind clinical trial, comparing urinary function outcomes after 
total and subtotal abdominal hysterectomy, found reductions in SUI symptoms in both 
treatment groups, and the reductions were similar in the two groups (Thakar et al. 2002). The 
authors stated that improvements in SUI symptoms were not associated with the presence or 
absence of UL, without providing any data to support their claim, and further concluded that 
improvements could not be attributed to the elimination of the pressure effects of the UL. 
In a prospective observational study designed to compare the effects of different 
hysterectomy techniques (total abdominal, vaginal, laparoscopic, and subtotal) on urinary 
and sexual function, patients reported significantly lower rates of SUI six months after 
surgery than before the operation, regardless of the technique used (El-Toukhy et al. 2004).  
The primary indications for hysterectomy were abnormal uterine bleeding (43%) and UL 
(41%). The prevalence of SUI dropped from 36% before the surgery to 19% 6 months after 
the surgery (p=0.005). It was also stated that the presence of UL before surgery was 
associated with improvement in urinary symptoms after hysterectomy, without specific 
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reference to improvement of SUI symptoms. The authors attributed the improvement in some 
of the urinary symptoms to postoperative urethral obstruction and bladder neck elevation 
associated with hysterectomy. 
A Danish multicenter randomized controlled trial, investigating lower urinary tract 
symptoms after total and subtotal hysterectomy, found a decreased number of patients 
reporting SUI after surgery (Gimbel et al. 2005). In the total hysterectomy group the 
prevalence decreased from 9% to 2% one year later. In the subtotal hysterectomy group the 
decrease was smaller, from 9% to 6% one year later. The reduction of SUI in both groups 
was attributed to the removal of uteri with large UL; the larger reduction in the total 
hysterectomy group was attributed to the minor bladder neck suspension associated with the 
procedure. 
 19  
REFERENCES 
 
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van KP, Victor A, Wein A. 
      The standardisation of terminology of lower urinary tract function: report from the 
      Standardisation Sub-committee of the International Continence Society.  Am J Obstet  
      Gynecol. 2002 Jul;187:116-126. 
 
Altman D, Lopez A, Falconer C, Zetterstrom J. The impact of hysterectomy on lower urinary  
      tract symptoms.  Int Urogynecol J Pelvic Floor Dysfunct. 2003 Dec;14:418-423. 
 
Baird DD, Kesner JS, Dunson DB. Luteinizing hormone in premenopausal women may  
      stimulate uterine leiomyomata development.  J Soc Gynecol Investig. 2006 Feb;13:130- 
      135. 
 
Baird DD. Invited commentary: uterine leiomyomata-we know so little but could learn so  
      much.  Am J Epidemiol. 2004 Jan 15;159:124-126. 
 
Baird DD, Dunson DB. Why is parity protective for uterine fibroids?  Epidemiology. 2003  
      Mar;14:247-250. 
 
Baird DD, Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine  
      leiomyoma development.  Reprod Toxicol. 2005 May-Jun;20:81-84. 
 
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. Association of physical activity  
      with development of uterine leiomyoma.  Am J Epidemiol. 2007 Jan 15;165:157-163. 
 
Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of  
      uterine leiomyoma in black and white women: ultrasound evidence.  Am J Obstet  
      Gynecol. 2003 Jan;188:100-107. 
 
Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage.  Hum Reprod Update. 2000  
      Nov-Dec;6:614-620. 
 
Birnbaum H, Leong S, Kabra A. Lifetime medical costs for women: cardiovascular disease,  
      diabetes, and stress urinary incontinence.  Womens Health Issues. 2003 Nov-Dec;13:204- 
      213. 
 
Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R. A prospective study  
      of hypertension and risk of uterine leiomyomata.  Am J Epidemiol. 2005 Apr 1;161:628- 
      638. 
 
Brett KM, Marsh JV, Madans JH. Epidemiology of hysterectomy in the United States:  
      demographic and reproductive factors in a nationally representative sample.  J Womens  
      Health. 1997;6:309-316. 
 
Brosens I, Deprest J, Dal CP, Van dH: Clinical significance of cytogenetic abnormalities in  
 20  
      uterine myomas.  Fertil Steril. 1998; 69:232-235 
 
Brosens J, Campo R, Gordts S, Brosens I: Submucous and outer myometrium leiomyomas  
      are two distinct clinical entities.  Fertil Steril. 2003 Jun;79:1452-1454 
 
Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and urinary incontinence: a  
      systematic review.  Lancet. 2000 Aug 12;356:535-539. 
 
Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary  
      incontinence and associated risk factors in postmenopausal women. Heart &  
      Estrogen/Progestin Replacement Study (HERS) Research Group.  Obstet Gynecol. 1999;  
      94:66-70. 
 
Chen CR, Buck GM, Courey NG, Perez KM, Wactawski-Wende J. Risk factors for uterine  
      fibroids among women undergoing tubal sterilization.  Am J Epidemiol. 2001 Jan  
      1;153:20-26. 
 
Chen GD, Lin TL, Hu SW, Chen YC, Lin LY. Prevalence and correlation of urinary  
      incontinence and overactive bladder in Taiwanese women.   Neurourol Urodyn.  
      2003;22:109-117. 
 
Chiaffarino F, Parazzini F, La VC, Chatenoud L, Di CE, Marsico S. Diet and uterine  
      myomas.  Obstet Gynecol. 1999; 94:395-398. 
 
Chiaffarino F, Parazzini F, La VC, Marsico S, Surace M, Ricci E. Use of oral contraceptives  
      and uterine fibroids: results from a case-control study.  Br J Obstet Gynaecol.  
      1999;106:857-860. 
 
Contreras OO. Stress urinary incontinence in the gynecological practice.  Int J Gynaecol  
      Obstet. 2004 Jul;86 Suppl 1:S6-16. 
 
Cramer SF, Patel A. The frequency of uterine leiomyomas.  Am J Clin Pathol. 1990;94:435- 
      438. 
 
D'Aloisio AA, Baird DD. Variation in the association of alcohol intake with uterine fibroids  
      by race and tumor size.  Ann Epid. 2004;14:622-622. 
 
Dallosso HM, McGrother CW, Matthews RJ, Donaldson MM. The association of diet and  
      other lifestyle factors with overactive bladder and stress incontinence: a longitudinal  
      study in women.  BJU Int. 2003 Jul;92:69-77. 
 
DuBeau CE. Urinary incontinence management: new questions from old assumptions.  J Am  
      Geriatr Soc. 2001; Jun 49:829-830. 
 
El-Toukhy TA, Hefni M, Davies A, Mahadevan S. The effect of different types of  
      hysterectomy on urinary and sexual functions: a prospective study.  J Obstet Gynaecol.  
      2004 Jun;24:420-425. 
 21  
Eldar-Geva T, Meagher S, Healy DL, MacLachlan V, Breheny S, Wood C. Effect of  
      intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted  
      reproductive technology treatment.  Fertil Steril. 1998; 70:687-691. 
 
Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based  
      case-control study. II. Atherogenic risk factors and potential sources of uterine irritation.  
      Am J Epidemiol. 2001 Jan 1;153:11-19. 
 
Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based  
      case-control study. I. African-American heritage, reproductive history, body size, and  
      smoking.  Am J Epidemiol. 2001 Jan 1;153:1-10. 
 
Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997.  Obstet  
      Gynecol. 2002 Feb; 99:229-234. 
 
Fine PM, Antonini TG, Appell RA. Clinical evaluation of women with lower urinary tract  
      dysfunction.  Clin Obstet Gynecol. 2004; Mar;47:44-52. 
 
Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review.  
      Environ Health Perspect. 2003 Jun;111:1037-1054. 
 
Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors  
      in the United States.  Am J Obstet Gynecol. 2006 Oct;195:955-964. 
 
Foldspang A, Mommsen S, Lam GW, Elving L. Parity as a correlate of adult female urinary  
      incontinence prevalence.  J Epidemiol Community Health. 1992; 46:595-600. 
 
Fritel X, Fauconnier A, Levet C, Benifla JL. Stress urinary incontinence 4 years after the first  
      delivery: a retrospective cohort survey.  Acta Obstet Gynecol Scand. 2004 Oct;83:941- 
      945. 
 
Gimbel H, Zobbe V, Andersen BJ, Sorensen HC, Toftager-Larsen K, Sidenius K, Moller N,  
      Madsen EM, Vejtorp M, Clausen H, Rosgaard A, Villumsen J, Gluud C, Ottesen BS,  
      Tabor A. Lower urinary tract symptoms after total and subtotal hysterectomy: results of a  
      randomized controlled trial.  Int Urogynecol J Pelvic Floor Dysfunct. 2005 Jul- 
      Aug;16:257-262. 
 
Goldberg RP, Abramov Y, Botros S, Miller JJ, Gandhi S, Nickolov A, Sherman W, Sand PK.  
      Delivery mode is a major environmental determinant of stress urinary incontinence:  
      results of the Evanston-Northwestern Twin Sisters Study.  Am J Obstet Gynecol. 2005  
      Dec;193:2149-2153. 
 
Goldberg RP, Kwon C, Gandhi S, Atkuru LV, Sand PK. Urinary incontinence after multiple  
      gestation and delivery: impact on quality of life.  Int Urogynecol J Pelvic Floor Dysfunct.  
      2005 Sep-Oct;16:334-336. 
 
 22  
Goldberg RP, Kwon C, Gandhi S, Atkuru LV, Sorensen M, Sand PK. Urinary incontinence  
      among mothers of multiples: the protective effect of cesarean delivery.  Am J Obstet  
      Gynecol. 2003 Jun;188:1447-1450. 
 
Hampel C, Wienhold D, Benken N, Eggersmann C, Thuroff JW. Definition of overactive  
      bladder and epidemiology of urinary incontinence.  Urology. 1997; 50:4-14discussion. 
 
Hampel C, Wienhold D, Benken N, Eggersmann C, Thuroff JW. Prevalence and natural  
      history of female incontinence.  Eur Urol. 1997; 32 Suppl 2:3-12. 
 
Han MO, Lee NY, Park HS. Abdominal obesity is associated with stress urinary incontinence  
      in Korean women.  Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jan;17:35-39. 
 
Handa VL, Harvey L, Fox HE, Kjerulff KH. Parity and route of delivery: does cesarean  
      delivery reduce bladder symptoms later in life?  Am J Obstet Gynecol. 2004  
      Aug;191:463-469. 
 
Haney AF. Clinical decision making regarding leiomyomata: what we need in the next  
      millenium.  Environ Health Perspect. 2000 Oct;108 Suppl 5:835-839. 
 
Hannestad YS, Lie RT, Rortveit G, Hunskaar S. Familial risk of urinary incontinence in  
      women: population based cross sectional study.  BMJ. 2004 Oct 16;329:889-891. 
 
Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S. Are smoking and other lifestyle factors  
      associated with female urinary incontinence? The Norwegian EPINCONT Study.  BJOG.  
      2003 Mar;110:247-254. 
 
Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A,  
      Naughton MJ, Wallace RB, McNeeley SG. Effects of estrogen with and without  
      progestin on urinary incontinence.  JAMA. 2005 Feb 23;293:935-948. 
 
Hojberg KE, Salvig JD, Winslow NA, Lose G, Secher NJ. Urinary incontinence: prevalence  
      and risk factors at 16 weeks of gestation.  Br J Obstet Gynaecol. 1999;106:842-850. 
 
Isherwood PJ, Rane A. Pedunculated uterine leiomyoma causing acute urinary stress  
      incontinence.  J Obstet Gynaecol. 1999;19:440-441. 
 
Jackson RA, Vittinghoff E, Kanaya AM, Miles TP, Resnick HE, Kritchevsky SB, Simonsick  
      EM, Brown JS. Urinary incontinence in elderly women: findings from the Health, Aging,  
      and Body Composition Study.  Obstet Gynecol. 2004 Aug;104:301-307. 
 
Keshavarz H, Hillis S, Kieke B, and Marchbanks P. Hysterectomy Surveillance --- United  
      States, 1994--1999. 51(SS05); 1-8. 7-12-2002. CDC Surveillance Summaries. 
 
Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas.  
      Racial differences in severity, symptoms and age at diagnosis.  J Reprod Med.  
 23  
      1996;41:483-490. 
 
Kristiansson P, Samuelsson E, von SB, Svardsudd K. Reproductive hormones and stress  
      urinary incontinence in pregnancy.  Acta Obstet Gynecol Scand. 2001 Dec;80:1125-
1130. 
 
Kuh D, Cardozo L, Hardy R. Urinary incontinence in middle aged women: childhood  
      enuresis and other lifetime risk factors in a British prospective cohort.  J Epidemiol  
      Community Health. 1999;53:453-458. 
 
Langer R, Golan A, Neuman M, Schneider D, Bukovsky I, Caspi E. The effect of large  
      uterine fibroids on urinary bladder function and symptoms.  Am J Obstet Gynecol.  
      1990;163:1139-1141. 
 
Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul  
      Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine  
      leiomyomas: a multicentre case--control study.  Br J Obstet Gynaecol. 1996;103:909- 
      914. 
 
Manonai J, Poowapirom A, Kittipiboon S, Patrachai S, Udomsubpayakul U, Chittacharoen  
      A. Female urinary incontinence: a cross-sectional study from a Thai rural area.  Int  
      Urogynecol J Pelvic Floor Dysfunct. 2005 Sep 24;1-5. 
 
Marshall LM, Spiegelman D, Goldman MB, Manson JE, Colditz GA, Barbieri RL, Stampfer  
      MJ, Hunter DJ. A prospective study of reproductive factors and oral contraceptive use in  
      relation to the risk of uterine leiomyomata.  Fertil Steril. 1998;70:432-439. 
 
Marshall LM, Spiegelman D, Manson JE, Goldman MB, Barbieri RL, Stampfer MJ, Willett  
      WC, Hunter DJ. Risk of uterine leiomyomata among premenopausal women in relation to  
      body size and cigarette smoking.  Epidemiology. 1998;9:511-517. 
 
Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett  
      WC, Hunter DJ. Variation in the incidence of uterine leiomyoma among premenopausal  
      women by age and race.  Obstet Gynecol. 1997;90:967-973. 
 
McGrother CW, Donaldson MM, Hayward T, Matthews R, Dallosso HM, Hyde C. Urinary  
      storage symptoms and comorbidities: a prospective population cohort study in middle- 
      aged and older women.  Age Ageing. 2006 Jan;35:16-24. 
 
Melville JL, Katon W, Delaney K, Newton K. Urinary incontinence in US women: a  
      population-based study.  Arch Intern Med. 2005 Mar 14;165:537-542. 
 
Miller KL. Stress urinary incontinence in women: review and update on neurological control.  
      J Womens Health (Larchmt). 2005 Sep;14:595-608. 
 
Moller LA, Lose G, Jorgensen T. The prevalence and bothersomeness of lower urinary tract  
 24  
      symptoms in women 40-60 years of age.  Acta Obstet Gynecol Scand. 2000; Apr;79:298- 
      305. 
 
Mommsen S, Foldspang A. Body mass index and adult female urinary incontinence.  World J  
      Urol. 1994;12:319-322. 
 
Mommsen S, Foldspang A, Elving L, Lam GW. Association between urinary incontinence in  
      women and a previous history of surgery.  Br J Urol. 1993;72:30-37. 
 
Nygaard IE, Heit M. Stress urinary incontinence.  Obstet Gynecol. 2004 Sep;104:607-620. 
 
Nygaard IE. Does prolonged high-impact activity contribute to later urinary incontinence? A  
      retrospective cohort study of female Olympians.  Obstet Gynecol. 1997; 90:718-722. 
 
Parazzini F, Chiaffarino F, Polverino G, Chiantera V, Surace M, La VC. Uterine fibroids risk  
      and history of selected medical conditions linked with female hormones.  Eur J  
      Epidemiol. 2004;19:249-253. 
 
Parazzini F, Chiaffarino F, Lavezzari M, Giambanco V. Risk factors for stress, urge or mixed  
      urinary incontinence in Italy.  BJOG. 2003 Oct;110:927-933. 
 
Parazzini F, Negri E, La VC, Chatenoud L, Ricci E, Guarnerio P. Reproductive factors and  
      risk of uterine fibroids.  Epidemiology. 1996; 7:440-442. 
 
Parazzini F, Negri E, La VC, Rabaiotti M, Luchini L, Villa A, Fedele L. Uterine myomas and  
      smoking. Results from an Italian study.  J Reprod Med. 1996; 41:316-320. 
 
Parazzini F, La VC, Negri E, Cecchetti G, Fedele L. Epidemiologic characteristics of women  
      with uterine fibroids: a case-control study.  Obstet Gynecol. 1988; 72:853-857. 
 
Parazzini F, Negri E, La VC, Fedele L, Rabaiotti M, Luchini L. Oral contraceptive use and  
      risk of uterine fibroids.  Obstet Gynecol. 1992; 79:430-433. 
 
Peyrat L, Haillot O, Bruyere F, Boutin JM, Bertrand P, Lanson Y. Prevalence and risk factors  
      of urinary incontinence in young and middle-aged women.  BJU Int. 2002 Jan;89:61-66. 
 
Pritts EA. Fibroids and infertility: a systematic review of the evidence.  Obstet Gynecol Surv.  
      2001 Aug;56:483-491. 
 
Rackow BW, Arici A. Fibroids and in-vitro fertilization: which comes first?  Curr Opin  
      Obstet Gynecol. 2005 Jun;17:225-231. 
 
Ramcharan, S., Pellegrin, F. A., Ray, R. M., and Hsu, J. P. The Walnut Creek Contraceptive  
      Drug Study. A prospective study of the side effects of oral contraceptives. (3), 69-74. 12- 
      1981.  Center Popul Res Monogr. 
 
 25  
Reed SD, Cushing-Haugen KL, Daling JR, Scholes D, Schwartz SM. Postmenopausal  
      estrogen and progestogen therapy and the risk of uterine leiomyomas.  Menopause. 2004  
      Mar-Apr;11:214-222. 
 
Robboy SJ, Bentley RC, Butnor K, Anderson MC. Pathology and pathophysiology of uterine  
      smooth-muscle tumors.  Environ Health Perspect. 2000 Oct;108 Suppl 5:779-784. 
 
Rohr G, Stovring H, Christensen K, Gaist D, Nybo H, Kragstrup J. Characteristics of middle- 
      aged and elderly women with urinary incontinence.  Scand J Prim Health Care. 2005  
      Dec;23:203-208. 
 
Romieu I., Walker AM, and Jick S. Determinants of uterine fibroids. Post Market Surveil  
      1991 5: 119-133 
 
Rortveit G, Daltveit AK, Hannestad YS, Hunskaar S. Vaginal delivery parameters and  
      urinary incontinence: the Norwegian EPINCONT study.   Am J Obstet Gynecol. 2003  
      Nov;189:1268-1274. 
 
Rortveit G, Daltveit AK, Hannestad YS, Hunskaar S. Urinary incontinence after vaginal  
      delivery or cesarean section.  N Engl J Med. 2003 Mar 6;348:900-907. 
 
Rortveit G, Hannestad YS, Daltveit AK, Hunskaar S. Age- and type-dependent effects of  
      parity on urinary incontinence: the Norwegian EPINCONT study.  Obstet Gynecol. 2001  
      Dec;98:1004-1010. 
 
Rosati P, Bellati U, Exacoustos C, Angelozzi P, Mancuso S. Uterine myoma in pregnancy:  
      ultrasound study.  Int J Gynaecol Obstet. 1989; 28:109-117. 
 
Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine  
      fibroids: reduced risk associated with oral contraceptives.  Br Med J (Clin Res Ed). 1986;  
      293:359-362. 
 
Samadi AR, Lee NC, Flanders WD, Boring JR, Parris EB. Risk factors for self-reported  
      uterine fibroids: a case-control study.  Am J Public Health. 1996; 86:858-862. 
 
Sampselle CM, Harlow SD, Skurnick J, Brubaker L, Bondarenko I. Urinary incontinence  
      predictors and life impact in ethnically diverse perimenopausal women.  Obstet Gynecol.  
      2002 Dec;100:1230-1238. 
 
Sato F, Nishi M, Kudo R, Miyake H. Body fat distribution and uterine leiomyomas.  J  
      Epidemiol. 1998; 8:176-180. 
 
Schwartz SM. Epidemiology of uterine leiomyomata.  Clin Obstet Gynecol. 2001  
      Jun;44:316-326. 
 
Schwartz SM. Invited commentary: Studying the epidemiology of uterine leiomyomata--past,  
 26  
      present, and future.  Am J Epidemiol. 2001 Jan 1;153:27-29. 
 
Schytt E, Lindmark G, Waldenstrom U. Symptoms of stress incontinence 1 year after  
      childbirth: prevalence and predictors in a national Swedish sample.  Acta Obstet Gynecol  
      Scand. 2004 Oct;83:928-936. 
 
Song YF, Zhang WJ, Song J, Xu B. Prevalence and risk factors of urinary incontinence in  
      Fuzhou Chinese women.  Chin Med J (Engl). 2005 Jun 5;118:887-892. 
 
Stewart EA. Uterine fibroids.  Lancet. 2001 Jan 27;357:293-298. 
 
Stovall DW. Clinical symptomatology of uterine leiomyomas.  Clin Obstet Gynecol. 2001  
      Jun;44:364-371. 
 
Sze EH, Jones WP, Ferguson JL, Barker CD, Dolezal JM. Prevalence of urinary incontinence  
      symptoms among black, white, and Hispanic women.  Obstet Gynecol. 2002 Apr;99:572- 
      575. 
 
Teleman PM, Lidfeldt J, Nerbrand C, Samsioe G, Mattiasson A. Overactive bladder:  
      prevalence, risk factors and relation to stress incontinence in middle-aged women.  
      BJOG. 2004 Jun;111:600-604. 
 
Thakar R, Ayers S, Clarkson P, Stanton S, Manyonda I. Outcomes after total versus subtotal  
      abdominal hysterectomy.  N Engl J Med. 2002 Oct 24;347:1318-1325. 
 
Thom DH. Variation in estimates of urinary incontinence prevalence in the community:  
      effects of differences in definition, population characteristics, and study type.  J Am  
      Geriatr Soc. 1998; 46:473-480. 
 
Thom DH, van dK, Ragins AI, Wassel-Fyr C, Vittinghof E, Subak LL, Brown JS.  
      Differences in prevalence of urinary incontinence by race/ethnicity.  J Urol. 2006  
      Jan;175:259-264. 
 
Thom DH, Brown JS. Reproductive and hormonal risk factors for urinary incontinence in  
      later life: a review of the clinical and epidemiologic literature.  J Am Geriatr Soc. 1998;  
      46:1411-1417. 
 
Van Voorhis BJ, Romitti PA, Jones MP. Family history as a risk factor for development of  
      uterine leiomyomas. Results of a pilot study.  J Reprod Med. 2002 Aug;47:663-669. 
 
Velebil P, Wingo PA, Xia Z, Wilcox LS, Peterson HB. Rate of hospitalization for  
      gynecologic disorders among reproductive-age women in the United States.  Obstet  
      Gynecol. 1995;86:764-769. 
 
Viktrup L, Lose G. The risk of stress incontinence 5 years after first delivery.  Am J Obstet  
      Gynecol. 2001 Jul;185:82-87. 
 27  
 
Viktrup L, Lose G. Lower urinary tract symptoms in fertile women after pregnancy and  
      labor.  Ugeskr Laeger. 2001;2001 Sep 17;163:5180-5182. 
 
Walker CL, Stewart EA. Uterine fibroids: the elephant in the room.  Science. 2005 Jun  
      10;308:1589-1592. 
 
Walker CL, Cesen-Cummings K, Houle C, Baird D, Barrett JC, Davis B. Protective effect of  
      pregnancy for development of uterine leiomyoma.  Carcinogenesis. 2001 Dec;22:2049- 
      2052. 
 
Wilson L, Brown JS, Shin GP, Luc KO, Subak LL. Annual direct cost of urinary  
      incontinence.  Obstet Gynecol. 2001 Sep;98:398-406. 
 
Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL,  
      Rosenberg L. Influence of body size and body fat distribution on risk of uterine  
      leiomyomata in U.S. black women.  Epidemiology.  2005 May;16:346-354. 
 
Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self- 
      reported uterine leiomyomata in the Black Women's Health Study.  Obstet Gynecol. 2005  
      Mar;105:563-568. 
 
Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL,  
      Rosenberg L. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine  
      consumption in the Black Women's Health Study.  Hum Reprod. 2004 Aug;19:1746- 
      1754. 
 
Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL,  
      Rosenberg L. Reproductive factors, hormonal contraception, and risk of uterine  
      leiomyomata in African-American women: a prospective study.   Am J Epidemiol. 2004  
      Jan 15;159:113-123. 
 
 28 
T
A
B
L
E
 1
.1
. 
E
p
id
em
io
lo
g
ic
al
 p
ap
er
s 
th
at
 h
av
e 
in
v
es
ti
g
at
ed
 r
is
k
 f
ac
to
rs
 f
o
r 
u
te
ri
n
e 
le
io
m
y
o
m
at
a.
 
 S
tu
d
y
  
(y
ea
r)
 
P
o
p
u
la
ti
o
n
 
D
es
ig
n
 
S
am
p
le
 s
iz
e 
O
u
tc
o
m
e 
D
ef
in
it
io
n
 
R
is
k
 F
ac
to
rs
 E
x
am
in
ed
 
A
d
ju
st
ed
 f
o
r 
R
es
u
lt
s 
T
h
e 
R
o
y
al
 
C
o
ll
eg
e 
o
f 
G
en
er
al
 
P
ra
ct
it
io
n
er
s 
(1
9
7
4
) 
T
h
e 
O
ra
l 
C
o
n
tr
ac
ep
ti
o
n
 
S
tu
d
y
 o
f 
th
e 
R
C
G
P
 
P
ro
sp
ec
ti
v
e 
2
3
,6
1
1
 T
ak
er
s 
2
2
,7
6
6
 c
o
n
tr
o
ls
 
m
at
ch
ed
 b
y
 a
g
e 
an
d
 m
ar
it
al
 
st
at
u
s 
A
t 
le
as
t 
1
5
 
y
ea
rs
 o
ld
 
D
ia
g
n
o
st
ic
 b
as
ed
 o
n
 t
h
e 
re
so
u
rc
es
 o
f 
th
e 
N
at
io
n
al
 H
ea
lt
h
 S
er
v
ic
e 
an
d
 t
h
e 
as
se
ss
m
en
t 
o
f 
th
e 
g
en
er
al
 p
ra
ct
it
io
n
er
 
(I
C
D
 8
 c
o
d
e 
2
1
8
) 
U
se
 o
f 
o
ra
l 
co
n
tr
ac
ep
ti
v
es
 
In
d
ir
ec
t 
st
an
d
ar
d
iz
at
io
n
 
u
si
n
g
 a
g
e,
 p
ar
it
y
, 
so
ci
al
 c
la
ss
, 
an
d
 
ci
g
ar
et
te
 
co
n
su
m
p
ti
o
n
 
R
at
io
 o
f 
st
an
d
ar
d
iz
ed
 r
at
es
: 
T
ak
er
s 
v
s.
 
co
n
tr
o
ls
: 
0
.4
1
 
(p
<
0
.0
1
) 
R
am
ch
ar
an
 
et
 a
l.
 (
1
9
8
1
) 
T
h
e 
W
al
n
u
t 
C
re
ek
 
C
o
n
tr
ac
ep
ti
v
e 
D
ru
g
 S
tu
d
y
 
P
ro
sp
ec
ti
v
e 
1
4
,5
9
1
 w
o
m
en
 
1
8
 t
o
 5
4
 y
ea
rs
 
o
f 
ag
e 
M
ai
n
ly
 
C
au
ca
si
an
 
B
as
ed
 o
n
 h
o
sp
it
al
 
d
is
ch
ar
g
e 
d
ia
g
n
o
se
s 
an
d
 o
p
er
at
iv
e 
p
ro
ce
d
u
re
s 
co
d
ed
 w
it
h
 
IC
D
A
-8
 
(U
L
 I
C
D
A
 2
1
8
) 
U
se
 o
f 
o
ra
l 
co
n
tr
ac
ep
ti
v
es
 
In
d
ir
ec
t 
st
an
d
ar
d
iz
at
io
n
 
u
si
n
g
 a
g
e,
 p
ar
it
y
, 
ed
u
ca
ti
o
n
, 
sm
o
k
in
g
, 
an
d
 e
st
ro
g
en
 u
se
 
R
R
 (
re
la
ti
v
e 
ri
sk
) 
E
v
er
 u
se
rs
 v
s.
 
n
ev
er
 u
se
rs
: 
1
.5
 (
1
.9
-2
.7
) 
R
o
ss
 e
t 
al
. 
(1
9
8
6
) 
U
K
 
C
as
e-
co
n
tr
o
l 
st
u
d
y
 
5
3
5
 c
as
es
 
P
at
h
o
lo
g
ic
al
ly
 
co
n
fi
rm
ed
 
T
er
m
 p
re
g
n
an
ci
es
, 
ag
e 
at
 
fi
rs
t 
te
rm
 p
re
g
n
an
cy
, 
ag
e 
at
 l
as
t 
te
rm
 p
re
g
n
an
cy
, 
m
en
o
p
au
sa
l 
st
at
u
s,
 t
im
e 
M
at
ch
in
g
 b
y
 a
g
e,
 
d
at
e 
o
f 
en
tr
y
 i
n
to
 
th
e 
co
h
o
rt
, 
an
d
 
fa
m
il
y
 p
la
n
n
in
g
 
E
ac
h
 t
er
m
 b
ir
th
: 
0
.8
0
 
5
 y
ea
rs
 i
n
cr
ea
se
 i
n
 
ag
e 
at
 l
as
t 
te
rm
 
 29 
5
3
5
 c
o
n
tr
o
ls
 
O
x
fo
rd
 F
am
il
y
 
P
la
n
n
in
g
 
A
ss
o
ci
at
io
n
 
S
tu
d
y
 
si
n
ce
 l
as
t 
u
se
 o
f 
O
C
, 
d
u
ra
ti
o
n
 o
f 
u
se
 o
f 
O
C
 u
p
 
to
 6
 m
o
n
th
s 
b
ef
o
re
 
d
ia
g
n
o
si
s,
 w
ei
g
h
t,
 B
M
I,
 
n
u
m
b
er
 o
f 
ci
g
ar
et
te
s 
p
er
 
d
ay
 
cl
in
ic
 a
t 
re
cr
u
it
m
en
t 
M
u
tu
al
 a
d
ju
st
m
en
t 
b
ir
th
: 
0
.7
8
 
P
o
st
m
en
o
p
au
sa
l:
 
0
.1
8
 
5
 y
ea
rs
 u
se
 o
f 
O
C
: 
0
.8
3
 
1
0
 k
g
 i
n
cr
ea
se
 i
n
 
w
ei
g
h
t:
 1
.2
1
 
1
0
 c
ig
ar
et
te
s/
d
ay
: 
0
.8
2
 
P
ar
az
zi
n
i 
et
 
al
. 
(1
9
8
8
) 
It
al
y
 
H
o
sp
it
al
-b
as
ed
 
ca
se
-c
o
n
tr
o
l 
2
7
5
 c
as
es
 
7
2
2
 c
o
n
tr
o
ls
 
H
is
to
lo
g
ic
al
ly
 
co
n
fi
rm
ed
 (
af
te
r 
su
rg
er
y
 d
u
e 
to
 r
ec
u
rr
en
t 
m
en
o
rr
h
ag
ia
 o
r 
ec
h
o
g
ra
p
h
ic
 e
v
id
en
ce
 
o
f 
U
L
 >
 1
0
 c
m
) 
A
g
e,
 p
ar
it
y
/a
g
e 
at
 l
as
t 
b
ir
th
, 
ag
e 
at
 m
en
ar
ch
e,
 
m
en
o
p
au
sa
l 
st
at
u
s,
 I
U
D
 
u
se
, 
ed
u
ca
ti
o
n
, 
sm
o
k
in
g
, 
B
M
I 
M
u
tu
al
ly
 a
d
ju
st
ed
 
fo
r 
th
e 
ri
sk
 f
ac
to
rs
 
o
f 
in
te
re
st
 
P
ar
it
y
 3
+
 v
s.
 0
: 
 
0
.5
 (
0
.3
-0
.9
) 
P
o
st
 v
s.
 p
re
: 
 
0
.1
 (
0
.0
5
-0
.2
) 
1
5
+
 c
ig
/d
 v
s.
 
n
ev
er
: 
0
.5
 (
0
.3
-0
.8
) 
R
o
m
ie
u
 e
t 
al
. 
(1
9
9
1
) 
P
o
p
u
la
ti
o
n
-
b
as
ed
 c
as
e-
co
n
tr
o
l 
st
u
d
y
 
3
4
5
 c
as
es
 
7
4
9
 c
o
n
tr
o
ls
 
G
ro
u
p
 H
ea
lt
h
 
C
o
o
p
er
at
iv
e 
P
ri
m
ar
y
 h
o
sp
it
al
 
d
is
ch
ar
g
e 
d
ia
g
n
o
si
s 
af
te
r 
h
y
st
er
ec
to
m
y
 
A
g
e 
at
 m
en
ar
ch
e,
 a
g
e 
at
 
fi
rs
t 
b
ir
th
, 
O
C
 u
se
 a
n
d
 
d
u
ra
ti
o
n
, 
es
tr
o
g
en
 u
se
 
an
d
 d
u
ra
ti
o
n
, 
ci
g
ar
et
te
 
sm
o
k
in
g
, 
m
en
o
p
au
sa
l 
st
at
u
s,
 B
M
I 
A
g
e,
 d
u
ra
ti
o
n
 o
f 
O
C
 u
se
, 
d
u
ra
ti
o
n
 o
f 
es
tr
o
g
en
 u
se
, 
m
en
o
p
au
sa
l 
st
at
u
s,
 
sm
o
k
in
g
 s
ta
tu
s 
[A
g
e-
ad
ju
st
ed
] 
P
ri
o
r 
u
se
 o
f 
re
p
la
ce
m
en
t 
es
tr
o
g
en
: 
1
.9
 (
1
.5
-2
.5
) 
O
n
se
t 
o
f 
m
en
o
p
au
se
: 
0
.0
7
 (
0
.0
4
-0
.1
4
) 
E
v
er
 s
m
o
k
ed
: 
0
.6
5
 (
0
.4
8
-0
.8
8
) 
P
ar
az
zi
n
i 
et
 
al
. 
(1
9
9
2
) 
It
al
y
 
H
o
sp
it
al
-b
as
ed
 
ca
se
-c
o
n
tr
o
l 
3
9
0
 c
as
es
 
1
,1
3
6
 c
o
n
tr
o
ls
 
 
H
is
to
lo
g
ic
al
ly
 
co
n
fi
rm
ed
 (
af
te
r 
su
rg
er
y
 d
u
e 
to
 r
ec
u
rr
en
t 
m
en
o
rr
h
ag
ia
 o
r 
ec
h
o
g
ra
p
h
ic
 e
v
id
en
ce
 
o
f 
U
L
 >
 1
0
 c
m
) 
O
C
 u
se
, 
d
u
ra
ti
o
n
 o
f 
u
se
, 
ti
m
e 
si
n
ce
 l
as
t 
u
se
, 
ti
m
e 
si
n
ce
 f
ir
st
 u
se
  
A
g
e,
 e
d
u
ca
ti
o
n
, 
m
ar
it
al
 s
ta
tu
s,
 
p
ar
it
y
, 
n
r 
o
f 
sp
o
n
ta
n
eo
u
s 
ab
o
rt
io
n
s,
 n
r 
o
f 
in
d
u
ce
d
 a
b
o
rt
io
n
s,
 
N
o
 s
ta
ti
st
ic
al
ly
 
si
g
n
if
ic
an
t 
re
su
lt
s 
E
x
am
p
le
: 
E
v
er
 O
C
 u
se
 v
s.
 
n
ev
er
 
1
.1
 (
0
.8
-1
.5
) 
 30 
m
en
o
p
au
sa
l 
st
at
u
s 
L
u
m
b
ig
an
o
n
 
et
 a
l.
 (
1
9
9
6
) 
T
h
ai
la
n
d
 
H
o
sp
it
al
-b
as
ed
 
ca
se
-c
o
n
tr
o
l 
9
1
0
 c
as
es
 
2
7
0
9
 c
o
n
tr
o
ls
 
P
at
h
o
lo
g
ic
al
ly
 
co
n
fi
rm
ed
  
U
se
 o
f 
d
ep
o
t-
m
ed
ro
x
y
p
ro
g
es
te
ro
n
e 
ac
et
at
e 
(D
M
P
A
),
 
d
u
ra
ti
o
n
 o
f 
u
se
, 
ti
m
e 
si
n
ce
 l
as
t 
d
o
se
, 
o
ra
l 
co
n
tr
ac
ep
ti
v
es
 u
se
, 
IU
C
D
 u
se
, 
tu
b
al
 l
ig
at
io
n
, 
ag
e 
at
 m
en
ar
ch
e,
 a
g
e 
at
 
fi
rs
t 
d
el
iv
er
y
, 
ag
e 
at
 l
as
t 
d
el
iv
er
y
, 
p
ar
it
y
, 
n
u
m
b
er
 
o
f 
ab
o
rt
io
n
s,
 b
re
as
t-
fe
ed
in
g
, 
ag
e 
at
 f
ir
st
 
m
ar
ri
ag
e,
 m
ar
it
al
 s
ta
tu
s,
 
ra
ce
, 
ed
u
ca
ti
o
n
, 
o
cc
u
p
at
io
n
, 
sm
o
k
in
g
, 
B
M
I,
 O
C
 u
se
, 
tu
b
al
 
li
g
at
io
n
, 
fa
m
il
y
 h
is
to
ry
 
o
f 
U
L
 
M
u
tu
al
 a
d
ju
st
m
en
t 
E
v
er
 D
M
P
A
 u
se
 
v
s.
 n
ev
er
: 
 
0
.4
2
 (
0
.3
4
-0
.5
3
) 
D
M
P
A
 >
5
 y
ea
rs
 
v
s.
 n
ev
er
: 
0
.1
1
 (
0
.0
5
-0
.2
3
) 
D
M
P
A
 >
1
0
 y
ea
rs
 
si
n
ce
 l
as
t 
d
o
se
 v
s.
 
n
ev
er
: 
0
.6
6
 (
0
.5
0
-0
.8
6
) 
 E
v
er
 O
C
 u
se
 v
s.
 
n
ev
er
: 
0
.7
6
 (
0
.6
6
-0
.9
2
) 
T
u
b
al
 l
ig
at
io
n
: 
1
.6
7
 (
1
.4
2
-1
.9
7
) 
F
am
il
y
 h
is
to
ry
 o
f 
U
L
: 
3
.4
7
 (
2
.5
5
-4
.7
1
) 
P
ar
it
y
: 
0
.7
7
 (
0
.7
2
-0
.8
2
) 
E
d
u
ca
ti
o
n
 (
y
ea
rs
):
 
1
.0
3
 (
1
.0
2
-1
.0
6
) 
B
M
I 
(k
g
/m
2
):
 
1
.0
6
 (
1
.0
4
-1
.0
8
) 
S
m
o
k
in
g
: 
0
.6
3
 (
0
.4
0
-0
.9
9
) 
A
b
o
rt
io
n
s 
3
+
 v
s.
 
n
o
n
e:
 
1
.9
4
 (
1
.1
8
-3
.1
9
) 
 31 
S
am
ad
i 
et
 
al
. 
(1
9
9
6
) 
C
as
e-
co
n
tr
o
l 
2
0
1
 c
as
es
 
1
,5
0
3
 c
o
n
tr
o
ls
 
A
g
ed
 2
0
 t
o
 5
4
 
y
ea
rs
 o
ld
 
C
an
ce
r 
an
d
 
S
te
ro
id
 
H
o
rm
o
n
e 
S
tu
d
y
 
S
el
f-
re
p
o
rt
 o
f 
a 
p
h
y
si
ci
an
 d
ia
g
n
o
si
s 
o
f 
U
L
 
M
en
o
p
au
sa
l 
st
at
u
s,
 O
C
 
u
se
, 
fr
eq
u
en
cy
 o
f 
P
ap
 
sm
ea
rs
, 
ed
u
ca
ti
o
n
, 
B
M
I,
 
sm
o
k
in
g
 
 A
g
e 
at
 i
n
d
ex
 d
at
e,
 
ra
ce
, 
ag
e 
at
 
m
en
ar
ch
e,
 d
u
ra
ti
o
n
 
o
f 
b
re
as
t-
fe
ed
in
g
 
P
re
m
en
o
p
au
sa
l 
v
s.
 
p
o
st
m
en
o
p
au
sa
l:
 
3
.5
 (
1
.7
-7
.2
) 
O
C
 u
se
 3
+
 m
o
n
th
s 
v
s.
 <
 3
 m
o
n
th
s,
 
am
o
n
g
 t
h
o
se
 w
it
h
 
<
 1
 P
ap
 s
m
ea
r 
p
er
 
5
 y
ea
rs
: 
5
.0
 (
1
.1
-2
4
.0
) 
C
u
rr
en
t 
sm
o
k
er
s 
v
s.
 n
ev
er
 s
m
o
k
er
s 
am
o
n
g
 t
h
o
se
 w
it
h
 
lo
w
 B
M
I:
 
0
.3
 (
0
.2
-0
.5
) 
P
ar
az
zi
n
i 
et
 
al
. 
(1
9
9
5
) 
 
It
al
y
 
H
o
sp
it
al
-b
as
ed
 
ca
se
-c
o
n
tr
o
l 
4
7
6
 c
as
es
 
1
,2
8
3
 c
o
n
tr
o
ls
 
H
is
to
lo
g
ic
al
ly
 
co
n
fi
rm
ed
 a
ft
er
 s
u
rg
er
y
 
d
u
e 
to
 r
ec
u
rr
en
t 
m
en
o
rr
h
ag
ia
 o
r 
ec
h
o
g
ra
p
h
ic
 e
v
id
en
ce
 
o
f 
U
L
 >
 1
0
 c
m
 
S
m
o
k
in
g
 s
ta
tu
s,
 n
u
m
b
er
 
o
f 
ci
g
ar
et
te
s 
sm
o
k
ed
 p
er
 
d
ay
, 
d
u
ra
ti
o
n
 o
f 
sm
o
k
in
g
 
A
g
e,
 e
d
u
ca
ti
o
n
, 
p
ar
it
y
, 
B
M
I,
 a
n
d
 
o
ra
l 
co
n
tr
ac
ep
ti
v
e 
u
se
 
S
m
o
k
in
g
 c
u
rr
en
t 
v
s.
 n
ev
er
: 
0
.5
 (
0
.4
-0
.7
) 
P
ar
az
zi
n
i 
et
 
al
. 
(1
9
9
6
) 
 
It
al
y
 
H
o
sp
it
al
-b
as
ed
 
ca
se
-c
o
n
tr
o
l 
6
2
1
 c
as
es
 
1
,0
5
1
 c
o
n
tr
o
ls
 
A
g
e 
2
1
 t
o
 5
4
 
y
ea
rs
 o
ld
 
H
is
to
lo
g
ic
al
ly
 
co
n
fi
rm
ed
 a
ft
er
 s
u
rg
er
y
 
d
u
e 
to
 r
ec
u
rr
en
t 
m
en
o
rr
h
ag
ia
 o
r 
ec
h
o
g
ra
p
h
ic
 e
v
id
en
ce
 
o
f 
U
L
 >
 1
0
 c
m
 
R
ep
ro
d
u
ct
iv
e 
fa
ct
o
rs
: 
p
ar
it
y
, 
h
is
to
ry
 o
f 
sp
o
n
ta
n
eo
u
s 
ab
o
rt
io
n
s,
 
h
is
to
ry
 o
f 
in
d
u
ce
d
 
ab
o
rt
io
n
s,
 a
g
e 
at
 f
ir
st
 
b
ir
th
, 
ag
e 
at
 l
as
t 
b
ir
th
, 
h
is
to
ry
 o
f 
in
fe
rt
il
it
y
 
A
g
e,
 e
d
u
ca
ti
o
n
, 
m
en
o
p
au
sa
l 
st
at
u
s,
 
B
M
I,
 o
ra
l 
co
n
tr
ac
ep
ti
v
e 
u
se
, 
an
d
 e
ac
h
 
re
p
ro
d
u
ct
iv
e 
fa
ct
o
r 
si
n
g
ly
 
4
+
 v
s.
 n
u
ll
ip
ar
o
u
s:
 
0
.3
 (
0
.2
-0
.5
) 
2
+
 i
n
d
u
ce
d
 
ab
o
rt
io
n
s 
v
s.
 n
o
n
e:
 
0
.6
 (
0
.4
-0
.9
) 
In
fe
rt
il
it
y
 h
is
to
ry
: 
2
.0
 (
1
.1
-3
.7
) 
M
ar
sh
al
 e
t 
al
. 
(1
9
9
7
) 
 
P
re
m
en
o
p
au
sa
l 
n
u
rs
es
 
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 
S
el
f-
re
p
o
rt
ed
 c
o
n
fi
rm
ed
 
b
y
 u
lt
ra
so
u
n
d
 o
r 
h
y
st
er
ec
to
m
y
 
R
ac
e 
A
g
e,
 t
im
e 
p
er
io
d
, 
m
ar
it
al
 s
ta
tu
s,
 B
M
I,
 
ag
e 
at
 f
ir
st
 b
ir
th
, 
y
ea
rs
 s
in
ce
 l
as
t 
R
R
 (
re
la
ti
v
e 
ri
sk
) 
A
fr
ic
an
-A
m
er
ic
an
 
v
s.
 C
au
ca
si
an
 
3
.2
5
 (
2
.7
1
-3
.8
8
) 
 32 
9
4
,0
9
5
 
T
h
e 
N
u
rs
es
’ 
H
ea
lt
h
 S
tu
d
y
 
b
ir
th
, 
h
is
to
ry
 o
f 
in
fe
rt
il
it
y
, 
ag
e 
at
 
fi
rs
t 
O
C
 u
se
, 
cu
rr
en
t 
al
co
h
o
l 
co
n
su
m
p
ti
o
n
 
B
re
tt
 e
t 
al
. 
(1
9
9
7
) 
N
H
A
N
E
S
 I
 
E
p
id
em
io
lo
g
ic
 
F
o
ll
o
w
-u
p
 
S
tu
d
y
  
4
6
6
5
 w
o
m
en
 
2
5
-4
9
 y
ea
rs
 o
ld
 
H
y
st
er
ec
to
m
y
 d
u
e 
to
 
U
L
  
H
o
sp
it
al
 d
is
ch
ar
g
e 
d
ia
g
n
o
si
s 
af
te
r 
h
y
st
er
ec
to
m
y
; 
IC
D
-9
 
co
d
es
 2
1
8
, 
6
5
4
.1
 
 
A
g
e 
at
 b
as
el
in
e,
 
ed
u
ca
ti
o
n
al
 a
tt
ai
n
m
en
t,
 
ra
ce
, 
ag
e 
at
 f
ir
st
 b
ir
th
, 
n
u
m
b
er
 o
f 
p
re
g
n
an
ci
es
, 
n
u
m
b
er
 o
f 
m
is
ca
rr
ia
g
es
 
M
u
tu
al
 a
d
ju
st
m
en
t 
A
fr
ic
an
-A
m
er
ic
an
 
v
s.
 C
au
ca
si
an
: 
1
.9
 (
1
.3
-2
.9
) 
S
at
o
 e
t 
al
. 
(1
9
9
8
) 
C
as
e-
co
n
tr
o
l 
st
u
d
y
 
1
0
0
 c
as
es
 
2
0
0
 c
o
n
tr
o
ls
 
S
ap
p
o
ro
 C
it
y
, 
Ja
p
an
 
P
re
m
en
o
p
au
sa
l 
A
g
ed
 2
9
 t
o
 5
4
 
y
ea
rs
 
P
at
h
o
lo
g
ic
al
ly
 
d
ia
g
n
o
se
d
 c
as
es
, 
co
n
tr
o
ls
 w
er
e 
co
n
fi
rm
ed
 n
o
t 
to
 h
av
e 
U
L
 b
y
 c
li
n
ic
al
 
ex
am
in
at
io
n
 
B
M
I,
 p
er
ce
n
t 
b
o
d
y
 f
at
, 
o
b
es
it
y
 t
y
p
e,
 w
ai
st
-t
o
-h
ip
 
ra
ti
o
 
N
o
 a
d
ju
st
m
en
t 
P
er
ce
n
t 
b
o
d
y
 f
at
 
3
5
+
 v
s.
 <
2
5
: 
3
.2
2
 (
1
.3
4
-7
.7
4
) 
W
ai
st
-t
o
-h
ip
 r
at
io
 
0
.8
5
+
 v
s.
 <
0
.7
5
: 
1
2
.8
0
 (
4
.5
0
-3
6
.3
7
) 
M
ar
sh
al
 e
t 
al
. 
(1
9
9
8
) 
a 
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 
9
4
,0
9
5
 
p
re
m
en
o
p
au
sa
l 
w
o
m
en
 
A
g
ed
 2
5
 t
o
 4
2
 
y
ea
rs
 o
ld
 
T
h
e 
N
u
rs
es
’ 
H
ea
lt
h
 S
tu
d
y
 
S
el
f-
re
p
o
rt
ed
 c
o
n
fi
rm
ed
 
b
y
 u
lt
ra
so
u
n
d
 o
r 
h
y
st
er
ec
to
m
y
 
B
o
d
y
 s
iz
e 
(B
M
I,
 B
M
I 
at
 
ag
e 
1
8
, 
w
ei
g
h
t 
g
ai
n
 s
in
ce
 
ag
e 
1
8
, 
h
ei
g
h
t)
 a
n
d
 
ci
g
ar
et
te
 s
m
o
k
in
g
 
A
g
e,
 r
ac
e,
 m
ar
it
al
 
st
at
u
s,
 a
g
e 
at
 
m
en
ar
ch
e,
 a
g
e 
at
 
fi
rs
t 
b
ir
th
, 
y
ea
rs
 
si
n
ce
 l
as
t 
b
ir
th
, 
h
is
to
ry
 o
f 
in
fe
rt
il
it
y
, 
ag
e 
at
 
fi
rs
t 
O
C
 u
se
 
R
R
 (
re
la
ti
v
e 
ri
sk
) 
C
u
rr
en
t 
B
M
I 
 
3
0
+
 v
s.
 2
0
.0
-2
1
.9
: 
 
1
.2
3
 (
1
.0
9
-1
.3
9
) 
W
ei
g
h
t 
g
ai
n
 s
in
ce
 
ag
e 
1
8
 o
f 
1
5
 k
g
 o
r 
m
o
re
 v
s.
 s
ta
b
le
 
w
ei
g
h
t 
(±
3
.0
 k
g
):
 
1
.4
8
 (
1
.3
1
-1
.6
6
) 
 
 33 
M
ar
sh
al
l 
et
 
al
. 
(1
9
9
8
) 
b
  
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 
9
5
,0
6
1
 
p
re
m
en
o
p
au
sa
l 
w
o
m
en
 
ag
ed
 2
5
 t
o
 4
2
 
y
ea
rs
 o
ld
 
T
h
e 
N
u
rs
es
’ 
H
ea
lt
h
 S
tu
d
y
 
S
el
f-
re
p
o
rt
ed
 c
o
n
fi
rm
ed
 
b
y
 u
lt
ra
so
u
n
d
 o
r 
h
y
st
er
ec
to
m
y
 
R
ep
ro
d
u
ct
iv
e 
fa
ct
o
rs
 
(a
g
e 
at
 m
en
ar
ch
e,
 p
ar
it
y
, 
ag
e 
at
 f
ir
st
 b
ir
th
, 
y
ea
rs
 
si
n
ce
 l
as
t 
b
ir
th
, 
h
is
to
ry
 o
f 
in
fe
rt
il
it
y
) 
an
d
 O
C
 u
se
 
A
g
e,
 r
ac
e,
 m
ar
it
al
 
st
at
u
s,
 B
M
I,
 a
n
d
 
m
u
tu
al
ly
 a
d
ju
st
ed
 
fo
r 
th
e 
ri
sk
 f
ac
to
rs
 
o
f 
in
te
re
st
 
R
R
 (
re
la
ti
v
e 
ri
sk
) 
A
g
e 
at
 m
en
ar
ch
e 
1
6
+
 v
s.
 1
2
: 
0
.6
8
 (
0
.5
3
-0
.8
8
) 
P
ar
o
u
s 
v
s.
 
n
u
ll
ip
ar
o
u
s:
 
0
.6
7
 (
0
.6
1
-0
.7
4
) 
In
fe
rt
il
it
y
: 
1
.2
8
 (
1
.1
7
-1
.4
1
) 
F
ir
st
 u
se
d
 O
C
 
w
h
en
 1
3
-1
6
 y
ea
rs
 
o
ld
 v
s.
 n
ev
er
: 
 
1
.2
6
 (
1
.0
5
-1
.5
1
) 
C
h
ia
ff
ar
in
o
 
et
 a
l.
 (
1
9
9
9
) 
a 
It
al
y
 
C
as
e-
co
n
tr
o
l 
8
4
3
 c
as
es
 
1
5
5
7
 c
o
n
tr
o
ls
 
A
g
ed
 2
1
 t
o
 5
4
 
y
ea
rs
 o
ld
 
H
is
to
lo
g
ic
al
ly
 
co
n
fi
rm
ed
 a
ft
er
 s
u
rg
er
y
 
d
u
e 
to
 r
ec
u
rr
en
t 
m
en
o
rr
h
ag
ia
 o
r 
ec
h
o
g
ra
p
h
ic
 e
v
id
en
ce
 
o
f 
U
L
 >
 1
0
 c
m
  
A
v
er
ag
e 
w
ee
k
ly
 
fr
eq
u
en
cy
 o
f 
co
n
su
m
p
ti
o
n
 o
f:
 m
il
k
, 
b
ee
f 
an
d
 o
th
er
 r
ed
 m
ea
t,
 
li
v
er
, 
ca
rr
o
ts
, 
g
re
en
 
v
eg
et
ab
le
s,
 f
re
sh
 f
ru
it
, 
eg
g
s,
 h
am
, 
fi
sh
, 
ch
ee
se
, 
w
h
o
le
-g
ra
in
 f
o
o
d
s,
 
b
u
tt
er
, 
m
ar
g
ar
in
e,
 o
il
, 
co
ff
ee
, 
te
a;
 t
o
ta
l 
al
co
h
o
l 
in
ta
k
e 
A
g
e,
 e
d
u
ca
ti
o
n
, 
m
ar
it
al
 s
ta
tu
s,
 
m
en
o
p
au
sa
l 
st
at
u
s,
 
p
ar
it
y
, 
B
M
I,
 
sm
o
k
in
g
, 
ca
le
n
d
ar
 
y
ea
r 
at
 i
n
te
rv
ie
w
 
In
ta
k
e 
in
cr
ea
se
 o
f 
o
n
e 
se
rv
in
g
 p
er
 
d
ay
: 
B
ee
f 
an
d
 o
th
er
 r
ed
 
m
ea
t:
 
1
.8
 (
1
.3
-2
.4
) 
H
am
: 
1
.9
 (
1
.3
-2
.9
0
 
G
re
en
 v
eg
et
ab
le
s:
 
0
.6
 (
0
.5
-0
.8
) 
C
h
ia
ff
ar
in
o
 
et
 a
l.
 (
1
9
9
9
) 
b
 
It
al
y
 
C
as
e-
co
n
tr
o
l 
8
4
3
 c
as
es
 
1
5
5
7
 c
o
n
tr
o
ls
 
A
g
ed
 2
1
 t
o
 5
4
 
y
ea
rs
 o
ld
 
H
is
to
lo
g
ic
al
ly
 
co
n
fi
rm
ed
 a
ft
er
 s
u
rg
er
y
 
d
u
e 
to
 r
ec
u
rr
en
t 
m
en
o
rr
h
ag
ia
 o
r 
ec
h
o
g
ra
p
h
ic
 e
v
id
en
ce
 
o
f 
U
L
 >
 1
0
 c
m
 
O
ra
l 
co
n
tr
ac
ep
ti
v
e 
u
se
, 
d
u
ra
ti
o
n
 o
f 
u
se
, 
ti
m
e 
si
n
ce
 l
as
t 
u
se
, 
ti
m
e 
si
n
ce
 
fi
rs
t 
u
se
 
A
g
e,
 c
al
en
d
ar
 y
ea
r 
at
 i
n
te
rv
ie
w
, 
ed
u
ca
ti
o
n
, 
m
ar
it
al
 
st
at
u
s,
 m
en
o
p
au
sa
l 
st
at
u
s,
 p
ar
it
y
, 
B
M
I,
 
m
is
ca
rr
ia
g
es
, 
an
d
 
sm
o
k
in
g
 h
ab
it
s 
C
u
rr
en
t 
O
C
 u
se
rs
 
v
s.
 n
ev
er
 u
se
rs
: 
0
.3
 (
0
.2
-0
.6
) 
E
v
er
 u
se
rs
 f
o
r 
7
 
y
ea
rs
 o
r 
m
o
re
 v
s.
 
n
ev
er
 u
se
rs
: 
0
.5
 (
0
.3
-0
.9
) 
 34 
F
ae
rs
te
in
 e
t 
al
. 
(2
0
0
1
) 
a 
P
re
m
en
o
p
au
sa
l 
w
o
m
en
 
P
ra
ct
ic
e-
b
as
ed
 
ca
se
-c
o
n
tr
o
l 
3
1
8
 c
as
es
 
3
9
4
 c
o
n
tr
o
ls
 
(f
re
q
u
en
cy
 
m
at
ch
ed
) 
S
u
rg
ic
al
ly
 o
r 
so
n
o
g
ra
p
h
ic
al
ly
 
co
n
fi
rm
ed
 
A
g
e,
 m
ar
it
al
 s
ta
tu
s,
 
et
h
n
ic
it
y
, 
ed
u
ca
ti
o
n
, 
fr
eq
u
en
cy
 o
f 
g
y
n
ec
o
lo
g
ic
 
v
is
it
s 
p
er
 y
ea
r,
 f
am
il
y
 
h
is
to
ry
, 
m
en
st
ru
al
 
h
is
to
ry
, 
p
re
g
n
an
cy
 a
n
d
 
in
fe
rt
il
it
y
 h
is
to
ry
, 
B
M
I,
 
o
ra
l 
co
n
tr
ac
ep
ti
v
e 
u
se
, 
sm
o
k
in
g
  
A
d
ju
st
m
en
t 
v
ar
ia
b
le
s 
v
ar
ie
d
 a
n
d
 
in
cl
u
d
ed
 a
g
e,
 
et
h
n
ic
it
y
, 
cl
in
ic
, 
ed
u
ca
ti
o
n
, 
m
ar
it
al
 
st
at
u
s,
 f
am
il
y
 
h
is
to
ry
, 
an
d
 
m
en
st
ru
al
 h
is
to
ry
 
v
ar
ia
b
le
s 
A
fr
ic
an
-A
m
er
ic
an
 
v
s.
 C
au
ca
si
an
: 
9
.4
 (
5
.7
-1
5
.7
) 
A
g
e 
at
 m
en
ar
ch
e 
 
8
-1
0
 v
s.
 1
4
-1
7
: 
2
.4
 (
1
.1
-5
.6
) 
L
es
s 
th
an
 2
5
 y
ea
rs
 
o
ld
 w
h
en
 f
o
u
n
d
 t
o
 
b
e 
in
fe
rt
il
e 
v
s.
 
n
ev
er
 i
n
fe
rt
il
e:
 
2
.4
 (
1
.1
-5
.3
) 
C
u
rr
en
t 
O
C
 u
se
 v
s.
 
n
ev
er
 u
se
: 
0
.2
 (
0
.1
-0
.6
) 
B
M
I 
u
p
p
er
 q
u
ar
ti
le
 
v
s.
 l
o
w
er
 q
u
ar
ti
le
: 
2
.3
 (
1
.4
-3
.8
) 
S
m
o
k
ed
 1
9
+
 y
ea
rs
 
v
s.
 n
ev
er
 s
m
o
k
er
: 
0
.6
 (
0
.4
-1
.1
) 
 
F
ae
rs
te
in
 e
t 
al
. 
(2
0
0
1
) 
b
 
P
re
m
en
o
p
au
sa
l 
w
o
m
en
 
P
ra
ct
ic
e-
b
as
ed
 
ca
se
-c
o
n
tr
o
l 
3
1
8
 c
as
es
 
3
9
4
 c
o
n
tr
o
ls
 
(f
re
q
u
en
cy
 
m
at
ch
ed
) 
S
u
rg
ic
al
ly
 o
r 
so
n
o
g
ra
p
h
ic
al
ly
 
co
n
fi
rm
ed
 
H
y
p
er
te
n
si
o
n
 h
is
to
ry
, 
d
ia
b
et
es
 h
is
to
ry
, 
h
is
to
ry
 
o
f 
p
el
v
ic
 i
n
fl
am
m
at
o
ry
 
d
is
ea
se
, 
h
is
to
ry
 o
f 
se
v
er
al
 s
ex
u
al
ly
 
tr
an
sm
it
te
d
 d
is
ea
se
s,
 
ab
n
o
rm
al
 P
ap
 s
m
ea
r,
 u
se
 
o
f 
in
tr
au
te
ri
n
e 
d
ev
ic
es
, 
u
se
 o
f 
p
er
in
ea
l 
ta
lc
 
A
d
ju
st
m
en
t 
v
ar
ia
b
le
s 
in
cl
u
d
ed
 
ag
e,
 c
li
n
ic
, 
et
h
n
ic
it
y
, 
an
d
 B
M
I 
A
n
ti
h
y
p
er
te
n
si
v
e 
m
ed
ic
at
io
n
 
p
re
sc
ri
b
ed
; 
2
.1
 (
1
.1
-4
.1
) 
A
n
ti
h
y
p
er
te
n
si
v
e 
m
ed
ic
at
io
n
 
p
re
sc
ri
b
ed
 o
f 
5
 
y
ea
rs
 o
r 
m
o
re
: 
3
.1
 (
1
.2
-8
.2
) 
In
tr
au
te
ri
n
e 
d
ev
ic
e 
u
se
 w
h
en
 i
t 
ca
u
se
d
 
 35 
in
fe
ct
io
u
s 
co
m
p
li
ca
ti
o
n
s:
 
5
.3
 (
1
.8
-1
6
.3
) 
U
se
 o
f 
p
er
in
ea
l 
ta
lc
 
D
ai
ly
 v
s.
 n
ev
er
 
u
se
: 
2
.2
 (
1
.4
-3
.1
) 
C
h
en
 e
t 
al
. 
(2
0
0
1
) 
N
es
te
d
 c
as
e-
co
n
tr
o
l 
d
es
ig
n
 
3
1
7
 c
as
es
 
1
,2
6
8
 c
o
n
tr
o
ls
 
M
o
st
ly
 
C
au
ca
si
an
 
W
o
m
en
 
u
n
d
er
g
o
in
g
 
tu
b
al
 
st
er
il
iz
at
io
n
 
L
ap
ar
o
sc
o
p
ic
 e
v
id
en
ce
 
o
r 
se
lf
-r
ep
o
rt
ed
 h
is
to
ry
 
o
f 
U
L
 (
at
 t
h
e 
ti
m
e 
o
f 
tu
b
al
 s
te
ri
li
za
ti
o
n
) 
D
em
o
g
ra
p
h
ic
s 
(a
g
e,
 r
ac
e,
 
ed
u
ca
ti
o
n
, 
n
u
m
b
er
 o
f 
li
v
in
g
 c
h
il
d
re
n
),
 
m
en
st
ru
al
 c
y
cl
e 
ch
ar
ac
te
ri
st
ic
s 
(l
en
g
th
, 
re
g
u
la
ri
ty
, 
fl
o
w
, 
p
ai
n
, 
an
d
 s
p
o
tt
in
g
 b
et
w
ee
n
 
cy
cl
es
),
 r
ep
ro
d
u
ct
iv
e 
ch
ar
ac
te
ri
st
ic
s 
(t
im
e 
si
n
ce
 l
as
t 
d
el
iv
er
y
, 
ty
p
e 
o
f 
co
n
tr
ac
ep
ti
o
n
 u
se
d
) 
an
d
 l
if
es
ty
le
 
ch
ar
ac
te
ri
st
ic
s 
(c
ig
ar
et
te
 
sm
o
k
in
g
, 
B
M
I)
 
M
u
tu
al
 a
d
ju
st
m
en
t 
C
au
ca
si
an
 w
o
m
en
 
A
g
e 
4
0
-4
4
 v
s.
 <
3
0
: 
6
.3
 (
3
.5
-1
1
.6
) 
6
+
 d
ay
s 
m
en
st
ru
al
 
b
le
ed
in
g
 v
s.
 1
-5
: 
1
.4
 (
1
.0
-2
.0
) 
>
3
0
 d
ay
s 
m
en
st
ru
al
 c
y
cl
e 
le
n
g
th
 v
s.
 <
=
3
0
: 
1
.6
 (
1
.1
-3
.3
) 
2
+
 l
iv
in
g
 c
h
il
d
re
n
 
v
s.
 n
o
n
e 
(p
ro
x
y
 f
o
r 
p
ar
it
y
):
 
0
.2
 (
0
.1
-0
.3
) 
5
+
 y
ea
rs
 s
in
ce
 l
as
t 
d
el
iv
er
y
 v
s.
 <
1
 
y
ea
r:
 
1
.9
 (
1
.1
-3
.1
) 
1
+
 p
ac
k
/d
ay
 v
s.
 
n
ev
er
 s
m
o
k
er
: 
1
.6
 (
1
.1
-2
.3
) 
 A
fr
ic
an
-A
m
er
ic
an
 
 36 
w
o
m
en
 
A
g
e 
4
0
-4
4
 v
s.
 <
3
0
: 
2
7
.5
 (
5
.6
-8
3
.6
) 
V
an
 
V
o
o
rh
is
 e
t 
al
. 
(2
0
0
2
) 
H
o
sp
it
al
-b
as
ed
 
ca
se
-c
o
n
tr
o
l 
M
o
st
 C
au
ca
si
an
 
8
1
 c
as
es
 
1
0
3
 c
o
n
tr
o
ls
 
A
g
ed
 5
0
 o
r 
le
ss
 
C
as
es
: 
p
at
h
o
lo
g
ic
al
ly
 
co
n
fi
rm
ed
 
C
o
n
tr
o
ls
: 
p
at
h
o
lo
g
ic
 
ex
am
in
at
io
n
 o
r 
tr
an
sv
ag
in
al
 
u
lt
ra
so
n
o
g
ra
p
h
y
 
F
am
il
y
 h
is
to
ry
 o
f 
U
L
 
P
ar
it
y
 a
n
d
 a
g
e 
M
at
er
n
al
 h
is
to
ry
: 
2
.8
5
 (
1
.2
5
-6
.5
2
) 
P
ar
it
y
: 
0
.7
5
 (
0
.5
7
-0
.9
8
) 
R
ee
d
 e
t 
al
. 
(2
0
0
4
) 
P
er
i-
 a
n
d
 
p
o
st
m
en
o
p
au
sa
l 
C
as
e-
co
n
tr
o
l 
2
5
6
 c
as
es
 
2
7
6
 c
o
n
tr
o
ls
 
A
g
ed
 4
0
 t
o
 5
9
 
y
ea
rs
 o
ld
 
M
o
st
ly
 
C
au
ca
si
an
 
C
o
n
fi
rm
ed
 b
y
 s
u
rg
er
y
 
o
r 
u
lt
ra
so
u
n
d
 
U
se
 o
f 
es
tr
o
g
en
 a
n
d
 
p
ro
g
es
to
g
en
 t
h
er
ap
y
 
(E
P
T
) 
A
g
e 
at
 r
ef
er
en
ce
, 
re
fe
re
n
ce
 y
ea
r,
 
m
en
o
p
au
sa
l 
st
at
u
s,
 
an
d
 r
ac
e 
A
m
o
n
g
 t
h
o
se
 w
it
h
 
B
M
I 
<
 2
4
 k
g
/m
2
  
E
v
er
 E
P
T
 v
s.
 n
ev
er
 
o
r 
<
 3
 m
o
n
th
s:
 
2
.3
 (
1
.2
-4
.3
) 
5
+
 y
ea
rs
 o
f 
u
se
 v
s.
 
n
ev
er
 o
r 
<
 3
 
m
o
n
th
s:
 
4
.0
 (
1
.6
-1
0
.3
) 
W
is
e 
et
 a
l.
 
(2
0
0
4
) 
a 
P
re
m
en
o
p
au
sa
l 
A
fr
ic
an
-
A
m
er
ic
an
 
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 
2
2
,8
9
5
 w
o
m
en
 
B
la
ck
 
W
o
m
en
’s
 
H
ea
lt
h
 S
tu
d
y
 
A
g
e 
2
1
 t
o
 6
9
 
y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 c
o
n
fi
rm
ed
 
b
y
 u
lt
ra
so
u
n
d
 o
r 
h
y
st
er
ec
to
m
y
 
R
ep
ro
d
u
ct
iv
e 
ch
ar
ac
te
ri
st
ic
s 
(a
g
e 
at
 
m
en
ar
ch
e,
 p
ar
it
y
, 
ag
e 
at
 
fi
rs
t 
b
ir
th
, 
y
ea
rs
 s
in
ce
 
la
st
 b
ir
th
, 
d
u
ra
ti
o
n
 o
f 
la
ct
at
io
n
, 
h
is
to
ry
 o
f 
in
fe
rt
il
it
y
, 
n
u
m
b
er
 o
f 
sp
o
n
ta
n
eo
u
s 
ab
o
rt
io
n
s,
 
n
u
m
b
er
 o
f 
in
d
u
ce
d
 
ab
o
rt
io
n
s)
, 
h
o
rm
o
n
al
 
co
n
tr
ac
ep
ti
v
e 
u
se
 
(c
u
rr
en
t 
u
se
, 
y
ea
rs
 o
f 
u
se
, 
y
ea
rs
 s
in
ce
 l
as
t 
O
C
 
A
g
e,
 t
im
e 
p
er
io
d
, 
ag
e 
at
 m
en
ar
ch
e,
 
p
ar
it
y
, 
m
o
n
th
s 
o
f 
la
ct
at
io
n
, 
ag
e 
at
 
fi
rs
t 
b
ir
th
, 
y
ea
rs
 
si
n
ce
 l
as
t 
b
ir
th
, 
B
M
I,
 y
ea
rs
 o
f 
O
C
 
u
se
, 
sm
o
k
in
g
, 
an
d
 
cu
rr
en
t 
al
co
h
o
l 
co
n
su
m
p
ti
o
n
 
IR
R
 (
in
ci
d
en
ce
 
R
R
) 
A
g
e 
at
 m
en
ar
ch
e 
1
5
+
 v
s.
 <
1
1
: 
0
.7
 (
0
.5
-0
.8
) 
P
ar
it
y
: 
0
.7
 (
0
.6
-0
.8
) 
A
g
e 
at
 f
ir
st
 b
ir
th
  
3
0
+
 v
s.
 <
2
0
: 
0
.6
 (
0
.4
-0
.9
) 
Y
ea
rs
 s
in
ce
 l
as
t 
b
ir
th
 
2
0
+
 v
s.
 <
5
: 
 37 
u
se
, 
ag
e 
at
 f
ir
st
 O
C
 u
se
, 
es
tr
o
g
en
ic
 p
o
te
n
cy
, 
p
ro
g
es
ta
ti
o
n
al
 p
o
te
n
cy
, 
cl
as
si
fi
ca
ti
o
n
 o
f 
p
ro
g
es
ti
n
, 
es
tr
o
g
en
 
fo
rm
u
la
ti
o
n
) 
2
.2
 (
1
.4
-3
.2
) 
C
u
rr
en
t 
u
se
 o
f 
O
C
 
P
ro
g
es
ti
n
-o
n
ly
 
in
je
ct
ab
le
s 
v
s.
 
n
o
n
e:
 
0
.6
 (
0
.4
-0
.9
) 
W
is
e 
et
 a
l.
 
(2
0
0
4
) 
b
  
P
re
m
en
o
p
au
sa
l 
A
fr
ic
an
-
A
m
er
ic
an
 
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 
2
1
,8
8
5
 w
o
m
en
 
B
la
ck
 
W
o
m
en
’s
 
H
ea
lt
h
 S
tu
d
y
 
A
g
e 
2
1
 t
o
 6
9
 
y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 c
o
n
fi
rm
ed
 
b
y
 u
lt
ra
so
u
n
d
 o
r 
h
y
st
er
ec
to
m
y
 
V
ar
io
u
s 
m
ea
su
re
s 
o
f 
to
b
ac
co
, 
al
co
h
o
l 
an
d
 
ca
ff
ei
n
e 
co
n
su
m
p
ti
o
n
 
A
g
e,
 t
im
e 
p
er
io
d
, 
ag
e 
at
 m
en
ar
ch
e,
 
p
ar
it
y
, 
ag
e 
at
 f
ir
st
 
b
ir
th
, 
y
ea
rs
 s
in
ce
 
la
st
 b
ir
th
, 
O
C
 u
se
, 
ed
u
ca
ti
o
n
, 
B
M
I,
 
an
d
 m
u
tu
al
ly
 
ad
ju
st
ed
 f
o
r 
sm
o
k
in
g
, 
al
co
h
o
l,
 
an
d
 c
af
fe
in
e 
IR
R
 (
in
ci
d
en
ce
 
R
R
) 
B
ee
r,
 d
ri
n
k
s 
p
er
 
w
ee
k
, 
7
+
 v
s.
 n
o
n
e:
 
1
.5
7
 (
1
.1
7
-2
.1
1
) 
A
m
o
n
g
 w
o
m
en
 
<
3
5
 y
ea
rs
 o
ld
: 
C
o
ff
ee
 3
+
 
cu
p
s/
d
ay
 v
s.
 
al
m
o
st
 n
ev
er
: 
1
.5
3
 (
1
.0
6
-2
.2
2
) 
C
af
fe
in
e 
5
0
0
+
 v
s.
 
<
5
0
 m
g
/d
ay
: 
1
.7
0
 (
1
.2
3
-2
.3
6
) 
 
P
ar
az
zi
n
i 
et
 
al
. 
(2
0
0
4
) 
It
al
y
 
C
as
e-
co
n
tr
o
l 
8
4
3
 c
as
es
 
1
5
5
7
 c
o
n
tr
o
ls
 
ag
e 
2
1
 t
o
 5
4
 
y
ea
rs
 o
ld
 
H
is
to
lo
g
ic
al
ly
 
co
n
fi
rm
ed
 a
ft
er
 s
u
rg
er
y
 
d
u
e 
to
 r
ec
u
rr
en
t 
m
en
o
rr
h
ag
ia
 o
r 
ec
h
o
g
ra
p
h
ic
 e
v
id
en
ce
 
o
f 
U
L
 >
 1
0
 c
m
 
S
el
ec
te
d
 m
ed
ic
al
 
co
n
d
it
io
n
s 
su
ch
 a
s 
d
ia
b
et
es
, 
th
y
ro
id
 d
is
ea
se
, 
se
v
er
e 
o
v
er
w
ei
g
h
t,
 
h
y
p
er
te
n
si
o
n
, 
ch
o
le
li
th
ia
si
s,
 
h
y
p
er
li
p
id
ae
m
ia
, 
o
v
ar
ia
n
 
cy
st
s/
b
en
ig
n
 t
u
m
o
rs
, 
b
en
ig
n
 b
re
as
t 
d
is
ea
se
, 
p
re
v
io
u
s 
b
re
as
t 
b
io
p
si
es
 
A
g
e,
 e
d
u
ca
ti
o
n
, 
p
ar
it
y
, 
ci
g
ar
et
te
 
sm
o
k
in
g
, 
an
d
 
ca
le
n
d
ar
 y
ea
r 
at
 
in
te
rv
ie
w
 
C
li
n
ic
al
 h
is
to
ry
 o
f 
se
v
er
e 
o
v
er
w
ei
g
h
t:
 
0
.6
 (
0
.5
-0
.8
) 
H
is
to
ry
 o
f 
b
re
as
t 
b
io
p
si
es
: 
2
.0
 (
1
.2
-3
.5
) 
 38 
W
is
e 
et
 a
l.
 
(2
0
0
5
) 
P
re
m
en
o
p
au
sa
l 
A
fr
ic
an
-
A
m
er
ic
an
 
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 
2
1
,5
0
6
 w
o
m
en
 
B
la
ck
 
W
o
m
en
’s
 
H
ea
lt
h
 S
tu
d
y
 
A
g
e 
2
1
 t
o
 6
9
 
y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 c
o
n
fi
rm
ed
 
b
y
 u
lt
ra
so
u
n
d
 o
r 
h
y
st
er
ec
to
m
y
 
C
u
rr
en
t 
B
M
I,
 B
M
I 
at
 a
g
e 
1
8
, 
w
ei
g
h
t 
g
ai
n
 s
in
ce
 a
g
e 
1
8
, 
h
ei
g
h
t,
 w
ai
st
, 
h
ip
, 
w
ai
st
-t
o
-h
ip
 r
at
io
 
 
A
g
e,
 t
im
e 
p
er
io
d
, 
ag
e 
at
 m
en
ar
ch
e,
 
p
ar
it
y
, 
ag
e 
at
 f
ir
st
 
b
ir
th
, 
y
ea
rs
 s
in
ce
 
la
st
 b
ir
th
, 
O
C
 u
se
, 
ed
u
ca
ti
o
n
, 
sm
o
k
in
g
, 
cu
rr
en
t 
al
co
h
o
l 
co
n
su
m
p
ti
o
n
, 
g
eo
g
ra
p
h
ic
 r
eg
io
n
 
In
v
er
se
 J
-s
h
ap
ed
 
re
la
ti
o
n
 f
o
r 
B
M
I 
IR
R
 (
in
ci
d
en
ce
 
R
R
) 
A
m
o
n
g
 p
ar
o
u
s 
 
B
M
I 
2
7
.5
-2
9
.9
 v
s.
 
<
2
0
.0
: 
1
.8
1
 (
1
.1
5
-2
.8
6
) 
W
ei
g
h
t 
g
ai
n
 s
in
ce
 
ag
e 
1
8
, 
2
5
+
 v
s.
 <
5
: 
1
.5
4
 (
1
.2
1
-1
.9
8
) 
A
m
o
n
g
 n
u
ll
ip
ar
o
u
s 
B
M
I 
2
2
.5
-2
4
.9
 v
s.
 
<
2
0
.0
: 
1
.4
6
 (
1
.0
4
-2
.0
3
) 
B
o
y
n
to
n
-
Ja
rr
et
t 
et
 a
l.
 
(2
0
0
5
) 
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 
1
0
4
,2
3
3
 
p
re
m
en
o
p
au
sa
l 
w
o
m
en
 
A
g
ed
 2
5
 t
o
 4
2
 
y
ea
rs
 o
ld
 
T
h
e 
N
u
rs
es
’ 
H
ea
lt
h
 S
tu
d
y
  
S
el
f-
re
p
o
rt
ed
 c
o
n
fi
rm
ed
 
b
y
 u
lt
ra
so
u
n
d
 o
r 
h
y
st
er
ec
to
m
y
 
D
ia
st
o
li
c 
b
lo
o
d
 p
re
ss
u
re
, 
y
ea
rs
 s
in
ce
 d
ia
g
n
o
si
s 
o
f 
h
y
p
er
te
n
si
o
n
 
A
g
e,
 c
al
en
d
ar
 t
im
e,
 
B
M
I,
 a
g
e 
at
 
m
en
ar
ch
e,
 a
g
e 
at
 
fi
rs
t 
o
ra
l 
co
n
tr
ac
ep
ti
v
e 
u
se
, 
ti
m
e 
si
n
ce
 l
as
t 
b
ir
th
, 
ag
e 
at
 f
ir
st
 
b
ir
th
, 
m
ar
it
al
 s
ta
tu
s,
 
et
h
n
ic
it
y
, 
m
en
st
ru
al
 
cy
cl
e 
le
n
g
th
 a
n
d
 
re
g
u
la
ri
ty
, 
an
d
 
h
is
to
ry
 o
f 
in
fe
rt
il
it
y
 
R
R
 
N
o
n
u
se
rs
 o
f 
an
ti
h
y
p
er
te
n
si
v
e 
m
ed
ic
at
io
n
s:
  
D
ia
st
o
li
c 
b
lo
o
d
 
p
re
ss
u
re
 i
n
cr
ea
se
 
o
f 
1
0
 m
m
H
g
: 
1
.0
8
 (
1
.0
5
-1
.1
1
) 
U
se
rs
 o
f 
an
ti
h
y
p
er
te
n
si
v
e 
m
ed
ic
at
io
n
s:
  
D
ia
st
o
li
c 
b
lo
o
d
 
p
re
ss
u
re
 i
n
cr
ea
se
 
o
f 
1
0
 m
m
H
g
: 
1
.1
0
 (
1
.0
7
-1
.1
3
) 
 
 39 
B
ai
rd
 a
n
d
 
N
ew
b
o
ld
 
(2
0
0
5
) 
C
ro
ss
-s
ec
ti
o
n
al
 
8
1
9
 A
fr
ic
an
-
A
m
er
ic
an
 
5
0
4
 C
au
ca
si
an
 
A
g
ed
 3
5
 t
o
 4
9
 
y
ea
rs
 o
ld
 
N
IE
H
S
 U
te
ri
n
e 
F
ib
ro
id
 S
tu
d
y
 
U
lt
ra
so
u
n
d
, 
su
rg
ic
al
 
re
co
rd
 r
ev
ie
w
, 
se
lf
-
re
p
o
rt
 o
f 
p
ri
o
r 
d
ia
g
n
o
si
s  
P
re
n
at
al
 d
ie
th
y
ls
ti
lb
es
tr
o
l 
(D
E
S
) 
ex
p
o
su
re
 
A
g
e,
 a
g
e 
at
 
m
en
ar
ch
e,
 B
M
I,
 
ex
er
ci
se
, 
fa
m
il
y
 
h
is
to
ry
 o
f 
U
L
, 
an
d
 
n
u
m
b
er
 o
f 
fu
ll
 t
er
m
 
p
re
g
n
an
ci
es
 
d
el
iv
er
ed
 a
t 
ag
e 
2
5
 
o
r 
o
ld
er
 
C
au
ca
si
an
 w
o
m
en
 
2
.4
 (
1
.1
-5
.4
) 
[A
d
ju
st
ed
 f
o
r 
ag
e]
 
B
ai
rd
 e
t 
al
. 
(2
0
0
6
) 
C
ro
ss
-s
ec
ti
o
n
al
 
5
2
3
 w
o
m
en
 
p
o
st
m
en
o
p
au
sa
l 
 
A
g
ed
 3
5
 t
o
 4
9
 
y
ea
rs
 o
ld
 
N
IE
H
S
 U
te
ri
n
e 
F
ib
ro
id
 S
tu
d
y
 
U
lt
ra
so
u
n
d
, 
su
rg
ic
al
 
re
co
rd
 r
ev
ie
w
, 
se
lf
-
re
p
o
rt
 o
f 
p
ri
o
r 
d
ia
g
n
o
si
s 
L
u
te
in
iz
in
g
 h
o
rm
o
n
e 
le
v
el
s 
A
g
e,
 e
th
n
ic
it
y
, 
ag
e 
at
 m
en
ar
ch
e,
 B
M
I,
 
n
u
m
b
er
 o
f 
fu
ll
-t
er
m
 
p
re
g
n
an
ci
es
 a
ft
er
 
ag
e 
2
4
, 
an
d
 
ex
er
ci
se
 
T
er
ti
le
s 
2
n
d
 v
s.
 1
st
: 
1
.7
 (
1
.0
-2
.7
) 
T
er
ti
le
s 
3
rd
 v
s.
 1
st
: 
2
.0
 (
1
.2
-3
.4
) 
A
g
e 
(5
 y
ea
rs
):
 
1
.7
 (
1
.3
-2
.1
) 
 
 40 
T
A
B
L
E
 1
.2
. 
E
p
id
em
io
lo
g
ic
al
 p
ap
er
s 
th
at
 h
av
e 
in
v
es
ti
g
at
ed
 r
is
k
 f
ac
to
rs
 f
o
r 
st
re
ss
 u
ri
n
ar
y
 i
n
co
n
ti
n
en
ce
 (
S
U
I)
. 
 S
tu
d
y
 
(y
ea
r)
 
P
o
p
u
la
ti
o
n
 
D
es
ig
n
 
S
am
p
le
 s
iz
e 
O
u
tc
o
m
e 
D
ef
in
it
io
n
 
R
is
k
 F
ac
to
rs
 E
x
am
in
ed
 
A
d
ju
st
ed
 f
o
r 
R
es
u
lt
s 
F
o
ld
sp
an
g
 
et
 a
l.
 
(1
9
9
2
) 
C
ro
ss
-s
ec
ti
o
n
al
 
2
,6
3
1
 w
o
m
en
 
A
g
ed
 3
0
-5
9
 y
ea
rs
 o
ld
 
A
ar
h
u
s,
 D
en
m
ar
k
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
d
u
ri
n
g
 
th
e 
la
st
 y
ea
r 
P
ar
it
y
 v
ar
ia
b
le
s 
A
g
e,
 o
cc
u
p
at
io
n
, 
m
en
o
p
au
se
, 
an
d
 
ex
p
o
su
re
 t
o
 
ab
d
o
m
in
al
, 
g
y
n
ec
o
lo
g
ic
al
-
o
b
st
et
ri
c 
o
r 
u
ro
lo
g
ic
al
 s
u
rg
er
y
 
N
u
m
b
er
 o
f 
ch
il
d
b
ir
th
s:
 
1
.2
 (
1
.1
-1
.3
) 
 P
ar
it
y
: 
1
.6
 (
1
.2
-2
.3
) 
T
h
re
e 
o
r 
m
o
re
 
ch
il
d
b
ir
th
s:
 
1
.4
 (
1
.1
-1
.8
) 
M
o
m
m
se
n
 
et
 a
l.
 
(1
9
9
3
) 
C
ro
ss
-s
ec
ti
o
n
al
 s
tu
d
y
 
2
,6
3
1
 w
o
m
en
 
A
g
ed
 3
0
-5
9
 y
ea
rs
 o
ld
 
A
ar
h
u
s,
 D
en
m
ar
k
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
d
u
ri
n
g
 
th
e 
la
st
 y
ea
r 
H
is
to
ry
 o
f 
ab
d
o
m
in
al
, 
g
y
n
ec
o
lo
g
ic
al
 a
n
d
 
u
ro
lo
g
ic
al
 s
u
rg
er
y
 
A
g
e,
 o
cc
u
p
at
io
n
, 
p
ar
it
y
 a
n
d
 
m
en
o
p
au
se
 
A
b
d
o
m
in
al
: 
1
.4
2
 (
1
.0
3
-1
.9
6
) 
 G
y
n
ec
o
lo
g
ic
al
: 
1
.6
9
 (
1
.3
4
-2
.1
5
) 
U
ro
lo
g
ic
al
: 
2
.6
0
 (
1
.4
6
-4
.6
3
) 
M
o
m
m
se
n
 
an
d
 
F
o
ld
sp
an
g
 
(1
9
9
4
) 
C
ro
ss
-s
ec
ti
o
n
al
 
2
,5
8
9
 w
o
m
en
 
A
g
ed
 3
0
-5
9
 y
ea
rs
 o
ld
 
A
ar
h
u
s,
 D
en
m
ar
k
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
d
u
ri
n
g
 
th
e 
la
st
 y
ea
r 
B
M
I 
A
g
e,
 p
ar
it
y
, 
su
rg
ic
al
 o
p
er
at
io
n
s,
 
cy
st
it
is
, 
m
en
o
p
au
se
, 
an
d
 o
cc
u
p
at
io
n
 
P
er
 B
M
I 
u
n
it
: 
1
.0
7
 (
1
.0
4
-1
.1
0
) 
N
y
g
aa
rd
 
(1
9
9
7
) 
R
et
ro
sp
ec
ti
v
e 
co
h
o
rt
 
st
u
d
y
 
1
0
4
 w
o
m
en
 A
m
er
ic
an
 
O
ly
m
p
ia
n
s 
A
g
ed
 3
0
 t
0
 6
3
 y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
 
H
ig
h
-i
m
p
ac
t 
(g
y
m
n
as
ti
cs
 
an
d
 t
ra
ck
 a
n
d
 f
ie
ld
) 
v
s.
 
lo
w
-i
m
p
ac
t 
sp
o
rt
s 
(s
w
im
m
in
g
),
 a
g
e,
 B
M
I,
 
p
ar
it
y
, 
in
co
n
ti
n
en
ce
 
d
u
ri
n
g
 O
ly
m
p
ic
 s
p
o
rt
 
M
u
tu
al
 a
d
ju
st
m
en
t 
In
co
n
ti
n
en
ce
 d
u
ri
n
g
 
O
ly
m
p
ic
 s
p
o
rt
: 
1
1
.5
3
 (
3
.0
4
-4
3
.7
8
) 
 P
ar
it
y
: 
1
.5
3
 (
1
.0
3
-2
.2
8
0
 
 41 
K
u
h
 e
t 
al
. 
(1
9
9
9
) 
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 
1
3
3
3
 w
o
m
en
 a
g
e 
4
8
 
y
ea
rs
 
U
.K
. 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
C
h
il
d
h
o
o
d
 e
n
u
re
si
s 
(w
h
en
 
si
x
 y
ea
rs
 o
ld
),
 n
u
m
b
er
 o
f 
ch
il
d
re
n
, 
ag
e 
at
 f
ir
st
 b
ir
th
, 
ag
e 
at
 l
as
t 
b
ir
th
, 
ty
p
e 
o
f 
d
el
iv
er
y
, 
u
ri
n
ar
y
 o
f 
k
id
n
ey
 
in
fe
ct
io
n
s 
(1
5
 t
o
 4
3
 y
ea
rs
 
o
ld
),
 m
en
o
p
au
sa
l 
st
at
u
s,
 
B
M
I 
at
 a
g
e 
4
3
, 
re
ce
n
t 
sy
m
p
to
m
s,
 m
ed
ic
al
 
co
n
su
lt
at
io
n
s 
d
u
ri
n
g
 l
as
t 
y
ea
r,
 e
d
u
ca
ti
o
n
 
M
u
tu
al
 a
d
ju
st
m
en
t 
A
g
e 
at
 f
ir
st
 b
ir
th
 
3
0
+
 y
ea
rs
 o
ld
 a
n
d
 
v
ag
in
al
 d
el
iv
er
ie
s 
v
s.
 n
o
 b
ir
th
s:
 
3
.1
 (
1
.5
-6
.0
) 
N
at
u
ra
ll
y
 
p
o
st
m
en
o
p
au
sa
l:
 
0
.5
4
 (
0
.3
2
-0
.9
1
) 
B
M
I 
p
er
 5
 u
n
it
s:
 
1
.2
 (
1
.0
-1
.4
) 
R
ec
en
t 
sy
m
p
to
m
s 
(q
u
in
ti
le
s)
: 
1
.1
 (
1
.0
-1
.2
) 
C
o
n
su
lt
at
io
n
s:
 
1
.4
 (
1
.0
-1
.9
) 
E
d
u
ca
ti
o
n
 (
p
er
 
d
eg
re
e 
le
v
el
):
 
1
.3
 (
1
.2
-1
.5
) 
B
ro
w
n
 e
t 
al
. 
(1
9
9
9
) 
C
ro
ss
-s
ec
ti
o
n
al
 
2
7
6
3
 p
o
st
m
en
o
p
au
sa
l 
w
o
m
en
 y
o
u
n
g
er
 t
h
an
 8
0
 
y
ea
rs
 o
ld
, 
m
o
st
ly
 
C
au
ca
si
an
 
B
as
el
in
e 
d
at
a 
fr
o
m
 t
h
e 
H
ea
rt
 a
n
d
 
E
st
ro
g
en
/P
ro
g
es
ti
n
 
R
ep
la
ce
m
en
t 
S
tu
d
y
 
S
el
f-
re
p
o
rt
ed
 
in
co
n
ti
n
en
ce
 
d
u
ri
n
g
 t
h
e 
p
ri
o
r 
w
ee
k
 
 S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
A
g
e,
 e
th
n
ic
it
y
, 
n
u
m
b
er
 o
f 
p
re
g
n
an
ci
es
, 
p
ar
it
y
, 
y
ea
rs
 
si
n
ce
 f
ir
st
 b
ir
th
, 
y
ea
rs
 
si
n
ce
 m
en
o
p
au
se
, 
B
M
I,
 
w
ai
st
/h
ip
 r
at
io
, 
o
v
er
al
l 
h
ea
lt
h
 s
ta
tu
s,
 m
ed
ic
al
 
co
n
d
it
io
n
s,
 m
ed
ic
at
io
n
 
u
se
, 
n
u
m
b
er
 o
f 
u
ri
n
ar
y
 
tr
ac
t 
in
fe
ct
io
n
s 
d
u
ri
n
g
 
p
ri
o
r 
y
ea
r,
 a
lc
o
h
o
l 
co
n
su
m
p
ti
o
n
, 
sm
o
k
in
g
  
  
M
u
tu
al
 a
d
ju
st
m
en
t 
 
C
au
ca
si
an
 v
s.
 A
-A
: 
2
.8
4
 (
1
.6
0
-5
.0
5
) 
B
M
I 
p
er
 5
 u
n
it
s:
 
1
.1
3
 (
1
.0
1
-1
.2
7
) 
W
ai
st
-t
o
-h
ip
 r
at
io
 
p
er
 0
.1
 u
n
it
: 
1
.1
8
 (
1
.0
-1
.3
9
) 
 42 
H
o
jb
er
g
 e
t 
al
. 
(1
9
9
9
) 
H
o
sp
it
al
-b
as
ed
 
C
ro
ss
-s
ec
ti
o
n
al
 s
tu
d
y
 
7
,7
9
5
 w
o
m
en
  
  C
o
h
o
rt
 s
u
b
-s
tu
d
y
 
1
7
8
1
 w
o
m
en
 
 A
g
ed
 1
5
+
 
 D
en
m
ar
k
 
S
el
f-
re
p
o
rt
ed
 
at
 l
ea
st
 o
n
ce
 a
 
w
ee
k
 d
u
ri
n
g
 
th
e 
la
st
 y
ea
r,
 
at
 1
6
 w
ee
k
s 
o
f 
g
es
ta
ti
o
n
 
A
g
e,
 p
ar
it
y
 a
n
d
 m
o
d
e 
o
f 
d
el
iv
er
y
, 
B
M
I,
 s
m
o
k
in
g
, 
p
re
v
io
u
s 
m
is
ca
rr
ia
g
es
, 
p
re
v
io
u
s 
lo
w
er
 a
b
d
o
m
in
al
 
o
r 
u
ro
lo
g
ic
al
 s
u
rg
er
y
 
L
en
g
th
 o
f 
se
co
n
d
 s
ta
g
e,
 
ep
is
io
to
m
y
, 
sp
o
n
ta
n
eo
u
s 
p
er
in
ea
l 
la
ce
ra
ti
o
n
 >
 3
 c
m
, 
v
ac
u
u
m
 e
x
tr
ac
ti
o
n
, 
o
u
tl
et
 
fo
rc
ep
s,
 v
ag
in
al
 
la
ce
ra
ti
o
n
, 
th
ir
d
 d
eg
re
e 
an
al
 s
p
h
in
ct
er
 t
ea
r,
 w
ei
g
h
t 
o
f 
in
fa
n
t 
>
 4
,0
0
0
g
r,
 t
im
e 
si
n
ce
 l
as
t 
d
el
iv
er
y
, 
o
x
y
to
ci
n
 s
ti
m
u
la
ti
o
n
, 
p
u
d
en
d
al
 b
lo
ck
 
M
u
tu
al
 a
d
ju
st
m
en
t 
    A
g
e,
 B
M
I,
 
sm
o
k
in
g
, 
an
d
 
m
u
tu
al
 a
d
ju
st
m
en
t 
P
ri
m
ip
ar
o
u
s 
w
h
o
 
d
el
iv
er
ed
 v
ag
in
al
ly
 
v
s.
 n
u
ll
ip
ar
o
u
s:
 
5
.7
 (
3
.9
-8
.3
) 
B
M
I 
>
 3
5
 v
s.
 2
0
-3
0
: 
2
.5
 (
1
.0
-6
.0
0
) 
 E
p
is
io
to
m
y
 a
n
d
 
b
ir
th
w
ei
g
h
t 
>
 
4
,0
0
0
g
r:
 
3
.5
 (
1
.2
-1
0
.2
) 
M
o
ll
er
 e
t 
al
. 
(2
0
0
0
) 
P
o
p
u
la
ti
o
n
-b
as
ed
  
C
as
e-
co
n
tr
o
l 
st
u
d
y
 
4
8
7
 c
as
es
 
5
6
4
 c
o
n
tr
o
ls
 
4
0
-6
0
 y
ea
rs
 o
ld
 
D
en
m
ar
k
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
w
ee
k
ly
 
o
r 
m
o
re
 b
y
 
q
u
es
ti
o
n
n
ai
re
 
A
g
e,
 B
M
I,
 p
ar
it
y
, 
ep
is
io
to
m
y
, 
an
al
 s
p
h
in
ct
er
 
d
ef
ec
t,
 f
et
al
 w
ei
g
h
t,
 p
ri
o
r 
h
y
st
er
ec
to
m
y
, 
p
ri
o
r 
an
te
ri
o
r 
v
ag
in
al
 r
ep
ai
r,
 
p
ri
o
r 
o
p
er
at
io
n
 f
o
r 
u
te
ri
n
e 
p
ro
la
p
se
, 
h
o
rm
o
n
al
 s
ta
tu
s,
 
u
se
 o
f 
d
iu
re
ti
cs
, 
p
h
y
si
ca
l 
ac
ti
v
it
y
, 
an
d
 m
ed
ic
at
io
n
 
M
u
tu
al
 a
d
ju
st
m
en
t 
P
ar
it
y
 4
+
 v
s.
 0
: 
7
.8
 (
3
.3
-1
8
.4
) 
D
iu
re
ti
cs
: 
2
.2
 (
1
.2
-3
.9
) 
B
M
I 
h
ig
h
es
t 
q
u
ar
ti
le
 
v
s.
 l
o
w
es
t:
 
4
.2
 (
2
.7
-6
.7
) 
H
y
st
er
ec
to
m
y
: 
2
.4
 (
1
.6
-3
.7
) 
V
ik
tr
u
p
 
an
d
 L
o
se
 
(2
0
0
1
) 
L
o
n
g
it
u
d
in
al
 c
o
h
o
rt
 
st
u
d
y
 
2
7
8
 w
o
m
en
 f
o
ll
o
w
ed
 f
o
r 
5
 y
ea
rs
 a
ft
er
 f
ir
st
 
d
el
iv
er
y
 
A
g
ed
 1
7
 t
o
 4
1
 y
ea
rs
 o
ld
  
S
el
f-
re
p
o
rt
ed
 
S
U
I 
O
n
se
t 
an
d
 t
im
in
g
 o
f 
S
U
I,
 
g
es
ta
ti
o
n
al
 a
g
e,
 l
en
g
th
 o
f 
th
e 
st
ag
es
 o
f 
la
b
o
r,
 b
ir
th
 
w
ei
g
h
t,
 h
ea
d
 
ci
rc
u
m
fe
re
n
ce
, 
v
ac
u
u
m
 
ex
tr
ac
ti
o
n
, 
ep
is
io
to
m
y
 
M
u
tu
al
 a
d
ju
st
m
en
t 
O
n
se
t 
o
f 
S
U
I 
d
u
ri
n
g
 
th
e 
fi
rs
t 
p
re
g
n
an
cy
 
v
s.
 n
o
 S
U
I 
d
u
ri
n
g
 
th
e 
fi
rs
t 
p
re
g
n
an
cy
 
o
r 
th
e 
3
 m
o
n
th
s 
p
u
er
p
er
iu
m
: 
 43 
D
en
m
ar
k
 
3
.8
 (
1
.9
-7
.5
) 
O
n
se
t 
o
f 
S
U
I 
d
u
ri
n
g
 
th
e 
fi
rs
t 
p
u
er
p
er
iu
m
 
v
s.
 n
o
 S
U
I 
d
u
ri
n
g
 
th
e 
fi
rs
t 
p
re
g
n
an
cy
 
o
r 
th
e 
3
 m
o
n
th
s 
p
u
er
p
er
iu
m
: 
4
.5
 (
1
.5
-1
3
.2
) 
R
o
rt
v
ei
t 
et
 
al
. 
(2
0
0
1
) 
C
ro
ss
-s
ec
ti
o
n
al
 s
tu
d
y
 
2
7
,9
0
0
 w
o
m
en
 
2
0
 y
ea
rs
 o
ld
 o
r 
o
ld
er
 
E
P
IN
C
O
N
T
 
N
o
rw
ay
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
b
y
 
q
u
es
ti
o
n
n
ai
re
 
 S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
P
ar
it
y
 
S
tr
at
if
ic
at
io
n
 b
y
 a
g
e 
A
g
e 
g
ro
u
p
 2
0
-3
4
 
y
ea
rs
 o
ld
: 
P
ri
m
ip
ar
o
u
s:
 
2
.7
 (
2
.0
-3
.5
) 
G
ra
n
d
 m
u
lt
ip
ar
o
u
s 
(4
+
):
 
4
.0
 (
2
.5
-6
.4
) 
E
ff
ec
ts
 o
f 
p
ar
it
y
 
se
em
 t
o
 d
is
ap
p
ea
r 
w
it
h
 o
ld
er
 a
g
e 
P
ey
ra
t 
et
 
al
. 
(2
0
0
2
) 
C
ro
ss
-s
ec
ti
o
n
al
 s
tu
d
y
 
F
re
n
ch
 a
ca
d
em
ic
 
h
o
sp
it
al
 
1
7
0
0
 w
o
m
en
 
A
g
ed
 2
0
 t
o
 6
2
 y
ea
rs
 o
ld
 
(d
u
ri
n
g
 1
9
9
8
) 
S
el
f-
re
p
o
rt
ed
 
cu
rr
en
t 
S
U
I 
b
y
 
q
u
es
ti
o
n
n
ai
re
 
 S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
A
g
e,
 o
b
es
it
y
, 
p
re
g
n
an
cy
, 
p
re
v
io
u
s 
ce
sa
re
an
 
d
el
iv
er
y
, 
p
re
v
io
u
s 
v
ag
in
al
 
d
el
iv
er
y
, 
p
o
st
p
ar
tu
m
 
in
co
n
ti
n
en
ce
, 
h
y
st
er
ec
to
m
y
 
N
o
 a
d
ju
st
m
en
t 
A
g
e 
4
0
+
 
2
.1
8
 (
1
.6
6
-2
.8
7
) 
P
re
g
n
an
cy
 
2
.3
6
 (
1
.5
5
-3
.5
8
) 
P
re
v
io
u
s 
v
ag
in
al
 
d
el
iv
er
y
 
2
.4
7
 (
1
.7
0
-3
.5
9
) 
 P
o
st
p
ar
tu
m
 
in
co
n
ti
n
en
ce
 
2
.7
8
 (
2
.1
4
-3
.6
1
) 
H
y
st
er
ec
to
m
y
 
2
.8
3
 (
1
.9
3
-4
.1
5
) 
 44 
R
o
rt
v
ei
t 
et
 
al
. 
(2
0
0
3
) 
a   
C
o
m
m
u
n
it
y
-b
as
ed
 
co
h
o
rt
 
E
P
IN
C
O
N
T
 s
tu
d
y
 
1
5
,3
0
7
 w
o
m
en
 
2
0
 t
o
 6
4
 y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 
S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
M
o
d
e 
o
f 
d
el
iv
er
y
 
A
g
e,
 p
ar
it
y
, 
y
ea
rs
 
si
n
ce
 l
as
t 
d
el
iv
er
y
, 
an
d
 B
M
I 
V
ag
in
al
 o
n
ly
 v
s.
 
C
es
ar
ea
n
 o
n
ly
: 
2
.4
 (
1
.7
-3
.2
) 
R
o
rt
v
ei
t 
et
 
al
. 
(2
0
0
3
) 
b
 
C
o
m
m
u
n
it
y
-b
as
ed
 
co
h
o
rt
 
E
P
IN
C
O
N
T
 s
tu
d
y
 
1
1
,3
9
7
 w
o
m
en
 
2
0
 t
o
 6
4
 y
ea
rs
 o
ld
 
V
ag
in
al
 d
el
iv
er
ie
s 
o
n
ly
 
S
el
f-
re
p
o
rt
ed
 
 S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
N
in
e 
d
el
iv
er
y
 v
ar
ia
b
le
s:
 
h
ig
h
 b
ir
th
 w
ei
g
h
t 
(4
0
0
0
g
 
o
r 
m
o
re
),
 g
es
ta
ti
o
n
al
 a
g
e 
o
f 
4
0
 w
ee
k
s 
o
r 
m
o
re
, 
h
ea
d
 
ci
rc
u
m
fe
re
n
ce
 o
f 
3
8
 c
m
 o
r 
m
o
re
, 
b
re
ec
h
 d
el
iv
er
y
, 
in
ju
ri
es
 i
n
 d
el
iv
er
y
 
ch
an
n
el
, 
fu
n
ct
io
n
al
 
d
el
iv
er
y
 d
is
o
rd
er
s,
 f
o
rc
ep
s 
d
el
iv
er
y
, 
v
ac
u
u
m
 d
el
iv
er
y
, 
ep
id
u
ra
l 
A
g
e,
 B
M
I,
 p
ar
it
y
, 
an
d
 y
ea
rs
 s
in
ce
 l
as
t 
d
el
iv
er
y
, 
an
d
 t
h
e 
re
m
ai
n
in
g
 d
el
iv
er
y
 
v
ar
ia
b
le
s 
H
ig
h
 b
ir
th
 w
ei
g
h
t:
 
1
.2
 (
1
.1
-1
.3
) 
E
p
id
u
ra
l 
an
es
th
es
ia
: 
1
.2
 (
1
.0
-1
.5
) 
 
P
ar
az
zi
n
i 
et
 a
l.
 
(2
0
0
3
) 
C
as
e-
co
n
tr
o
l 
st
u
d
y
 
It
al
y
 
1
0
6
2
 c
as
es
 
1
1
4
3
 c
o
n
tr
o
ls
 
4
0
 t
o
 8
8
 y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
d
u
ri
n
g
 
la
st
 m
o
n
th
 b
y
 
q
u
es
ti
o
n
n
ai
re
 
 S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
A
g
e,
 e
d
u
ca
ti
o
n
, 
B
M
I,
 
sm
o
k
in
g
, 
al
co
h
o
l 
d
ri
n
k
in
g
 
h
ab
it
s,
 m
o
d
e 
o
f 
d
el
iv
er
y
, 
m
en
o
p
au
sa
l 
st
at
u
s,
 a
g
e 
at
 
m
en
o
p
au
se
, 
H
R
T
 u
se
, 
h
y
st
er
ec
to
m
y
, 
ab
d
o
m
in
al
 
su
rg
er
y
, 
re
cu
rr
en
t 
u
ri
n
ar
y
 
in
fe
ct
io
n
s,
 d
ia
b
et
es
, 
p
er
in
ea
l 
tr
au
m
as
, 
ch
ro
n
ic
 
o
b
st
ru
ct
iv
e 
p
u
lm
o
n
ar
y
 
d
is
ea
se
, 
n
eu
ro
lo
g
ic
al
 
d
is
ea
se
s 
A
g
e,
 e
d
u
ca
ti
o
n
, 
B
M
I,
 o
b
st
et
ri
c 
h
is
to
ry
, 
H
R
T
 u
se
 
[A
g
e-
ad
ju
st
ed
] 
H
ig
h
 B
M
I;
 
1
.8
 (
1
.3
-2
.5
) 
1
-2
 v
ag
in
al
 b
ir
th
s 
v
s.
 n
u
ll
ip
ar
o
u
s:
 
5
.4
 (
1
.9
-1
5
.0
) 
C
ae
sa
re
an
 s
ec
ti
o
n
 
v
s.
 n
o
 b
ir
th
: 
3
.3
 (
1
.1
-1
0
.1
) 
E
v
er
 H
R
T
 u
se
: 
0
.6
 (
0
.4
-0
.9
) 
P
er
in
ea
l 
tr
au
m
as
: 
1
.9
 (
1
.2
-2
.9
) 
  
 45 
G
o
ld
b
er
g
 
et
 a
l.
 
(2
0
0
3
) 
C
ro
ss
-s
ec
ti
o
n
al
 
T
h
e 
E
v
an
st
o
n
-
N
o
rt
h
w
es
te
rn
 M
o
th
er
s 
o
f 
M
u
lt
ip
le
s 
S
u
rv
ey
 
7
3
3
 m
o
th
er
s 
o
f 
m
u
lt
ip
le
s 
M
o
st
ly
 C
au
ca
si
an
 
2
2
 t
o
 7
5
 y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
M
o
d
e 
o
f 
d
el
iv
er
y
 
A
g
e,
 B
M
I,
 p
ar
it
y
 
C
es
ar
ea
n
 o
n
ly
 v
s.
 a
t 
le
as
t 
o
n
e 
v
ag
in
al
 
d
el
iv
er
y
: 
0
.5
2
 (
0
.3
5
-0
.7
8
) 
 
C
h
en
 e
t 
al
. 
(2
0
0
3
) 
C
o
m
m
u
n
it
y
-b
as
ed
 
C
ro
ss
-s
ec
ti
o
n
al
 s
tu
d
y
 
1
,2
5
3
 w
o
m
en
 
A
g
ed
 2
0
 y
ea
rs
 a
n
d
 o
ld
er
 
T
ai
w
an
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
w
it
h
 
B
ri
st
o
l 
F
em
al
e 
U
ri
n
ar
y
 T
ra
ct
 
S
y
m
p
to
m
s 
Q
u
es
ti
o
n
n
ai
re
 
 S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
A
g
e,
 m
en
o
p
au
sa
l 
st
at
u
s,
 
o
cc
u
p
at
io
n
 w
it
h
 h
ea
v
y
 
li
ft
in
g
, 
ch
il
d
b
ir
th
, 
v
ag
in
al
 
d
el
iv
er
y
, 
B
M
I,
 p
re
v
io
u
s 
g
y
n
ec
o
lo
g
ic
al
 s
u
rg
er
y
, 
an
d
 s
ev
er
al
 m
ed
ic
al
 
co
n
d
it
io
n
s 
M
u
tu
al
 a
d
ju
st
m
en
t 
P
ar
it
y
 3
+
 v
s.
 <
2
: 
2
.0
3
 (
1
.0
9
-3
.7
7
) 
P
re
se
n
ce
 o
f 
u
te
ro
v
ag
in
al
 
p
ro
la
p
se
: 
3
2
.9
5
 (
1
2
.4
6
-8
7
.1
4
) 
P
re
v
io
u
s 
g
y
n
ec
o
lo
g
ic
al
 
su
rg
er
y
: 
2
.0
3
 (
1
.1
3
-3
.6
6
) 
D
ia
b
et
es
 m
el
li
tu
s 
h
is
to
ry
: 
3
.3
2
 (
1
.4
6
-7
.5
8
) 
D
al
lo
ss
o
 
et
 a
l.
 
(2
0
0
3
) 
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 s
tu
d
y
 
L
ei
ce
st
er
sh
ir
e 
M
R
C
 
In
co
n
ti
n
en
ce
 S
tu
d
y
, 
U
K
 
6
4
2
4
 w
o
m
en
 
A
g
ed
 4
0
 y
ea
rs
 a
n
d
 o
ld
er
 
 
S
el
f-
re
p
o
rt
ed
 
S
U
I,
 a
t 
le
as
t 
se
v
er
al
 t
im
es
 
a 
m
o
n
th
, 
at
 1
 
y
ea
r 
fo
ll
o
w
-
u
p
 
A
g
e,
 B
M
I,
 p
h
y
si
ca
l 
ac
ti
v
it
y
, 
sm
o
k
in
g
, 
fo
o
d
 
g
ro
u
p
s 
an
d
 d
ri
n
k
s 
 
M
u
tu
al
 a
d
ju
st
m
en
t 
O
b
es
e 
v
s.
 
ac
ce
p
ta
b
le
 w
ei
g
h
t:
 
1
.7
4
 (
1
.2
2
-2
.4
8
) 
C
ar
b
o
n
at
ed
 d
ri
n
k
s 
d
ai
ly
 o
r 
m
o
re
 v
s.
 
le
ss
 t
h
an
 w
ee
k
ly
: 
1
.6
2
 (
1
.1
8
-2
.2
2
) 
M
o
re
 t
h
an
 d
ai
ly
 
b
re
ad
 c
o
n
su
m
p
ti
o
n
: 
0
.7
6
 (
0
.6
1
-0
.9
6
) 
 46 
H
an
n
es
ta
d
 
et
 a
l.
 
(2
0
0
3
) 
P
o
p
u
la
ti
o
n
-b
as
ed
 c
ro
ss
-
se
ct
io
n
al
 s
tu
d
y
 
2
7
,9
3
6
 w
o
m
en
 
A
g
e 
2
0
 a
n
d
 o
ld
er
 
E
P
IN
C
O
N
T
 s
tu
d
y
 
N
o
rw
ay
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
b
y
 
q
u
es
ti
o
n
n
ai
re
 
 S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
S
m
o
k
in
g
, 
st
at
u
s,
 n
u
m
b
er
 
o
f 
ci
g
ar
et
te
s 
p
er
 d
ay
, 
p
ac
k
 
y
ea
rs
, 
B
M
I,
 l
o
w
 i
m
p
ac
t 
p
h
y
si
ca
l 
ac
ti
v
it
y
/w
ee
k
, 
h
ig
h
 i
m
p
ac
t 
p
h
y
si
ca
l 
ac
ti
v
it
y
/w
ee
k
, 
cu
p
s 
o
f 
te
a/
d
ay
, 
cu
p
s 
o
f 
co
ff
ee
/d
ay
, 
n
u
m
b
er
 o
f 
g
la
ss
es
 o
f 
al
co
h
o
li
c 
b
ev
er
ag
es
/t
w
o
 w
ee
k
s 
A
d
ju
st
m
en
t 
fo
r 
ag
e,
 
co
u
g
h
in
g
, 
w
h
ee
zi
n
g
/d
y
sp
n
o
ea
, 
an
d
 m
u
tu
al
 
ad
ju
st
m
en
t 
fo
r 
th
e 
v
ar
ia
b
le
s 
o
f 
in
te
re
st
 
B
M
I 
4
0
+
 v
s.
 <
2
5
: 
2
.4
 (
1
.7
-3
.3
) 
C
u
rr
en
t 
<
2
0
 c
ig
/d
ay
 
v
s.
 n
ev
er
: 
0
.8
 (
0
.7
-0
.9
) 
L
o
w
 i
m
p
ac
t 
P
A
 3
+
 
v
s.
 <
1
 h
rs
/w
ee
k
: 
0
.8
 (
0
.7
-0
.9
) 
C
u
p
s 
o
f 
te
a 
3
+
 v
s.
 0
 
p
er
 d
ay
: 
1
.3
 (
1
.1
-1
.5
) 
C
u
p
s 
o
f 
co
ff
ee
 3
+
 
v
s.
 0
 p
er
 d
ay
: 
1
.2
 (
1
.1
-1
.5
) 
1
.3
  
F
ri
te
l 
et
 a
l.
 
(2
0
0
4
) 
R
et
ro
sp
ec
ti
v
e 
co
h
o
rt
 
su
rv
ey
 
3
0
7
 w
o
m
en
 
F
re
n
ch
 u
n
iv
er
si
ty
 
h
o
sp
it
al
 
P
ri
m
ip
ar
o
u
s 
w
o
m
en
 
S
el
f-
re
p
o
rt
ed
 
st
re
ss
 u
ri
n
ar
y
 
in
co
n
ti
n
en
ce
 
4
 y
ea
rs
 a
ft
er
 
th
e 
fi
rs
t 
d
el
iv
er
y
 
A
g
e 
at
 f
ir
st
 d
el
iv
er
y
, 
B
M
I,
 
b
ir
th
 w
ei
g
h
t,
 d
u
ra
ti
o
n
 o
f 
la
b
o
r,
 d
u
ra
ti
o
n
 o
f 
ac
ti
v
e 
se
co
n
d
 s
ta
g
e,
 m
o
d
e 
o
f 
d
el
iv
er
y
, 
th
ir
d
 d
eg
re
e 
p
er
in
ea
l 
te
ar
, 
se
co
n
d
 
d
el
iv
er
y
, 
u
ri
n
ar
y
 l
ea
k
ag
e 
b
ef
o
re
 f
ir
st
 p
re
g
n
an
cy
, 
u
ri
n
ar
y
 l
ea
k
ag
e 
d
u
ri
n
g
 t
h
e 
fi
rs
t 
p
re
g
n
an
cy
 
M
u
tu
al
 a
d
ju
st
m
en
t 
L
ea
k
ag
e 
b
ef
o
re
 1
st
 
p
re
g
n
an
cy
: 
1
8
.7
 (
3
.6
-9
6
.4
) 
L
ea
k
ag
e 
d
u
ri
n
g
 1
st
 
p
re
g
n
an
cy
: 
2
.5
 (
1
.3
-4
.8
) 
M
o
re
 t
h
an
 3
0
 y
ea
rs
 
o
ld
 a
t 
1
st
 d
el
iv
er
y
: 
2
.4
 (
1
.4
-4
.2
) 
D
u
ra
ti
o
n
 o
f 
la
b
o
r 
o
f 
at
 l
ea
st
 8
 h
o
u
rs
: 
3
.1
 (
1
.7
-5
.7
) 
C
es
ar
ea
n
 a
t 
1
st
 
d
el
iv
er
y
: 
0
.3
 (
0
.1
-0
.9
) 
 
 
 47 
H
an
n
es
ta
d
 
et
 a
l.
 
(2
0
0
4
) 
C
ro
ss
-s
ec
ti
o
n
al
 
E
P
IN
C
O
N
T
 s
tu
d
y
 
N
o
rw
ay
 
C
o
h
o
rt
 1
: 
6
0
2
1
 m
o
th
er
s,
 
7
6
2
9
 d
au
g
h
te
rs
, 
3
3
2
 
g
ra
n
d
d
au
g
h
te
rs
 
D
au
g
h
te
rs
 a
g
ed
 2
6
 t
o
 4
0
 
y
ea
rs
 
C
o
h
o
rt
 2
: 
2
1
0
4
 o
ld
er
 
si
st
er
s,
 2
4
2
6
 s
is
te
rs
 
Y
o
u
n
g
er
 s
is
te
rs
 a
g
ed
 2
8
 
to
 4
0
 y
ea
rs
 
S
el
f-
re
p
o
rt
ed
  
 S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
F
am
il
y
 h
is
to
ry
 (
m
o
th
er
, 
o
ld
er
 s
is
te
r)
 
A
d
ju
st
ed
 f
o
r 
ag
e,
 
B
M
I,
 a
n
d
 p
ar
it
y
 
M
o
th
er
 w
it
h
 S
U
I:
 
1
.5
2
 (
1
.2
8
-1
.8
1
) 
O
ld
er
 s
is
te
r 
w
it
h
 
S
U
I:
 
1
.8
 (
1
.3
-2
.3
) 
 
T
el
em
an
 e
t 
al
. 
(2
0
0
4
) 
C
ro
ss
-s
ec
ti
o
n
al
 
p
o
p
u
la
ti
o
n
-b
as
ed
 
S
w
ed
en
 
2
6
8
2
 w
o
m
en
 
W
o
m
en
’s
 H
ea
lt
h
 i
n
 t
h
e 
L
u
n
d
 A
re
a 
st
u
d
y
 
A
g
ed
 5
0
-5
9
 
S
el
f-
re
p
o
rt
ed
 
S
U
I,
 w
it
h
 
B
ri
st
o
l 
F
em
al
e 
L
o
w
er
 
U
ri
n
ar
y
 T
ra
ct
 
S
y
m
p
to
m
s 
Q
u
es
ti
o
n
n
ai
re
 
 S
o
m
et
im
es
 o
r 
m
o
re
 v
s.
 n
o
 o
r 
o
cc
as
io
n
al
ly
 
B
M
I,
 E
le
v
at
io
n
 o
f 
B
M
I 
si
n
ce
 a
g
e 
2
5
,c
u
rr
en
t 
H
R
T
 
u
se
, 
al
co
h
o
l 
co
n
su
m
p
ti
o
n
 
M
u
tu
al
 a
d
ju
st
m
en
t 
B
M
I 
3
0
+
 v
s.
 <
3
0
: 
1
.5
5
 (
1
.1
7
-2
.0
5
) 
E
le
v
at
ed
 B
M
I 
b
y
 
2
5
%
 s
in
ce
 a
g
e 
2
5
: 
1
.6
9
 (
1
.3
8
-2
.0
6
) 
C
u
rr
en
t 
H
R
T
 u
se
: 
1
.4
7
 (
1
.2
2
-1
.7
8
) 
M
o
d
er
at
e 
al
co
h
o
l 
co
n
su
m
p
ti
o
n
: 
0
.6
4
 (
0
.4
6
-0
.8
8
) 
Ja
ck
so
n
 e
t 
al
. 
(2
0
0
4
) 
C
ro
ss
-s
ec
ti
o
n
al
 s
tu
d
y
 
1
,5
8
4
 C
au
ca
si
an
 a
n
d
 
A
fr
ic
an
-A
m
er
ic
an
 
w
o
m
en
 a
g
ed
 7
0
-7
9
 
y
ea
rs
 
T
h
e 
H
ea
lt
h
, 
A
g
in
g
, 
an
d
 
B
o
d
y
 C
o
m
p
o
si
ti
o
n
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
o
cc
u
rr
in
g
 
w
ee
k
ly
 o
r 
m
o
re
 d
u
ri
n
g
 
th
e 
p
as
t 
1
2
 
m
o
n
th
s 
b
y
 
q
u
es
ti
o
n
n
ai
re
 
A
g
e,
 r
ac
e,
 B
M
I,
 p
ar
it
y
, 
h
y
st
er
ec
to
m
y
, 
o
ra
l 
es
tr
o
g
en
 u
se
, 
d
ia
b
et
es
, 
p
o
o
r 
h
ea
lt
h
 s
ta
tu
s,
 c
h
ro
n
ic
 
o
b
st
ru
ct
iv
e 
p
u
lm
o
n
ar
y
 
d
is
ea
se
, 
st
ro
k
e,
 a
rt
h
ri
ti
s,
 
an
d
 d
ep
re
ss
iv
e 
sy
m
p
to
m
s 
A
d
ju
st
ed
 f
o
r 
re
cr
u
it
m
en
t 
si
te
, 
al
te
rn
at
iv
e 
an
th
ro
p
o
m
o
rp
h
ic
 
m
ea
su
re
s,
 a
n
d
 t
h
e 
o
th
er
 f
ac
to
rs
 
C
h
ro
n
ic
 o
b
st
ru
ct
iv
e 
p
u
lm
o
n
ar
y
 d
is
ea
se
: 
5
.6
 (
1
.3
-2
3
.2
) 
C
au
ca
si
an
 v
s.
 
A
fr
ic
an
-A
m
er
ic
an
: 
4
.1
 (
2
.5
-6
.7
) 
C
u
rr
en
t 
o
ra
l 
 48 
S
tu
d
y
 
  
es
tr
o
g
en
 u
se
: 
2
.0
 (
1
.3
-3
.1
) 
B
M
I 
(p
er
 5
 u
n
it
s)
: 
(1
.1
-1
.6
) 
H
an
d
a 
et
 
al
. 
(2
0
0
4
) 
C
ro
ss
-s
ec
ti
o
n
al
 s
tu
d
y
 
1
2
9
3
 w
o
m
en
 s
ch
ed
u
le
d
 
fo
r 
h
y
st
er
ec
to
m
y
 
T
h
e 
M
ar
y
la
n
d
 W
o
m
en
’s
 
H
ea
lt
h
 S
tu
d
y
 
<
3
0
 t
o
 6
0
+
 y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
d
u
ri
n
g
 
la
st
 m
o
n
th
, 
w
it
h
 t
h
e 
U
ri
n
ar
y
 
S
y
m
p
to
m
 
S
ca
le
 f
o
r 
W
o
m
en
 
q
u
es
ti
o
n
n
ai
re
  
 S
o
m
e 
o
f 
th
e 
ti
m
e 
o
r 
m
o
re
 
v
s.
 n
o
t 
at
 a
ll
 
o
r 
li
tt
le
 o
f 
th
e 
ti
m
e 
A
g
e,
 r
ac
e,
 B
M
I,
 s
m
o
k
in
g
, 
U
L
 a
s 
p
ri
m
ar
y
 d
ia
g
n
o
si
s,
 
u
te
ri
n
e 
w
ei
g
h
t,
 p
ar
it
y
, 
ro
u
te
 o
f 
d
el
iv
er
y
 
M
u
tu
al
 a
d
ju
st
m
en
t 
A
ll
 w
o
m
en
: 
P
ar
it
y
 1
-3
 v
s.
 0
: 
1
.9
6
 (
1
.2
8
-3
.0
0
) 
P
ar
it
y
 4
+
 v
s.
 0
; 
3
.1
0
 (
1
.8
2
-5
.3
0
) 
C
au
ca
si
an
 v
s.
 
A
fr
ic
an
-A
m
er
ic
an
: 
1
.4
9
 (
1
.1
5
-1
.9
5
) 
B
M
I 
(p
er
 1
 u
n
it
):
 
1
.0
6
 (
1
.0
4
-1
.0
8
) 
 P
ar
o
u
s 
w
o
m
en
: 
C
es
ar
ea
n
 d
el
iv
er
y
 
o
n
ly
 v
s.
 a
t 
le
as
t 
o
n
e 
v
ag
in
al
: 
0
.6
0
 (
0
.3
9
-0
.9
3
) 
P
ar
it
y
 4
+
 v
s.
 1
-3
: 
1
.5
5
 (
1
.0
6
-2
.2
6
) 
C
au
ca
si
an
 v
s.
 
A
fr
ic
an
-A
m
er
ic
an
: 
1
.5
2
 (
1
.1
5
-2
.0
2
) 
B
M
I 
(p
er
 1
 u
n
it
):
 
1
.0
6
 (
1
.0
4
-1
.0
8
) 
S
ch
y
tt
 e
t 
al
. 
(2
0
0
4
) 
C
o
h
o
rt
 s
tu
d
y
 
2
3
9
0
 w
o
m
en
 f
o
ll
o
w
ed
 
o
n
e 
y
ea
r 
af
te
r 
ch
il
d
b
ir
th
 
M
ed
ia
n
 a
g
e 
2
9
 y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
d
u
ri
n
g
 
th
e 
la
st
 w
ee
k
 
A
g
e,
 e
d
u
ca
ti
o
n
, 
m
ar
it
al
 
st
at
u
s,
 n
at
iv
e 
la
n
g
u
ag
e,
 
n
u
m
b
er
 o
f 
ch
il
d
re
n
, 
m
o
d
e 
o
f 
d
el
iv
er
y
 f
o
r 
p
re
v
io
u
s 
M
u
tu
al
 a
d
ju
st
m
en
t 
P
ar
it
y
: 
1
.4
 (
1
.1
-1
.8
) 
C
o
n
st
ip
at
io
n
 4
-8
 
w
ee
k
s 
af
te
r 
 49 
S
w
ed
en
 
p
re
g
n
an
ci
es
, 
an
d
 v
ar
ia
b
le
s 
re
la
te
d
 t
o
 t
h
e 
cu
rr
en
t 
p
re
g
n
an
cy
 (
co
n
st
ip
at
io
n
, 
u
ri
n
ar
y
 i
n
co
n
ti
n
en
ce
, 
m
o
d
e 
o
f 
d
el
iv
er
y
, 
p
re
se
n
ta
ti
o
n
, 
in
fa
n
t 
b
ir
th
 
w
ei
g
h
t,
 i
n
fa
n
t 
h
ea
d
 
ci
rc
u
m
fe
re
n
ce
, 
sp
o
n
ta
n
eo
u
s 
p
er
in
ea
l 
ru
p
tu
re
, 
ep
is
io
to
m
y
, 
sm
o
k
in
g
) 
ch
il
d
b
ir
th
: 
1
.4
 (
1
.1
-1
.9
0
 
U
ri
n
ar
y
 
in
co
n
ti
n
en
ce
 4
-8
 
w
ee
k
s 
af
te
r 
ch
il
d
b
ir
th
: 
5
.7
 (
4
.3
-7
.6
) 
C
es
ar
ea
n
 s
ec
ti
o
n
 v
s.
 
v
ag
in
al
 d
el
iv
er
y
 f
o
r 
cu
rr
en
t 
p
re
g
n
an
cy
: 
0
.5
 (
0
.3
-0
.9
) 
A
g
e 
>
 3
5
 y
ea
rs
 o
ld
: 
1
.5
 (
1
.0
-2
.1
) 
O
b
es
it
y
: 
1
.5
 (
1
.0
-2
.2
) 
H
an
 e
t 
al
. 
(2
0
0
5
) 
C
ro
ss
-s
ec
ti
o
n
al
 s
tu
d
y
 
7
6
9
 w
o
m
en
 
A
g
ed
 3
0
 a
n
d
 o
ld
er
 
S
o
u
th
 K
o
re
a 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
d
u
ri
n
g
 
th
e 
p
as
t 
1
2
 
m
o
n
th
s 
A
g
e,
 o
cc
u
p
at
io
n
, 
al
co
h
o
l 
co
n
su
m
p
ti
o
n
, 
sm
o
k
in
g
 
st
at
u
s,
 p
h
y
si
ca
l 
ex
er
ci
se
, 
to
ta
l 
n
u
m
b
er
 o
f 
v
ag
in
al
 
d
el
iv
er
ie
s,
 m
en
o
p
au
sa
l 
st
at
u
s,
 u
se
 o
f 
p
o
st
m
en
o
p
au
sa
l 
h
o
rm
o
n
e 
th
er
ap
y
, 
d
ia
b
et
es
, 
h
y
p
er
te
n
si
o
n
, 
h
y
st
er
ec
to
m
y
 
M
u
tu
al
 a
d
ju
st
m
en
t 
B
lu
e 
co
ll
ar
 v
s.
 w
h
it
e 
co
ll
ar
: 
3
.2
3
 (
1
.2
1
-8
.5
8
) 
 V
ag
in
al
 d
el
iv
er
y
 4
+
 
v
s.
 0
-1
: 
5
.3
3
 (
2
.8
1
-1
0
.0
9
) 
W
ai
st
 c
ir
cu
m
fe
re
n
ce
 
9
0
+
 c
m
 v
s.
 <
7
8
 c
m
: 
6
.0
7
 (
3
.2
3
-1
1
.4
0
) 
R
o
h
r 
et
 a
l.
 
(2
0
0
5
) 
P
o
p
u
la
ti
o
n
-b
as
ed
 c
ro
ss
-
se
ct
io
n
al
 s
tu
d
y
 
5
7
9
5
 w
o
m
en
 
4
6
+
 y
ea
rs
 o
ld
 
D
en
m
ar
k
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
d
u
ri
n
g
 
la
st
 m
o
n
th
 
A
g
e,
 B
M
I,
 p
ar
it
y
, 
u
se
 o
f 
d
iu
re
ti
cs
, 
H
R
T
, 
p
re
v
io
u
s 
st
ro
k
e,
 p
re
v
io
u
s 
m
y
o
ca
rd
ia
l 
in
fa
rc
ti
o
n
, 
p
re
v
io
u
s 
h
y
st
er
ec
to
m
y
, 
d
ia
b
et
es
, 
P
ar
k
in
so
n
, 
M
u
tu
al
 a
d
ju
st
m
en
t 
A
g
e 
8
0
+
 v
s.
 <
6
0
: 
2
.3
9
 (
1
.9
7
-2
.9
0
) 
B
M
I 
3
0
+
 v
s.
 <
2
5
: 
1
.7
8
 (
1
.4
0
-2
.2
7
) 
P
ar
it
y
 
 50 
ch
ro
n
ic
 l
u
n
g
 d
is
ea
se
 
3
+
 v
s.
 0
: 
1
.2
7
 (
1
.0
4
-1
.5
5
) 
C
h
ro
n
ic
 l
u
n
g
 
d
is
ea
se
: 
1
.6
5
 (
1
.3
5
-2
.0
2
) 
S
tr
o
k
e:
 
1
.8
0
 (
1
.1
9
-2
.7
2
) 
U
se
 o
f 
d
iu
re
ti
cs
: 
1
.2
2
 (
1
.0
6
-1
.4
2
) 
G
o
ld
b
er
g
 
et
 a
l.
 
(2
0
0
5
) 
C
ro
ss
-s
ec
ti
o
n
al
 
2
7
1
 i
d
en
ti
ca
l 
tw
in
 s
is
te
r 
p
ai
rs
 
T
h
e 
E
v
an
st
o
n
-
N
o
rt
h
w
es
te
rn
 T
w
in
 
si
st
er
 s
tu
d
y
 
1
5
 t
o
 8
5
 y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
w
it
h
 t
h
e 
P
el
v
ic
 F
lo
o
r 
D
is
tr
es
s 
In
v
en
to
ry
 a
n
d
 
In
co
n
ti
n
en
ce
 
Im
p
ac
t 
Q
u
es
ti
o
n
n
ai
re
 
A
g
e,
 n
u
m
b
er
 o
f 
p
re
g
n
an
ci
es
, 
to
ta
l 
p
ar
it
y
, 
sm
o
k
in
g
 h
is
to
ry
, 
p
at
er
n
al
 
an
d
 m
at
er
n
al
 B
M
I,
 
m
en
o
p
au
se
, 
d
u
ra
ti
o
n
 o
f 
th
e 
se
co
n
d
 s
ta
g
e 
o
f 
la
b
o
r,
 
as
th
m
a,
 h
y
st
er
ec
to
m
y
; 
b
ir
th
 m
o
d
e 
(v
ag
in
al
 
d
el
iv
er
y
 v
s.
 c
es
ar
ea
n
 
se
ct
io
n
),
 w
ei
g
h
t 
o
f 
la
rg
es
t 
b
ab
y
; 
ep
is
io
to
m
y
, 
fo
rc
ep
s 
M
u
tu
al
 a
d
ju
st
m
en
t 
 
A
g
e 
4
0
-4
9
 v
s.
 <
 4
0
: 
2
.3
 
M
en
o
p
au
se
: 
1
.4
9
 
P
ar
it
y
 2
+
 v
s.
0
: 
4
.3
3
 
B
M
I 
>
3
0
: 
3
.3
9
 
 A
m
o
n
g
 p
ar
o
u
s-
p
ar
o
u
s 
tw
in
 p
ai
rs
: 
V
ag
in
al
 d
el
iv
er
y
 v
s.
 
ce
sa
re
an
 s
ec
ti
o
n
: 
2
.2
8
 (
1
.1
4
-4
.5
5
) 
S
o
n
g
 e
t 
al
. 
(2
0
0
5
) 
C
ro
ss
-s
ec
ti
o
n
al
 
4
6
8
4
 w
o
m
en
 
A
g
e 
2
0
 y
ea
rs
 a
n
d
 o
ld
er
 
F
u
zh
o
u
, 
C
h
in
a 
S
el
f-
re
p
o
rt
ed
 
S
U
I,
 w
it
h
 
B
ri
st
o
l 
F
em
al
e 
L
o
w
er
 
U
ri
n
ar
y
 T
ra
ct
 
S
y
m
p
to
m
s 
Q
u
es
ti
o
n
n
ai
re
 
A
g
e,
 B
M
I,
 s
m
o
k
in
g
 
st
at
u
s,
 p
ar
it
y
, 
ro
u
te
 o
f 
d
el
iv
er
y
 (
o
n
ly
 C
es
ar
ea
n
, 
at
 l
ea
st
 o
n
e 
v
ag
in
al
),
 
ep
is
io
to
m
y
 (
d
u
ri
n
g
 t
h
e 
se
co
n
d
 s
ta
g
e 
o
f 
la
b
o
r)
, 
ed
u
ca
ti
o
n
, 
p
o
st
m
en
o
p
au
sa
l 
st
at
u
s,
 
d
ia
b
et
es
 m
el
li
tu
s,
 
h
y
p
er
te
n
si
o
n
, 
o
cc
u
p
at
io
n
, 
co
n
st
ip
at
io
n
, 
fe
ta
l 
M
u
tu
al
 a
d
ju
st
m
en
t 
A
g
e 
(1
0
 y
rs
 g
ro
u
p
s)
: 
1
.3
 (
1
.1
-1
.4
) 
V
ag
in
al
 d
el
iv
er
y
: 
3
.0
 (
1
.9
-4
.7
) 
P
ar
it
y
 >
 2
: 
2
.1
 (
1
.5
-2
.9
) 
H
y
p
er
te
n
si
o
n
: 
2
.7
 (
1
.4
-5
.6
) 
C
o
n
st
ip
at
io
n
: 
2
.6
 (
1
.8
-3
.8
) 
A
lc
o
h
o
l 
u
se
 
 51 
b
ir
th
w
ei
g
h
t,
 a
lc
o
h
o
l 
co
n
su
m
p
ti
o
n
 
(d
ri
n
k
s/
w
ee
k
):
 
4
.7
 (
1
.1
-2
0
.2
) 
E
p
is
io
to
m
y
: 
1
.7
 (
1
.4
-2
.0
) 
H
ig
h
er
 B
M
I 
(7
5
th
 
p
er
ce
n
ti
le
 o
r 
m
o
re
):
 
1
.8
 (
1
.5
-2
.2
) 
U
n
sk
il
le
d
 w
o
rk
er
: 
0
.7
 (
0
.5
-0
.8
) 
H
en
d
ri
x
 e
t 
al
. 
(2
0
0
5
) 
M
u
lt
ic
en
te
r,
 d
o
u
b
le
-
b
li
n
d
, 
p
la
ce
b
o
-
co
n
tr
o
ll
ed
 c
li
n
ic
al
 t
ri
al
s 
W
o
m
en
’s
 H
ea
lt
h
 
In
it
ia
ti
v
e 
2
3
,2
9
6
 p
o
st
m
en
o
p
au
sa
l 
w
o
m
en
 a
g
ed
 5
0
 t
o
 7
9
 
y
ea
rs
 o
ld
 
In
ci
d
en
ce
 a
n
d
 
w
o
rs
en
in
g
 (
o
f 
am
o
u
n
t,
 o
f 
fr
eq
u
en
cy
, 
o
r 
o
f 
d
eg
re
e 
o
f 
b
o
th
er
) 
o
f 
se
lf
-r
ep
o
rt
ed
 
st
re
ss
 u
ri
n
ar
y
 
in
co
n
ti
n
en
ce
 
(d
u
ri
n
g
 t
h
e 
la
st
 y
ea
r)
 
 S
tr
es
s 
o
n
ly
 
v
s.
 n
o
 
in
co
n
ti
n
en
ce
 
M
en
o
p
au
sa
l 
h
o
rm
o
n
e 
th
er
ap
y
 (
M
H
T
):
 e
st
ro
g
en
 
+
 p
ro
g
es
ti
n
 (
co
n
ju
g
at
ed
 
eq
u
in
e 
es
tr
o
g
en
 (
C
E
E
) 
an
d
 m
ed
ro
x
y
p
ro
g
es
te
ro
n
e 
ac
et
at
e 
(M
P
A
),
 e
st
ro
g
en
 
al
o
n
e 
A
g
e,
 y
ea
rs
 s
in
ce
 
m
en
o
p
au
se
, 
et
h
n
ic
it
y
, 
B
M
I,
 
p
ri
o
r 
M
H
T
 u
se
 a
n
d
 
d
u
ra
ti
o
n
, 
sm
o
k
in
g
, 
h
is
to
ry
 o
f 
d
ia
b
et
es
, 
as
th
m
a,
 
em
p
h
y
se
m
a,
 o
r 
st
ro
k
e,
 a
g
e 
at
 f
ir
st
 
b
ir
th
, 
p
ar
it
y
, 
b
re
as
t 
fe
ed
in
g
, 
u
se
 o
f 
d
iu
re
ti
cs
, 
u
se
 o
f 
o
th
er
 m
ed
ic
at
io
n
s,
 
al
co
h
o
l 
u
se
 
C
E
E
 +
 M
P
A
: 
In
ci
d
en
ce
: 
1
.8
7
 (
1
.6
1
-2
.1
8
) 
W
o
rs
en
in
g
 o
f 
fr
eq
u
en
cy
: 
1
.4
1
 (
1
.2
1
-1
.6
4
) 
C
E
E
: 
In
ci
d
en
ce
: 
2
.1
5
 (
1
.7
7
-2
.6
2
) 
W
o
rs
en
in
g
 o
f 
am
o
u
n
t:
 
2
.1
8
 (
1
.6
9
-2
.8
1
) 
W
o
rs
en
in
g
 o
f 
d
eg
re
e 
o
f 
b
o
th
er
: 
1
.6
5
 (
1
.4
2
-1
.9
3
) 
 
M
an
o
n
ai
 
et
 a
l.
 
(2
0
0
5
) 
P
o
p
u
la
ti
o
n
-b
as
ed
 c
ro
ss
-
se
ct
io
n
al
 s
tu
d
y
 
1
,1
2
6
 w
o
m
en
 
M
o
st
ly
 p
re
m
en
o
p
au
sa
l 
A
g
ed
 1
5
 t
o
 9
5
 y
ea
rs
 o
ld
 
R
u
ra
l 
ar
ea
 
T
h
ai
la
n
d
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
w
it
h
in
 
th
e 
p
re
v
io
u
s 
m
o
n
th
 
M
ar
it
al
 s
ta
tu
s,
 o
cc
u
p
at
io
n
, 
m
en
o
p
au
sa
l 
st
at
u
s,
 h
is
to
ry
 
o
f 
ch
il
d
b
ir
th
 
 A
m
o
n
g
 p
ar
o
u
s 
w
o
m
en
: 
p
ar
it
y
 a
n
d
 r
o
u
te
 o
f 
d
el
iv
er
y
 
M
u
tu
al
 a
d
ju
st
m
en
t 
P
er
i/
p
o
st
m
en
o
p
au
sa
l 
v
s.
 p
re
m
en
o
p
au
sa
l:
 
1
.5
0
 (
1
.0
8
-2
.0
8
0
 
H
is
to
ry
 o
f 
ch
il
d
b
ir
th
: 
2
.4
5
 (
1
.5
5
-3
.8
8
) 
A
m
o
n
g
 p
ar
o
u
s 
 52 
w
o
m
en
: 
V
ag
in
al
 v
s.
 
C
es
ar
ea
n
: 
1
.8
9
 (
1
.2
5
-2
.8
7
) 
M
cG
ro
th
er
 
et
 a
l.
 
(2
0
0
6
) 
P
ro
sp
ec
ti
v
e 
co
h
o
rt
 s
tu
d
y
 
L
ei
ce
st
er
sh
ir
e 
M
R
C
 
In
co
n
ti
n
en
ce
 S
tu
d
y
 
2
0
,2
4
7
 w
o
m
en
 
A
g
e 
4
0
 t
o
 9
8
 y
ea
rs
 o
ld
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
b
y
 p
o
st
al
 
q
u
es
ti
o
n
n
ai
re
 
o
cc
u
rr
in
g
 
m
o
n
th
ly
 o
r 
m
o
re
 
v
al
id
at
ed
 
ag
ai
n
st
 p
ad
 
te
st
 a
n
d
 d
ia
ry
 
 B
as
el
in
e 
an
d
 
1
 y
ea
r 
fo
ll
o
w
-
u
p
 
P
ar
k
in
so
n
’s
 d
is
ea
se
, 
m
u
lt
ip
le
 s
cl
er
o
si
s,
 
ep
il
ep
sy
, 
sp
in
al
 c
o
rd
 
in
ju
ry
, 
d
em
en
ti
a,
 
o
st
eo
p
o
ro
si
s,
 
h
y
p
er
te
n
si
o
n
, 
an
g
in
a,
 
h
ea
rt
 a
tt
ac
k
, 
b
lo
ck
ed
 l
eg
 
ar
te
ri
es
, 
d
ee
p
-v
ei
n
 
th
ro
m
b
o
si
s,
 R
ay
n
au
d
’s
 
d
is
ea
se
, 
d
ia
b
et
es
, 
rh
eu
m
at
o
id
 a
rt
h
ri
ti
s,
 
d
ep
re
ss
io
n
, 
jo
in
t 
p
ai
n
/s
ti
ff
n
es
s,
 
b
re
at
h
le
ss
n
es
s,
 a
n
k
le
 
sw
el
li
n
g
, 
b
al
an
ce
/d
iz
zi
n
es
s,
 f
al
ls
, 
h
ea
ri
n
g
 p
ro
b
le
m
s,
 
m
em
o
ry
 p
ro
b
le
m
s,
 v
is
io
n
 
p
ro
b
le
m
s,
 s
tr
o
k
e,
 m
in
im
al
 
tr
au
m
a 
fr
ac
tu
re
, 
cy
st
it
is
, 
b
o
w
el
 s
y
m
p
to
m
s,
 h
ay
 
fe
v
er
, 
d
er
m
at
it
is
 o
r 
ec
ze
m
a,
 a
st
h
m
a,
 p
h
y
si
ca
l 
im
p
ai
rm
en
t 
in
 t
er
m
s 
o
f 
ac
ti
v
it
ie
s 
o
f 
d
ai
ly
 l
iv
in
g
, 
B
M
I 
A
g
e,
 p
ar
it
y
, 
an
d
 t
h
e 
o
th
er
 v
ar
ia
b
le
s 
P
re
v
al
en
ce
: 
G
en
er
al
 h
ea
lt
h
 p
o
o
r 
v
s.
 e
x
ce
ll
en
t/
v
er
y
 
g
o
o
d
: 
2
.0
 (
1
.3
-3
.1
) 
A
D
L
 3
 v
s.
 1
 (
b
es
t)
: 
1
.8
 (
1
.4
-2
.3
) 
B
M
I 
o
b
es
e 
v
s.
 
ac
ce
p
ta
b
le
: 
1
.7
 (
1
.4
-2
.1
) 
A
g
e 
(1
0
 y
ea
rs
 
in
cr
ea
se
):
 
0
.8
 (
0
.7
-0
.8
) 
 
D
ep
re
ss
io
n
: 
 
1
.4
 (
1
.1
-1
.7
) 
M
em
o
ry
: 
1
.4
 (
1
.1
-1
.7
) 
B
re
at
h
le
ss
n
es
s:
 
1
.4
 (
1
.1
-1
.8
) 
A
st
h
m
a:
 
1
.5
 (
1
.1
-1
.9
) 
C
y
st
it
is
: 
1
.5
 (
1
.2
-1
.9
0
 
B
o
w
el
 s
tr
ai
n
in
g
: 
1
.5
 (
1
.2
-1
.9
) 
P
ar
it
y
 3
+
 v
s.
 0
; 
1
.7
 (
1
.2
-2
.3
) 
 53 
In
ci
d
en
ce
: 
B
M
I 
o
b
es
e 
v
s.
 
ac
ce
p
ta
b
le
: 
2
.3
 (
1
.6
-3
.3
) 
C
y
st
it
is
: 
1
.9
 (
1
.3
-2
.7
) 
A
g
e 
(1
0
 y
ea
rs
 
in
cr
ea
se
):
 
0
.8
 (
0
.6
-0
.9
) 
T
h
o
m
 e
t 
al
. 
(2
0
0
6
) 
P
o
p
u
la
ti
o
n
-b
as
ed
 c
o
h
o
rt
 
st
u
d
y
 
2
,1
0
9
 r
an
d
o
m
ly
 s
el
ec
te
d
 
m
id
d
le
-a
g
ed
 a
n
d
 o
ld
er
 
w
o
m
en
 
R
R
IS
K
 s
tu
d
y
 
B
et
w
ee
n
 4
0
 a
n
d
 6
9
 
y
ea
rs
 o
ld
 a
s 
o
f 
Ja
n
u
ar
y
 
1
, 
1
9
9
9
 
K
ai
se
r 
P
er
m
an
en
te
 
M
ed
ic
al
 C
ar
e 
P
ro
g
ra
m
 
o
f 
N
o
rt
h
er
n
 C
al
if
o
rn
ia
 
S
el
f-
re
p
o
rt
ed
 
S
U
I 
d
u
ri
n
g
 
th
e 
la
st
 y
ea
r,
 
b
y
 
q
u
es
ti
o
n
n
ai
re
s 
an
d
 i
n
te
rv
ie
w
 
R
ac
e/
E
th
n
ic
it
y
 
A
g
e,
 p
ar
it
y
, 
h
y
st
er
ec
to
m
y
, 
cu
rr
en
t 
es
tr
o
g
en
 
u
se
, 
B
M
I,
 
m
en
o
p
au
sa
l 
st
at
u
s,
 
an
d
 d
ia
b
et
es
 
A
fr
ic
an
-A
m
er
ic
an
 
v
s.
 C
au
ca
si
an
: 
0
.3
6
 (
0
.2
3
-0
.5
7
) 
A
si
an
 v
s.
 
C
au
ca
si
an
: 
0
.5
4
 (
0
,3
4
-0
,8
4
) 
 
    
CHAPTER II 
STATEMENT OF SPECIFIC AIMS 
Risk Factors Associated with Subtypes of Uterine Leiomyomata 
No population-based epidemiological studies have investigated if the associations 
between risk factors and UL subtypes are similar. The association of age at first birth and age 
at first being detected infertile with the location of UL as an outcome has been examined 
only as a secondary analysis in a practice-based case-control study (Faerstein et al. 2001 a). 
The research described in this dissertation included premenopausal African-American and 
Caucasian women from the baseline phase of the NIEHS Uterine Fibroid Study. The USF 
study combines the strengths of having detailed information on the location of UL with the 
inclusion of a large number of African-American women. 
The risk factors considered were age, age at menarche, parity, BMI, current cigarette 
smoking status, and current physical activity. When examining parity, full-term births after 
age 24 were considered the primary variable (Baird et al. 2003). Separate investigations were 
performed for each ethnic group. The UL subtypes considered were: submucosal UL (i.e. at 
least one submucosal UL present), intramural/subserosal UL (i.e. focal UL present, but only 
of intramural or subserosal type), and diffuse only (i.e. only a diffuse heterogeneous 
echopattern present). 
The specific aims were to investigate for each ethnic group if the associations 
between a risk factor and the three UL subtypes (submucosal UL, intramural/subserosal 
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UL, and diffuse only) are similar, or equivalently if the three corresponding odds ratios are 
equal. The specific study questions considered were: 
Are the associations similar between age and the three UL subtypes among the 
African-American premenopausal women? Are the associations similar between age and the 
three UL subtypes among the Caucasian premenopausal women? 
Are the associations similar between age at menarche and the three UL subtypes 
among the African-American premenopausal women? Are the associations similar between 
age at menarche and the three UL subtypes among the Caucasian premenopausal women? 
Are the associations similar between any full-term births after age 24 and the three 
UL subtypes among the African-American premenopausal women? Are the associations 
similar between any full-term births after age 24 and the three UL subtypes among the 
Caucasian premenopausal women? 
Are the associations similar between BMI and the three UL subtypes among the 
African-American premenopausal women? Are the associations similar between BMI and the 
three UL subtypes among the Caucasian premenopausal women? 
Are the associations similar between smoking status and the three UL subtypes 
among the African-American premenopausal women? Are the associations similar between 
smoking status and the three UL subtypes among the Caucasian premenopausal women? 
Are the associations similar between physical activity and the three UL subtypes 
among the African-American premenopausal women? Are the associations similar between 
physical activity and the three UL subtypes among the Caucasian premenopausal women? 
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Self-Reported Urinary Symptoms Associated with Uterine Leiomyomata 
No population-based observational studies have assessed the association between the 
characteristics of UL and SUI. The research described in this dissertation included African-
American and Caucasian premenopausal women from the first follow-up of the NIEHS 
Uterine Fibroid Study. This study combines the strengths of detailed information on the size 
and location of UL with the inclusion of a large number of African-American women, who 
are at increased risk of UL compared with Caucasian women.  
The proposed aims were to: 
1. Estimate the association between the presence of UL and SUI, and assess if this 
association differs by ethnicity and parity. 
2. Estimate the association between the size of the largest UL (small, medium, large) 
and SUI, and assess if this association differs by ethnicity and parity. 
3. Estimate the association between the presence of a large (≥ 4cm diameter) anterior 
UL in a non-retroverted uterus and SUI, and assess if this association differs by 
ethnicity and parity. 
4. Estimate the association between the presence of a medium/large (≥ 2cm diameter) 
anterior UL in a non-retroverted uterus and SUI, and assess if this association differs 
by ethnicity and parity. 
5. Estimate the association between the size of uterus (small, medium, large, very large) 
and SUI, and assess if this association differs by ethnicity and parity. 
The presence of a large anterior UL in a non-retroverted uterus is very likely to exert 
pressure on the bladder; by contrast the presence of a large anterior UL in a retroverted uterus 
may have much lesser impact on the bladder, if any. 
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The interest in effect modification by ethnicity was motivated by the African-American 
women being at an increased risk of UL, but at a decreased risk of SUI when compared with 
Caucasian women. The interest in the effect modification by parity was motivated by the fact 
that pregnancies loosen the pelvic floor. 
The specific study questions considered were: 
Are premenopausal women with UL more likely to report symptoms of SUI than 
premenopausal women without UL? Does this association differ by ethnicity or parity? 
Are premenopausal women with large (≥ 4 cm diameter) UL more likely to report 
symptoms of SUI than premenopausal women without UL? Are premenopausal women with 
medium (2-4 cm) UL more likely to report symptoms of SUI than premenopausal women 
without UL? Are premenopausal women with small (<2 cm) UL more likely to report 
symptoms of SUI than premenopausal women without UL? Do these associations differ by 
ethnicity or parity? 
Are premenopausal women with large (≥ 4 cm diameter) anterior UL in a non-
retroverted uterus more likely to report symptoms of SUI than premenopausal women 
without UL? Are premenopausal women with other types of UL more likely to report 
symptoms of SUI than premenopausal women without UL? Do these associations differ by 
ethnicity or parity? 
Are premenopausal women with medium/large (≥ 2 cm diameter) anterior UL in a 
non-retroverted uterus more likely to report symptoms of SUI than premenopausal women 
without UL? Are premenopausal women with other types of UL more likely to report 
symptoms of SUI than premenopausal women without UL? Do these associations differ by 
ethnicity or parity? 
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Are premenopausal women with very large uterine size (above the 83rd percentile of 
uterine volume) more likely to report symptoms of SUI than premenopausal women with 
small uterine size (lower tertile of uterine volume)? Are premenopausal women with large 
uterine size (67th to 83rd percentile of uterine volume) more likely to report symptoms of SUI 
than premenopausal women with small uterine size (lower tertile of uterine volume)? Are 
premenopausal women with medium uterine size (middle tertile of uterine volume) more 
likely to report symptoms of SUI than premenopausal women with small uterine size (lower 
tertile of uterine volume)? Do these associations differ by ethnicity or parity? 
    
CHAPTER III 
METHODS 
Study Design and Study Population 
The investigation used data from the NIEHS Uterine Fibroid Study, a study 
specifically designed to reduce detection bias by randomly selecting women and screening 
them for UL using a standardized protocol, in contrast with prior studies that have identified 
women based on clinical diagnosis. The study was approved by the Humans Subject’s 
Review Boards at the NIEHS and at George Washington University.  
Women, aged 35 to 49 years old, were selected randomly from a computerized list of 
the members of a health plan at its Washington, DC, site. The prepaid urban health plan was 
chosen because of the overall characteristics of its membership. About half of the members 
were African-American, and the health plan had a broad socioeconomic base. The specific 
age range was selected because it covers the late premenopausal years (when UL are most 
prevalent) and because ultrasound screening can be used for the majority of the women 
within this age range, since a small proportion of them is expected to be surgically or 
naturally menopausal.  
A random sample of 2,384 health plan records of women aged 35-49 with telephone 
contact information was obtained. The randomly selected women were sent a letter 
describing the study. A phone call was attempted to confirm their eligibility with respect to 
gender, age (35 to 49 years old), health plan membership at the Washington, DC, site, and 
ability to complete data collection in English. A small proportion (129 (5%)) could not be 
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reached, 150 (6%) refused screening for eligibility, and 3 were not contacted due to error. Of 
the 2102 women screened, 316 (15%) were ineligible, primarily because they did not obtain 
care at the Washington, DC health plan site. Of the 1786 eligible women, 335 (19%) refused 
to participate. Also prior to data collection contact was lost with 17 (1%) who initially agreed 
to participate and 4 who were undecided about participation. At the end, 1430 women, 
constituting 80% of the eligible women, participated in the study. The baseline phase was 
conducted between 1996 and 1999.  
Out of the 1245 premenopausal women from the baseline phase of the NIEHS 
Uterine Fibroid Study 1,229 have been followed for symptoms including SUI. The first 
follow-up was conducted between 2001-2002. 
 
Baseline Data Collection 
A mail questionnaire which took about 30 minutes to complete was used to collect 
data regarding medical history (Section A), symptoms (Section B), employment and 
household exposures (Sections C and D), pets (Section E), household pests (Section F), 
alcohol use (Section G), demographics (Section H), and stress (Section I).  
The phone interview, which lasted about an hour, collected information about age 
(Section A), occupational history (Section B), menstruation and douching (Section C), 
contraceptive history (Section D), hormone medication history (Section E), pregnancy 
history (Section F), residential history and childhood factors (Section G), physical activity 
(Section H), smoking history (Section I), hair products (Section J), nonprescription 
medication and sleep patterns (Section K), and fibroid-related medical history (Section L). 
The last section complemented Section A of the mail questionnaire, and included information 
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about medical procedures or conditions such as tubal ligation, pelvic surgeries, UL diagnosis 
and treatment, and ultrasound/sonograms.  
The women were told that the goal of the research was to study UL. All interviewers 
were trained by the study interviewer supervisor on how to conduct the interviews and record 
responses. Interviewers were unaware of the UL status of the study participant when they 
conducted most of the phone interview. All data were double entered.  
The determination of UL status involved, as a first step, a self-reported UL diagnosis 
at the telephone interview. The question used was: “Have you ever been told by a doctor or 
other health professional that you have uterine fibroid tumors or a leiomyoma, a benign 
tumor of the uterus or womb?” Women, who answered affirmatively and did not report 
misdiagnosis in subsequent questions about diagnostic, follow-up examinations, treatment, 
and persistence of UL, were classified as having a previous diagnosis of UL. 
Women were classified as premenopausal if they had a menstrual period or were 
pregnant or breast-feeding during the previous 12 months. 
For premenopausal women who had had a pelvic ultrasound examination recently at 
the health plan, that examination was used to assess the UL status. For the remaining 
premenopausal women, a subsequent pelvic ultrasound examination at the primary care site 
provided further UL status assessment for those with a previous diagnosis, and allowed the 
identification of undiagnosed UL for those with no previous diagnosis of UL. Women who 
failed to visit the clinic for an ultrasound examination but reported a previous diagnosis were 
included as UL cases, but those without ultrasound and no prior diagnosis were left with an 
undefined UL status.  
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The study ultrasound included both a transabdominal and a transvaginal ultrasound. 
The transabdominal ultrasound allowed identification of UL in the upper uterus, which may 
be difficult to detect with a transvaginal ultrasound. 
Both the transabdominal and transvaginal ultrasound examinations were performed 
by sonographers who were certified by the American Registry of Diagnostic Medical 
Sonographers, under the supervision of a radiologist with fellowship training in sonography. 
A single radiologist reviewed any questionable sonograms. The examinations were 
performed with ultrasound units ATL HDI 9 (ATL, Bothell, Washington), Acuson 128 XP 
(Siemens, Issaquah, Washington), and Diasonics DRF 400 (General Electric, Milwaukee, 
Wisconsin), using transabdominal ultrasound probes (3.5-5.0 MHz) and transvaginal 
ultrasound probes (5.0-7.0 MHz). The sonographers filled out a study-specific data collection 
form that included data on uterine size, uterine contour, heterogeneity of the echo pattern, 
number of focal UL, the size and location of the two largest UL (if more than 2 cm in 
diameter), and the size of the three largest submucosal UL. 
Sonogram data, including the size and location of UL when present were available for 
1083 women (87% of the premenopausal participants). About 20% of sonograms from the 
NIEHS Uterine Fibroid Study indicated a diffuse heterogeneous echopattern only (Wegienka 
et al. 2003). This echopattern was extensive (rather than occurring only along the 
endometrial stripe as with adenomyosis). Women with this pattern were classified as having 
“diffuse only”. There was also a very small number of participants with only submucosal UL, 
which prevented the categorization of women with focal UL into “submucosal only”, 
“nonsubmucosal only”, and “both submucosal and nonsubmucosal”. Because of these 
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reasons the UL subtype was categorized as “diffuse only”, “intramural/subserosal UL”, and 
“submucosal UL”.  
 
Follow-up Data Collection 
A computer-assisted telephone interview was used to collect data on employment, 
medical insurance, and general health status (Section A), pregnancy history since enrollment 
(Section B), medical history (Section C), new UL diagnosis (Section D), sonograms and MRI 
(Section E), major UL treatment and hysterectomy (Section F), menstruation (Section G), 
symptoms (Section H), medication (Section I), and demographics (Section J). 
The urinary symptoms investigated were the self-reported (at the follow-up) presence 
of SUI. More precisely the following question from Section H from the follow-up phone 
questionnaire was used: “During the [last 12 months/12 months before your last period/12 
months before the (Procedure)], have you ever had urine leak when you cough or sneeze?” 
The “procedure” mentioned in the question was the procedure reported in Section F (Major 
UL treatment and hysterectomy) of the phone interview, and it was one of the following: 
myomectomy, hystereoscopic resection, uterine artery embolization, or hysterectomy. 
For women currently menstruating, who did not undergo any of the procedures listed 
above, the time frame for the question was “last 12 months”. For those without a period in 
the last two months the time frame for the question was “12 months before your last period”. 
For those who underwent surgery the time frame was “12 months before the procedure”. 
Procedure had precedent (i.e. “12 months before the procedure” was asked) if women were 
still menstruating and have had one of the surgical procedures listed. 
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Data Analysis for Paper 1 
We defined four possible outcome groups:  
1) “No UL”,  
2) “Submucosal UL” (i.e. at least one submucosal focal UL present, with or without 
other UL), 
3) “Intramural/subserosal UL” (i.e. focal intramural or subserosal UL present, and 
no submucosal UL), and  
4) “Diffuse only” (defined in this study as a diffuse heterogeneous echo pattern with 
no measurable focal UL).  
Risk factors analyzed for the current study included age at ultrasound examination, 
age at menarche, having at least one full-term pregnancy after age 24, body mass index 
(BMI, kg/m2, categorized as <25, 25+), current physical activity (low/medium vs. high/very 
high), and current cigarette smoking (yes, no). Earlier work with the NIEHS UFS showed 
that pregnancies early in life were not associated with UL risk, but full-term pregnancies 
after age 24 were inversely associated with risk (Baird and Dunson 2003). The physical 
activity variable was categorized as in Baird et al. 2006, based on self-reported hours/week of 
vigorous activities, moderate activities or walking, and the estimated metabolic units 
associated with each type of activity. 
Separate analyses were performed for each ethnic group (African-American and 
Caucasian women), and for all women combined. Ethnicity was determined by self-report. 
Univariate analyses were performed to describe the distributions of exposures and outcomes, 
and assess missing data. 
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The models of interest were the race-specific polytomous logistic regression models 
that included all six risk factors. A polytomous logistic regression model for all data 
combined was also performed. The later model included ethnicity in addition to the six risk 
factors of interest. The referent group for the polytomous logistic regression models was “no 
UL”. Age and age at menarche were modeled as continuous variables after confirming the 
assumption of linearity. Tests of equal effects across UL subtypes were performed for each 
variable of interest in all models, using Wald chi-squared tests of corresponding contrasts. 
All analyses were performed using the SAS software package (SAS v.9.1; SAS Institute, 
Inc., Cary, North Carolina). 
 
Data Analysis for Paper 2 
The outcome variable considered was the presence of self-reported SUI (“yes”/”no”). 
UL status was classified according to: 
1) The presence of any UL: “any UL” vs. “no UL” 
2) The size of the largest UL: “no UL”, “small (< 2cm) UL”, “medium (2-4cm) 
UL”, and “large (≥ 4cm) UL)”  
3) The presence of a large (≥ 4cm) anterior UL in a non-retroverted uterus: “no 
UL”, “large (≥ 4cm) anterior UL in non-retroverted uterus”, and “other UL”  
4) The presence of a medium/large (≥ 2cm) anterior UL in a non-retroverted uterus: 
“no UL”, “medium/large (≥ 2cm) anterior UL in non-retroverted uterus”, and 
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5) Uterine size: “small (lowest 33% of overall uterine volume distribution)”, 
“medium (middle 33%)”, “large (those in 67th to 83rd percentile)”, and “very 
large (those above the 83rd percentile)”. 
The uterine volume was calculated using the prolate ellipsoid formula (0.52 x length 
x width x anterior/posterior diameter). The actual cut points used to define the four categories 
of uterine size were: 91.4 cm3 (the 33rd percentile), 147.8 cm3 (the 66th percentile), and 206.5 
cm3 (the 83rd percentile).  
Potential confounders, selected based on a review of the literature regarding risk 
factors for UL and SUI, included age at the reference date (continuous or categorized as <40, 
[40,45), [45,50), 50+), ethnicity (African-American, Caucasian), BMI at baseline (kg/m2, 
categorized as <25, [25,30), [30,35), 35+), and the number of deliveries prior to the reference 
date (categorical, 0, 1, 2, 3+). A composite variable involving the number and the type of 
deliveries (none, only C-section deliveries, 1 vaginal delivery, 2 vaginal deliveries, 3+ 
vaginal deliveries) was also evaluated as a potential confounder, but was not used since 
results were comparable with those adjusted for the number of deliveries. 
Univariate analyses were performed to describe the distributions of exposures and 
outcomes, and assess missing data. Given the prevalence of the outcome under study (about 
50% of the participants have reported SUI), odds ratios are an overestimate for the relative 
risk. Therefore, we used linear risk models to estimate prevalence differences (PD) and 
corresponding 95% confidence intervals (CI) (Spiegelman and Hertzmark, 2005). Separate 
linear risk models were used to evaluate the association between each of the five variables of 
interest and self-reported SUI. We estimated crude, ethnicity-adjusted, and fully-adjusted 
PDs with 95% CIs, with the fully-adjusted estimates from linear risk models that included 
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age at reference (continuous), ethnicity, BMI, and number of deliveries. All model estimates 
were evaluated to confirm that predicted prevalences were between 0 and 1. 
Ethnicity was evaluated as a potential effect modifier since African American women 
are at increased risk of UL but at decreased risk of SUI compared with Caucasians. In 
addition we evaluated effect modification by parity (nulliparous vs. parous) as pregnancy 
loosens the pelvic floor. Formal evaluation of effect modification by ethnicity and parity was 
performed using likelihood ratio tests (α = 0.10). All analyses were performed using the SAS 
software package (SAS v.9.1; SAS Institute, Inc., Cary, North Carolina).  
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CHAPTER IV 
PAPER 1: RISK FACTORS ASSOCIATED WITH SUBTYPES OF UTERINE 
LEIOMYOMATA 
Abstract 
OBJECTIVE: To compare risk factors for each of three uterine leiomyomata (UL) 
subtypes (submucosal UL, intramural/subserosal UL, and diffuse only) among 
premenopausal African-American and Caucasian women. 
METHODS: This cross-sectional study used data from 986 premenopausal aged 35 to 
49 years old that were enrolled in the National Institute of Environmental Health Sciences 
Uterine Fibroid Study. Participants were randomly selected from the membership list of a 
Washington, DC health plan, and data were collected between 1996 and 1999.  UL were 
identified and subtyped based on transabdominal and transvaginal ultrasound examinations. 
Polytomous logistic regression models were used to estimate associations between six 
potential risk factors and UL subtypes within each ethnic group and for all women combined. 
RESULTS: For both African-American and Caucasian women, age at ultrasound 
examination, age at menarche, body mass index, and current physical activity had similar 
associations across the three UL subtypes. Inverse associations with pregnancies after age 24 
appeared to be stronger for the submucosal UL subtype than for the other two subtypes 
(aOR=0.59 95% CI: 0.35, 1.01 in African-Americans and aOR=0.25 95% CI: 0.10, 0.58 in 
Caucasians). Current smoking was positively associated with the diffuse only subtype 
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(aOR=1.97 95% CI: 1.11, 3.51 in African-Americans, aOR=3.00 95% CI: 1.07, 8.38 in 
Caucasians), but was not associated with focal UL subtypes in either ethnic group. 
CONCLUSIONS: Despite possible histopathologic differences that have been noted 
in the literature, the two focal UL subtypes appeared to have similar risk factor profiles for 
the factors examined. In contrast, the diffuse only subtype appeared to have a distinctive risk 
profile with regard to current smoking. Further study of the epidemiological and 
histopathologic correlates of diffuse heterogeneity seen with uterine ultrasound are needed. 
 
Introduction 
Uterine leiomyomata (UL) are the most prevalent solid tumors among women in the 
United States (Flake et al. 2003). Based on cross-sectional screening for UL among women 
aged 35 to 49 years old, the National Institute of Environmental Health Sciences (NIEHS) 
Uterine Fibroid Study estimated that more than 80% of African-American women and that 
about 70% of Caucasian women develop UL by age 50 (Baird et al. 2003). Although only 20 
to 50% of women with UL experience related symptoms (Stovall 2001), the economic impact 
of UL is considerable. Estimates for the direct cost of treating UL have been as high as $2.15 
billion per year (Flynn et al. 2006). 
UL are benign tumors derived from smooth muscle cells in the uterine myometrium. 
UL are sub-classified as submucosal, intramural, or subserosal according to their position 
within the uterine myometrial wall. Specifically, submucosal UL lie immediately adjacent to 
or protrude into the endometrial cavity; intramural UL are contained within the muscle layer; 
and subserosal UL lie immediately adjacent to or protrude into the peritoneal cavity (Stewart 
2001). Although there is evidence that differences exist beyond the position of UL subtypes 
(Marugo et al. 1989, Brosens et al. 1998, Brosens 2003), published research on risk factors 
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for UL subtypes is limited to a small secondary analysis of subtype-specific associations with 
parity and infertility in a practice-based case-control study of 111 women with known 
location of UL (Faerstein et al. 2001 a). The objective of this study was to compare risk 
factors for UL subtypes among premenopausal African-American and Caucasian women in 
the NIEHS Uterine Fibroid Study. 
 
Methods 
The NIEHS Uterine Fibroid Study (UFS) was specifically designed to reduce 
detection bias by randomly selecting women for UL screening using a standardized protocol, 
in contrast with most studies that determined UL status based on clinical diagnosis only. The 
study was approved by Humans Subject Review Boards at the NIEHS and George 
Washington University.  
Women aged 35 to 49 years old were selected randomly from a computerized list of 
health plan members at a Washington, DC, site. The prepaid urban health plan was chosen 
because about half of its members were African-American, and it had a broad socioeconomic 
base. The specific age range was selected because it covers the late premenopausal years 
(when UL are most prevalent), and because relatively few women in this age group were 
expected to be surgically or naturally menopausal.  
A random sample of 2,384 health plan records of women aged 35-49 with telephone 
contact information was obtained. The randomly selected women were sent a letter 
describing the study, which was followed by a phone call to confirm eligibility with respect 
to gender, age, health plan membership at the Washington, DC, site, and ability to complete 
data collection in English. A small proportion (129
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refused screening for eligibility, and 3 were not contacted due to error. Of the 2,102 women 
screened, 316 (15%) were ineligible, primarily because they did not obtain care at the 
Washington, DC health plan site. Of the 1,786 eligible women, 335 (19%) refused to 
participate, and 24 (1%) were lost to contact prior to data collection. In total, 1,430 women, 
constituting 80% of those determined to be eligible, participated in the UFS.  
Baseline data collection for the UFS was conducted between 1996 and 1999 using a 
mail questionnaire that took about 30 minutes to complete, and a phone interview, which 
lasted about an hour. All interviewers were trained, and all data were double entered and 
verified.  
The study was designed to evaluate UL status by ultrasound for all premenopausal 
women with intact uteri, and this analysis is limited to that group. Women were classified as 
premenopausal if they had a menstrual period or were pregnant or breast-feeding during the 
previous 12 months. If participants had had a recent pelvic ultrasound at the clinic we 
abstracted data from that to determine UL status (sonograms within 5 years that showed UL 
were used; sonograms within 2 years that showed “No UL” were used). All others were 
asked to have a study ultrasound examination. 
The study ultrasound included both transabdominal and transvaginal examinations, 
with the former used to facilitate identification of UL in the upper uterus. Examinations were 
performed by sonographers certified by the American Registry of Diagnostic Medical 
Sonographers, under the supervision of a radiologist with fellowship training in sonography. 
A single radiologist reviewed all questionable sonograms. The examinations were performed 
with ultrasound units ATL HDI 9 (ATL, Bothell, Washington), Acuson 128 XP (Siemens, 
Issaquah, Washington), and Diasonics DRF 400 (General Electric, Milwaukee, Wisconsin), 
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using transabdominal ultrasound probes (3.5-5.0 MHz) and transvaginal ultrasound probes 
(5.0-7.0 MHz). Sonographers filled out a study-specific data collection form that included 
data on uterine size, uterine shape, diffuse heterogeneous echo pattern (yes/no), number of 
focal UL, the size and location of the two largest UL (if more than 2 cm in diameter), and the 
size of the three largest submucosal UL.  
We defined four possible outcome groups: 1) no UL, 2) submucosal UL (i.e. at least 
one submucosal focal UL present, with or without other UL), 3) intramural/subserosal UL 
(i.e. focal intramural or subserosal UL present, and no submucosal UL), and 4) diffuse only 
(defined in this study as a diffuse heterogeneous echo pattern with no measurable focal UL).  
Women were eligible for the current study if they were premenopausal African-
American or Caucasian participants in the baseline phase of NIEHS UFS (n = 1,144). 
Women were excluded if they were missing UL subtype data (n = 158); therefore the final 
population included 986 women (86% of those eligible). 
Risk factors analyzed for the current study included age at ultrasound examination, 
age at menarche, having at least one full-term pregnancy after age 24, body mass index 
(BMI, kg/m2, categorized as <25, 25+), current physical activity (low/medium vs. high/very 
high), and current cigarette smoking (yes, no). Earlier work with the NIEHS UFS showed 
that pregnancies early in life were not associated with UL risk, but full-term pregnancies 
after age 24 were inversely associated with risk (Baird and Dunson 2003). The physical 
activity variable was categorized as in our previous analysis (Baird et al. 2006), based on 
self-reported hours/week of vigorous activities, moderate activities or walking, and the 
estimated metabolic units associated with each type of activity. 
  74  
Separate analyses were performed for each ethnic group (African-American and 
Caucasian women), and for all women combined. Ethnicity was determined by self-report. 
Univariate analyses were performed to describe the distributions of exposures and outcomes, 
assess missing data, and identify potential outliers. 
The models of interest were the race-specific polytomous logistic regression models 
that included all six risk factors. A polytomous logistic regression model for all data 
combined was also performed. The later model included ethnicity in addition to the six risk 
factors of interest. The referent group for the polytomous logistic regression models was “no 
UL”. Age and age at menarche were modeled as continuous variables after confirming the 
assumption of linearity. Tests of equal effects across UL subtypes were performed for each 
variable of interest in all models, using Wald chi-squared tests of corresponding contrasts. 
All analyses were performed using the SAS software package (SAS v.9.1; SAS Institute, 
Inc., Cary, North Carolina).  
 
Results 
Characteristics of the sample of 986 premenopausal women included in the current 
study are presented in Table 4.1. More African-American women than Caucasian women had 
early (< 12 years old) menarche (27% vs. 19%), had a high BMI (mean BMI 30.4 vs. 25.9 
kg/m2, with 43% vs. 18% classified as obese), were current smokers (29% vs. 8%), reported 
full term pregnancies after age 24, and reported low or medium physical activity. 
Overall, 63% of the analysis sample had UL, including 72% of African Americans 
and 50% of Caucasians (Table 4.1). In both racial groups, about 20% of women with UL 
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were classified as having diffuse only, about 20% had submucosal UL, and the remaining 
60% had intramural/subserosal UL. 
African-American women had a higher prevalence of all three UL subtypes than 
Caucasian women, but the association with ethnicity was somewhat weaker for the diffuse 
only subtype (adjusted odds ratio (aOR) 1.86, 95% confidence interval (95% CI): 1.14, 3.06, 
adjusted for age, age at menarche, full term pregnancies after age 24, BMI, physical activity 
and current smoking) than for submucosal UL (aOR=3.30 95% CI: 2.05, 5.34) and 
intramural/subserosal UL (aOR=2.72 95% CI: 1.94, 3.83). However, the three estimated 
adjusted ORs were not statistically different from each other (p = 0.157).  
For most potential risk factors, associations were similar for all three subtypes of UL 
(Figure 4.1, Table 4.2). For both African Americans and Caucasians, age was positively 
associated with all three UL subtypes, without clear differences in the magnitude of subtype-
specific associations (p-values for differences among UL subtypes estimated adjusted ORs 
were 0.438 and 0.084 for African American and Caucasians, respectively, see Table 4.3). 
Age at menarche and physical activity were inversely associated with all three UL subtypes 
among women in both ethnic groups, and there was no significant difference between 
subtypes (all p-values for difference > 0.500, see Table 4.3). Subtype-specific associations 
with BMI also were comparable within ethnic groups; however, associations were positive 
among African Americans and weak among Caucasians, consistent with previous studies of 
UL in general (Marshal et al. 1998 a, Wise at al. 2005, Baird et al. 2006).  
Pregnancies after age 24 were inversely associated with submucosal UL in both 
African-Americans and Caucasians (aOR=0.59 95% CI: 0.35, 1.01 and aOR=0.25 95% CI: 
0.10, 0.58 respectively), while the associations were weaker for the other UL subtypes in 
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both ethnic groups. There was even a non-significant positive association with the diffuse 
only subtype for Caucasians (aOR=1.58 95% CI: 0.76, 3.28), where the effects across UL 
subtypes were significantly different (p < 0.001). 
Associations with smoking also differed across UL subtypes, and patterns were 
similar between African Americans and Caucasians. Specifically, smoking was positively 
associated with the diffuse only subtype (aOR=1.97 95% CI: 1.11, 3.51 in African 
Americans, aOR=3.00 95% CI: 1.07, 8.38 in Caucasians), but was not associated with 
submucosal or intramural/subserosal UL. P-values for differential effects across UL subtypes 
were 0.014, 0.036, and 0.002 for African Americans, Caucasians and all women combined, 
respectively. 
 
Discussion 
The NIEHS Uterine Fibroid Study used ultrasound to screen for UL, which allowed 
for outcome categorization according to UL subtypes. We examined the association of six 
putative risk factors with each of the three UL subtypes examined, using separate analyses 
for African-American and Caucasian women. Within each ethnic group age, age at 
menarche, BMI, and physical activity had very similar associations across UL subtypes. 
There was more variation among subtypes in association with pregnancies after age 24 
especially for Caucasians, and current smoking had significant differential subtype-specific 
associations in both ethnic groups. The effect was different for the diffuse only subtype than 
for focal UL (submucosal and intramural/subserosal UL) subtypes. 
Although UL subtypes may develop in response to different environmental or 
endogenous factors, this is the first epidemiological study to systematically evaluate risk 
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factors for UL subtypes. We examined submucosal UL as a separate subtype based on 
evidence that the subendometrial myometrium (i.e. the junctional zone adjacent to the 
endometrium) is structurally and functionally different from the outer myometrium (Brosens 
2003). In addition, pathophysiological data suggest that submucosal UL are distinct clinical 
entities from other UL. Specifically, abnormal karyotypes have been reported to be less 
prevalent in submucosal UL than in intramural or subserosal UL (Brosens et al. 1998), and 
estrogen receptor and progesterone receptor levels were found to be higher in submucosal 
UL than in subserosal UL, both during the proliferative phase and the secretive phase of the 
menstrual cycle (Marugo et al. 1989).  
Very little is known about the pathophysiology of the diffuse only subtype. The 
diffuse heterogeneous echo pattern associated with this subtype may result from multiple 
small focal UL, or from larger UL that lack the usual distinct histological demarcation from 
the surrounding myometrium. We considered the diffuse heterogeneous echo pattern as a UL 
subtype because like focal UL, in the NIEHS UFS it is associated with enlargement of the 
uterus (Baird et al. 2003) and excess bleeding (Wegienka et al. 2003). Adenomyosis also can 
present as a diffuse heterogeneous echo pattern, but adenomyosis is usually accompanied by 
UL in uteri > 280g and occurs alone in only a minority of smaller uteri (LevGur 1996). 
Current smoking was positively associated with the diffuse only subtype among both 
African American and Caucasian women (aOR 2.13 95% CI: 1.29, 3.53 for all women 
combined), but appeared to have little or no association with either submucosal UL or 
intramural/subserosal UL. The lack of an association between smoking and submucosal or 
intramural/subserosal UL is consistent with data for clinically diagnosed UL from the Nurses 
Health Study (Marshal et al. 1998 a) and the Black Women’s Health Study (Wise et al. 2004 
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b). The positive association between smoking and the diffuse only subtype supports our 
assumption that this ultrasound finding is not a marker for adenomyosis, which has been 
found to be inversely associated with smoking in a previous study (Parazzini et al. 1997). 
The associations we see are quite strong (adjusted ORs of 2.0 and 3.0) and the fact that it is 
seen in two separate groups strengthens the likelihood that this is a real association. 
Our findings with regard to pregnancies did not replicate those of Faerstein et al. 
(2001 a), who reported that parity was negatively associated with “any submucosal UL” but 
positively associated with “non-submucosal UL” in a clinic-based study population that 
included 111 women with information on UL location. In contrast, we noted inverse 
associations for both focal UL subtypes and pregnancies after age 24, in both African 
American and Caucasian women, after adjusting for age, age at menarche, BMI, physical 
activity, and current smoking. However it should be noted that we also found that 
submucosal UL were the subtype with the strongest inverse association with our parity 
measure. 
One possible explanation may be the hypothesized protective effect of postpartum 
involution of the uterus, which may clear small UL during the remodeling of the myometrial 
tissue (Baird and Dunson 2003). The stronger negative association between pregnancies and 
submucosal UL versus intramural/subserosal UL could be due to the expulsion of (especially 
submucosal) UL during pregnancy. Previously reported inverse associations between parity 
and UL in general could not be explained by UL-related infertility (Marshall et al. 1998 b) 
(Baird and Dunson, 2003), and in the present study the associations between pregnancies 
after age 24 and UL subtypes were very similar after the exclusion of women who reported 
being infertile after age 25 (data not shown). 
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The primary strength of our study is the sonogram-based screening for UL among 
randomly selected premenopausal women irrespective of clinical symptoms. As such women 
with both symptomatic and asymptomatic UL could be accurately classified according to UL 
status and subtype. In addition, we were able to estimate subtype-specific associations 
separately by ethnicity. Consistent associations for most exposures across ethnic groups 
support the validity of our subtype-specific estimates. A major limitation is the cross-
sectional study design, which does not allow for confirmation that exposures to extrinsic risk 
factors preceded the onset of UL. In addition the Caucasian women in the study tended to be 
of high socioeconomic status (SES) and low parity and, as such, the finding noted may not be 
generalizable to US Caucasian women of low SES and/or high parity. Lastly, although 
overall sample sizes were relatively large, particularly for African American women, we had 
reduced power to estimate effects for UL subtypes, especially among Caucasians. 
In summary, despite possible histopathologic differences, submucosal UL appear to 
have a very similar risk factor profile to intramural/subserosal UL. In contrast, the diffuse 
only subtype may have a somewhat different risk factor profile. Smoking was unrelated to 
focal UL, but it appears to be a strong risk factor for the diffuse only subtype. These findings 
suggest that future studies of UL etiology should distinguish focal UL from the diffuse only 
subtype. 
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Table 4.1. Characteristics of premenopausal women from the NIEHS Uterine Fibroid Study 
by race and overall.  
 
Characteristic 
African American 
(N=581) 
No. (%) 
Caucasian 
(N=405) 
No. (%) 
All  
(N=986) 
No. (%) 
Age (years)    
<40 248 (42.7) 143 (35.3) 391 (39.7) 
40-44 194 (33.4) 130 (32.1) 324 (32.9) 
45+ 139 (23.9) 132 (32.6) 271 (27.5) 
Age at Menarche    
<11   61 (10.6) 18 (4.5) 79 (8.1) 
11 93 (16.1) 59 (14.6) 152 (15.5) 
12 160 (27.7) 111 (27.5) 271 (27.6) 
13 141 (24.4) 138 (34.2) 279 (28.4) 
14 54 (9.3) 43 (10.7) 97 (9.9) 
>14 69 (11.9) 34 (8.4) 103 (10.5) 
Missing 3 2 5 
Any Pregnancies    
No 297 (51.1) 256 (63.2) 553 (56.1) 
Yes 284 (48.9) 149 (36.8) 433 (43.9) 
Body Mass Index     
<25 148 (25.5) 234 (57.8) 382 (38.8) 
25-29.99 180 (31.0) 98 (24.2) 278 (28.2) 
30-34.99 115 (19.8) 37 (9.1) 152 (15.4) 
35+ 137 (23.6) 36 (8.9) 173 (17.6) 
Missing 1 0 1 
Physical Activity*    
Low/Medium 399 (69.2) 243 (60.2) 642 (65.4) 
High/Very 178 (30.9) 161 (39.9) 339 (34.6) 
Missing 4 1 5 
Current Smoking    
No 412 (70.9) 372 (91.9) 784 (79.5) 
Yes 169 (29.1) 33 (8.2) 202 (20.5) 
Location of UL    
           No UL 162 (27.9) 202 (49.9) 364 (36.9) 
           Diffuse only 78 (13.4) 40 (9.9) 118 (12.0) 
           Submucosal 93 (16.0) 40 (9.9) 133 (13.5) 
           248 (42.7) 123 (30.8) 371 (37.6) 
* Physical activity without chores (indexed to estimated hours/week of vigorous activity): 
low (<1.85), medium (1.85-4.14), high (4.15-6.55), very high (>6.55).  
 
  
 
83 
 
F
IG
U
R
E
 4
.1
. 
E
st
im
at
ed
 a
d
ju
st
ed
 o
d
d
s 
ra
ti
o
s 
fo
r 
th
e 
as
so
ci
at
io
n
s 
o
f 
u
te
ri
n
e 
le
io
m
y
o
m
at
a 
su
b
ty
p
es
 w
it
h
 a
g
e,
 a
g
e 
at
 m
en
ar
ch
e,
 f
u
ll
 
te
rm
 p
re
g
n
an
ci
es
 a
ft
er
 a
g
e 
2
4
, 
b
o
d
y
 m
as
s 
in
d
ex
 (
B
M
I;
 k
g
/m
2
),
 p
h
y
si
ca
l 
ac
ti
v
it
y
, 
an
d
 c
u
rr
en
t 
ci
g
ar
et
te
 s
m
o
k
in
g
 a
m
o
n
g
 A
fr
ic
an
 
A
m
er
ic
an
, 
C
au
ca
si
an
, 
an
d
 a
ll
 p
re
m
en
o
p
au
sa
l 
w
o
m
en
 i
n
 t
h
e 
N
IE
H
S
 U
te
ri
n
e 
F
ib
ro
id
 S
tu
d
y
. 
F
o
r 
th
e 
ra
ce
-s
p
ec
if
ic
 a
n
al
y
se
s 
th
e 
es
ti
m
at
ed
 o
d
d
s 
ra
ti
o
s 
fo
r 
ea
ch
 r
is
k
 f
ac
to
r 
ar
e 
ad
ju
st
ed
 f
o
r 
th
e 
o
th
er
 f
iv
e 
ri
sk
 f
ac
to
rs
; 
fo
r 
th
e 
o
v
er
al
l 
an
al
y
si
s 
th
ey
 a
re
 a
d
ju
st
ed
 f
o
r 
th
e 
o
th
er
 f
iv
e 
ri
sk
 f
ac
to
rs
 a
n
d
 r
ac
e.
 H
o
ri
zo
n
ta
l 
li
n
es
 a
re
 t
h
e 
co
rr
es
p
o
n
d
in
g
 9
5
%
 c
o
n
fi
d
en
ce
 i
n
te
rv
al
s.
 
  
 
84 
T
ab
le
 4
.2
. 
E
st
im
at
ed
 a
d
ju
st
ed
 o
d
d
s 
ra
ti
o
s 
fo
r 
th
e 
as
so
ci
at
io
n
s 
o
f 
U
L
 s
u
b
ty
p
es
 w
it
h
 a
g
e,
 a
g
e 
at
 m
en
ar
ch
e,
 a
n
y
 f
u
ll
 t
er
m
 
p
re
g
n
an
ci
es
 a
ft
er
 a
g
e 
2
4
, 
b
o
d
y
 m
as
s 
in
d
ex
 (
B
M
I;
 k
g
/m
2
),
 p
h
y
si
ca
l 
ac
ti
v
it
y
, 
an
d
 c
u
rr
en
t 
ci
g
ar
et
te
 s
m
o
k
in
g
 a
m
o
n
g
 A
fr
ic
an
 
A
m
er
ic
an
, 
C
au
ca
si
an
, 
an
d
 a
ll
 p
re
m
en
o
p
au
sa
l 
w
o
m
en
 i
n
 t
h
e 
N
IE
H
S
 U
te
ri
n
e 
F
ib
ro
id
 S
tu
d
y
. 
F
o
r 
th
e 
ra
ce
-s
p
ec
if
ic
 a
n
al
y
se
s 
th
e 
es
ti
m
at
ed
 o
d
d
s 
ra
ti
o
s 
fo
r 
ea
ch
 r
is
k
 f
ac
to
r 
ar
e 
ad
ju
st
ed
 f
o
r 
th
e 
o
th
er
 f
iv
e 
ri
sk
 f
ac
to
rs
; 
fo
r 
th
e 
o
v
er
al
l 
an
al
y
si
s 
th
ey
 a
re
 a
d
ju
st
ed
 f
o
r 
th
e 
o
th
er
 f
iv
e 
ri
sk
 f
ac
to
rs
 a
n
d
 r
ac
e.
 
 
 
A
fr
ic
a
n
 A
m
er
ic
a
n
 
C
a
u
ca
si
a
n
 
A
ll
 
 
N
*
 
a
O
R
 
9
5
%
 C
I 
N
*
 
a
O
R
 
9
5
%
 C
I 
O
R
 
9
5
%
 C
I 
A
g
e 
(5
 y
ea
rs
 i
n
cr
ea
se
) 
 
 
 
 
 
 
 
 
D
if
fu
se
 o
n
ly
 
- 
1
.2
8
 
0
.9
3
 ,
 1
.7
7
 
- 
1
.3
4
 
0
.8
9
 ,
 2
.0
4
 
1
.3
8
 
1
.0
7
 ,
 1
.7
8
 
S
u
b
m
u
co
sa
l 
- 
1
.4
2
 
1
.0
5
 ,
 1
.9
2
 
- 
2
.4
9
 
1
.6
2
 ,
 3
.8
3
 
1
.7
5
 
1
.3
7
 ,
 2
.2
3
 
In
tr
am
u
ra
l/
S
u
b
se
ro
sa
l 
- 
1
.1
8
 
0
.9
4
 ,
 1
.5
0
 
- 
1
.8
2
 
1
.3
7
 ,
 2
.4
1
 
1
.4
0
 
1
.1
8
 ,
 1
.6
8
 
 
 
 
 
 
 
 
 
 
A
g
e 
a
t 
M
en
a
rc
h
e 
(2
 y
ea
rs
 
in
cr
ea
se
) 
 
 
 
 
 
 
 
 
D
if
fu
se
 o
n
ly
 
- 
0
.8
3
 
0
.6
1
 ,
 1
.1
3
 
- 
0
.7
0
 
0
.4
1
 ,
 1
.1
8
 
0
.7
8
 
0
.6
0
 ,
 1
.0
2
 
S
u
b
m
u
co
sa
l 
- 
0
.8
4
 
0
.6
2
 ,
 1
.1
3
 
- 
0
.7
8
 
0
.4
7
 ,
 1
.3
0
 
0
.8
2
 
0
.6
4
 ,
 1
.0
6
 
In
tr
am
u
ra
l/
S
u
b
se
ro
sa
l 
- 
0
.7
8
 
0
.6
2
 ,
 0
.9
8
 
- 
0
.7
7
 
0
.5
5
 ,
 1
.0
7
 
0
.7
7
 
0
.6
4
 ,
 0
.9
4
 
 
 
 
 
 
 
 
 
 
F
u
ll
te
rm
 P
re
g
n
a
n
ci
es
 A
g
e 
2
5
+
  
(Y
es
 v
s.
 N
o
) 
 
 
 
 
 
 
 
 
N
o
 U
L
 
8
6
:7
6
 
1
.0
0
 
 
8
5
:1
1
7
 
1
.0
0
 
 
1
.0
0
 
 
D
if
fu
se
 o
n
ly
 
3
9
:3
9
 
0
.8
8
 
0
.5
0
 ,
 1
.5
4
 
2
3
:1
7
 
1
.5
8
 
0
.7
6
 ,
 3
.2
8
 
1
.0
1
 
0
.6
5
 ,
 1
.5
7
 
S
u
b
m
u
co
sa
l 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
3
7
:5
6
 
0
.5
9
 
0
.3
5
 ,
 1
.0
1
 
8
:3
2
 
0
.2
5
 
0
.1
0
 ,
 0
.5
8
 
0
.4
5
 
0
.2
9
 ,
 0
.6
9
 
In
tr
am
u
ra
l/
S
u
b
se
ro
sa
l 
 
1
2
2
:1
2
6
 
0
.8
8
 
0
.5
8
 ,
 1
.3
2
 
3
3
:9
0
 
0
.3
9
 
0
.2
3
 ,
 0
.6
5
 
0
.6
6
 
0
.4
8
 ,
 0
.9
0
 
 
 
 
 
 
 
 
 
 
B
M
I 
(k
g
/m
2
) 
(2
5
+
 v
s.
 <
2
5
) 
 
 
 
 
 
 
 
 
N
o
 U
L
 
1
0
8
:5
4
 
1
.0
0
 
 
8
0
:1
2
2
 
1
.0
0
 
 
1
.0
0
 
 
D
if
fu
se
 o
n
ly
 
6
3
:1
5
 
1
.9
9
 
1
.0
1
 ,
 3
.9
4
 
1
8
:2
2
 
1
.0
5
 
0
.5
1
 ,
 2
.1
5
 
1
.4
6
 
0
.9
1
 ,
 2
.3
7
 
S
u
b
m
u
co
sa
l 
  
7
1
:2
1
 
1
.4
3
 
0
.7
8
 ,
 2
.6
2
 
1
5
:2
5
 
0
.7
4
 
0
.3
5
 ,
 1
.5
8
 
1
.0
8
 
0
.6
9
 ,
 1
.7
1
 
In
tr
am
u
ra
l/
S
u
b
se
ro
sa
l 
1
9
0
:5
8
 
1
.3
9
 
0
.8
8
 ,
 2
.2
0
 
5
8
:6
5
 
1
.1
1
 
0
.6
8
 ,
 1
.8
2
 
1
.2
4
 
0
.8
9
 ,
 1
.7
2
 
  
 
85 
P
h
y
si
ca
l 
A
ct
iv
it
y
 
(H
ig
h
/V
er
y
 H
ig
h
 v
s.
 
L
o
w
/M
ed
iu
m
) 
 
 
 
 
 
 
 
 
N
o
 U
L
 
6
2
:9
9
 
1
.0
0
 
 
9
1
:1
1
0
 
1
.0
0
 
 
1
.0
0
 
 
D
if
fu
se
 o
n
ly
  
2
2
:5
6
 
0
.6
5
 
0
.3
5
 ,
 1
.1
9
 
1
1
:2
9
 
0
.5
6
 
0
.2
5
 ,
 1
.2
3
 
0
.6
2
 
0
.3
8
 ,
 0
.9
9
 
S
u
b
m
u
co
sa
l 
  
2
5
:6
7
 
0
.6
2
 
0
.3
5
 ,
 1
.1
1
 
1
6
:2
4
 
0
.7
1
 
0
.3
4
 ,
 1
.5
0
 
0
.6
7
 
0
.4
3
 ,
 1
.0
5
 
In
tr
am
u
ra
l/
S
u
b
se
ro
sa
l 
6
9
:1
7
7
 
0
.6
6
 
0
.4
3
 ,
 1
.0
2
 
4
3
:8
0
 
0
.6
2
 
0
.3
7
 ,
 1
.0
3
 
0
.6
6
 
0
.4
8
 ,
 0
.9
1
 
 
 
 
 
 
 
 
 
 
C
u
rr
en
t 
S
m
o
k
in
g
 (
Y
es
 v
s.
 N
o
) 
 
 
 
 
 
 
 
 
 
N
o
 U
L
 
4
6
:1
1
6
 
1
.0
0
 
 
1
4
:1
8
8
 
1
.0
0
 
 
1
.0
0
 
 
D
if
fu
se
 o
n
ly
 
3
3
:4
5
 
1
.9
7
 
1
.1
1
 ,
 3
.5
1
 
7
:3
3
 
3
.0
0
 
1
.0
7
 ,
 8
.3
8
 
2
.1
3
 
1
.2
9
 ,
 3
.5
3
 
S
u
b
m
u
co
sa
l 
2
8
:6
5
 
1
.1
3
 
0
.6
4
 ,
 2
.0
1
 
5
:3
5
 
1
.6
0
 
0
.5
2
 ,
 4
.9
8
 
1
.2
4
 
0
.7
4
 ,
 2
.0
7
 
In
tr
am
u
ra
l/
S
u
b
se
ro
sa
l 
6
2
:1
8
6
 
0
.8
9
 
0
.5
6
 ,
 1
.4
0
 
7
:1
1
6
 
0
.6
3
 
0
.2
3
 ,
 1
.7
4
 
0
.8
7
 
0
.5
8
 ,
 1
.3
2
 
*
 N
 r
ep
re
se
n
ts
 c
o
u
n
ts
 f
o
r 
E
x
p
o
se
d
: 
U
n
ex
p
o
se
d
  
  
 
86 
 T
ab
le
 4
.3
. 
P
-v
al
u
es
 f
ro
m
 t
es
ts
 o
f 
eq
u
al
 a
ss
o
ci
at
io
n
s*
 a
cr
o
ss
 t
h
e 
th
re
e 
U
L
 s
u
b
ty
p
es
 f
o
r 
ea
ch
 o
f 
th
e 
si
x
 r
is
k
 f
ac
to
r 
o
f 
in
te
re
st
, 
am
o
n
g
 A
fr
ic
an
 A
m
er
ic
an
, 
C
au
ca
si
an
, 
an
d
 a
ll
 p
re
m
en
o
p
au
sa
l 
w
o
m
en
 i
n
 t
h
e 
N
IE
H
S
 U
te
ri
n
e 
F
ib
ro
id
 S
tu
d
y
. 
   
A
fr
ic
an
-A
m
er
ic
an
 
C
au
ca
si
an
 
A
ll
 
A
g
e 
0
.4
3
8
 
0
.0
8
4
 
0
.1
6
2
 
A
g
e 
at
 M
en
ar
ch
e 
0
.8
4
9
 
0
.9
3
9
 
0
.9
0
0
 
A
n
y
 P
re
g
n
an
cy
 2
5
+
 
0
.2
6
5
 
<
 0
.0
0
1
 
0
.0
1
0
 
B
M
I 
0
.5
6
4
 
0
.5
8
8
 
0
.5
8
9
 
C
u
rr
en
t 
S
m
o
k
in
g
 
0
.0
1
4
 
0
.0
3
6
 
0
.0
0
2
 
P
h
y
si
ca
l 
A
ct
iv
it
y
 
0
.9
7
5
 
0
.8
8
6
 
0
.9
5
1
 
 *
 W
al
d
 c
h
i-
sq
u
ar
ed
 t
es
ts
 w
it
h
 2
 d
eg
re
es
 o
f 
fr
ee
d
o
m
 t
o
 t
es
t 
th
e 
eq
u
al
it
y
 o
f 
th
re
e 
ad
ju
st
ed
 o
d
d
s 
ra
ti
o
, 
o
n
e 
fo
r 
th
e 
as
so
ci
at
io
n
 w
it
h
 
ea
ch
 U
L
 s
u
b
ty
p
e.
 F
o
r 
th
e 
ra
ce
-s
p
ec
if
ic
 a
n
al
y
se
s 
th
e 
p
o
ly
to
m
o
u
s 
lo
g
is
ti
c 
re
g
re
ss
io
n
 m
o
d
el
s 
in
cl
u
d
es
 t
h
e 
si
x
 r
is
k
 f
ac
to
rs
; 
fo
r 
th
e 
o
v
er
al
l 
an
al
y
si
s 
th
e 
p
o
ly
to
m
o
u
s 
lo
g
is
ti
c 
re
g
re
ss
io
n
 m
o
d
el
 i
n
cl
u
d
es
 r
ac
e 
as
 w
el
l.
 P
-v
al
u
es
 <
 0
.0
5
 a
re
 b
o
ld
ed
. 
 
    
CHAPTER V 
PAPER 2: SELF-REPORTED URINARY SYMPTOMS ASSOCIATED WITH 
UTERINE LEIOMYOMATA 
Abstract 
OBJECTIVE: To investigate the association between uterine leiomyomata (UL) and 
self-reported stress urinary incontinence (SUI) in premenopausal women. 
METHODS: This study used baseline (1996-1999) and follow-up (2001-2002) data 
from 798 premenopausal participants (446 African-American and 352 Caucasian) in the 
National Institute of Environmental Health Sciences Uterine Fibroid Study. At follow-up, 
participants were asked about symptoms during a 12-month reference period, and women 
were classified as having SUI if they reported any urine leak when they coughed or sneezed. 
UL status was characterized at baseline using transabdominal and transvaginal ultrasound. 
The UL risk factors considered were: presence of any UL, size of the largest UL, presence of 
a large (≥ 4cm) anterior UL in a non-retroverted uterus, presence of a medium/large (≥ 2cm) 
anterior UL in a non-retroverted uterus, and uterine size. Linear risk models were used to 
estimate adjusted prevalence differences (aPD) and 95% confidence intervals (CI) controlling 
for age, ethnicity, body mass index (BMI), and the number of deliveries. In addition, 
ethnicity and parity were evaluated as effect measure modifiers. 
RESULTS: About half (51%) of study participants reported SUI during the reference 
period. Compared with women without any UL, SUI prevalence was higher among women 
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with any UL (aPD=6.7 95% CI: -0.5, 13.7), and with a medium or large UL (aPD=9.0 95% 
CI: 0.3, 17.4 and 8.6 95% CI: -1.4, 18.6, respectively). Anterior location was not associated 
with further increase in prevalence. Women with very large uterine volume (≥ 206.5 cm3) 
reported more SUI than those with small uterine volume (<91.4 cm3, aPD=9.1 95% CI: -1.5, 
19.5), but SUI was not associated with intermediate categories of uterine volume. There was 
no clear evidence of PD modification by ethnicity or parity. 
CONCLUSIONS: We found increases in SUI prevalence of about 7% to 9% with UL. 
The associations were not as strong as for established risk factors such as parity and obesity, 
which were associated with increased prevalences ranging from 13% to 22%. However, for a 
common outcome like SUI even this smaller increase in prevalence is important. Contrary to 
expectations, an anteriorly located UL was not associated with higher prevalence than UL in 
other locations. Uterine volume above the 83rd percentile for the population (>206.5 cm3), 
which may reflect the overall burden of UL better than the size of the largest UL, also was 
positively associated with SUI. Overall, these findings suggest that treatment for larger UL 
might enhance SUI treatment in some women. 
 
Introduction 
Urinary incontinence is one of the most common types of lower urinary tract 
dysfunction, affecting about a third of adult women in the United States (DuBeau 2001). The 
annual direct cost of urinary incontinence for women in the US is estimated as $12.4 billion 
(in 1995 dollars) (Wilson et al. 2001).  
Stress urinary incontinence (SUI), the complaint of involuntary leakage of urine on 
effort or exertion, or on sneezing or coughing (Abrams et al. 2002), is the most common type 
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of urinary incontinence in women, with about half of women with urinary incontinence 
suffering from SUI (Hampel et al. 1997). SUI accounts for 85% of treatment expenditures for 
urinary incontinence for women (Wilson et al. 2001), and also may have a substantial 
negative impact on the quality of life (Contreras-Ortiz 2004). 
Established risk factors for self-reported SUI symptoms include age, ethnicity, body 
mass index (BMI), parity, and mode of delivery. In particular several epidemiological studies 
have identified older age (Goldberg et al. 2005), Caucasian race (vs. African-American) 
(Jackson et al. 2004, Thom et al. 2006), high BMI (Mommsen and Foldspang 1994, Hojberg 
et al. 1999, Jackson et al. 2004), parity (Foldspang et al. 1992), and history of vaginal 
deliveries (Hojberg et al. 1999, Han et al. 2005) as risk factors for self-reported SUI. 
Uterine enlargement due to the presence of uterine leiomyomata (UL), in particular 
large UL in the anterior lower uterus, may cause urinary symptoms by extrinsically 
compressing the urinary bladder (Haney 2000). In particular, laughing, coughing, or 
sneezing, may displace UL against the bladder and cause involuntary loss of urine (i.e. SUI). 
It has been hypothesized that UL may be associated with SUI (Stovall 2001, Altman et al. 
2003, Sampselle et al. 2002, Nygaard and Heit 2004). There is also a case report of a 
pedunculated UL causing acute SUI (Isherwood et Rane 1999). However, an epidemiological 
study investigating the association of parity and route of delivery with self-reported SUI 
during the previous month, found no association between UL (as the primary indication for 
hysterectomy) and SUI (Handa et al. 2004). The authors compared the prevalence of SUI 
between women who had hysterectomies due to UL and women who had hysterectomies due 
to other causes. UL was not the main risk factor under investigation, and only an unadjusted 
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OR was reported for the association between UL and SUI. It should be noted that the study 
used a highly selective sample, not representative of women with UL or women with SUI. 
No population-based observational studies have directly assessed the association 
between UL and self-reported SUI. Therefore, the objective of this study was to investigate 
the association between SUI and UL overall, and between SUI and UL characteristics, 
among 446 African-American and 352 Caucasian premenopausal women who participated in 
the first follow-up interview of the National Institute of Environmental Health Science’s 
(NIEHS) Uterine Fibroid Study.  
 
Methods 
The NIEHS Uterine Fibroid Study (UFS), which was approved by Human Subject 
Review Boards at the NIEHS and George Washington University, was designed to measure 
the prevalence of UL, identify risk factors for UL, and evaluate UL-related symptoms among 
African American and Caucasian women. Enrollment occurred between 1996 and 1999 at 
which time participants were screened for UL and baseline data were collected using a mail 
questionnaire that took about 30 minutes to complete, and a telephone interview, which 
lasted one hour. Premenopausal participants were followed-up in 2001-2002 using a 
computer-assisted telephone interview. 
Study Participants: The UFS enrolled women aged 35 to 49 years old who were 
selected randomly from a computerized list of health plan members at a Washington, DC 
site. In addition to age and health plan membership requirements, eligible women had to be 
able to complete the UFS study interview in English. Of the 2,102 women screened for 
enrollment, 316 (15%) were ineligible, primarily because they did not obtain care at the 
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Washington, DC health plan site. Of the 1,786 eligible women, 335 (19%) refused to 
participate, and 24 (1%) were lost to contact prior to data collection. In total, 1,430 women, 
constituting 80% of the eligible women, participated in the baseline phase of the UFS.  
Out of the 1,430 baseline participants, 1,144 were premenopausal African-American 
or Caucasian women, and out of these 913 participated in the first follow-up of the NIEHS 
UFS. Women were excluded from the current study if they were missing data on SUI (n = 4) 
or on selected UL characteristics (n = 92). In addition, women who were pregnant during the 
12-month reference interval for self-reported history of SUI (n =14) and women for whom 
the age at reference was unknown (n = 5) were also excluded from the current study. The 
final population included 798 premenopausal women, 446 African-American and 352 
Caucasian. 
Determination of UL Status: During the baseline telephone interview, women were 
asked: “Have you ever been told by a doctor or other health professional that you have 
uterine fibroid tumors or a leiomyoma, a benign tumor of the uterus or womb?” Women who 
answered affirmatively and did not report a subsequent misdiagnosis in response to questions 
about diagnostic or follow-up examinations, UL treatment, or UL persistence, were classified 
as having a previous diagnosis of UL. For most women UL was identified or confirmed 
based on a pelvic ultrasound examination conducted for the study at the primary care site. 
Women who were previously diagnosed with UL and had an ultrasound during the previous 
five years, or were not diagnosed with UL and had an ultrasound during the previous two 
years, had those sonograms used instead of a study sonogram. 
Study ultrasound examinations included both transabdominal and transvaginal 
examinations to facilitate identification of UL in the upper uterus. Both examinations were 
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performed by sonographers certified by the American Registry of Diagnostic Medical 
Sonographers, under the supervision of a radiologist with fellowship training in sonography. 
A single radiologist reviewed all questionable sonograms. Sonographers filled out a study-
specific data collection form that included data on uterine size, uterine shape, the presence of 
diffuse heterogeneous echo pattern, number of focal UL, the size and location of the two 
largest UL (if at least 2cm in diameter), and the size of the three largest submucosal UL.  
UL status was classified according to 1) the presence of any UL (any UL vs. no UL), 
2) the size of the largest UL (no UL, small (< 2cm) UL, medium (2-4cm) UL, large (≥ 4cm) 
UL), 3) the presence of a large (≥ 4cm) anterior UL in a non-retroverted uterus (no UL, large 
(≥ 4cm) anterior UL in non-retroverted uterus, other UL), or 4) the presence of a 
medium/large (≥ 2cm) anterior UL in a non-retroverted uterus (no UL, medium/large (≥ 2cm) 
anterior UL in non-retroverted uterus, other UL). In addition, 774 women were classified 
according to overall uterine volume (small (lowest 33% of overall uterine volume 
distribution), medium (middle 33%), large (those in 67th to 83rd percentile), and very large 
(those above the 83rd percentile)), with uterine volume calculated using the prolate ellipsoid 
formula (0.52 x length x width x anterior/posterior diameter). The actual cut points used to 
define the four categories of uterine size were: 91.4 cm3 (the 33rd percentile), 147.8 cm3 (the 
66th percentile), and 206.5 cm3 (the 83rd percentile). 
For the previous definitions the “no UL” category included women who had neither 
focal UL nor a diffuse heterogeneous echo pattern present. The later may result from 
multiple small focal UL, or from larger UL that lack the usual distinct histological 
demarcation from the surrounding myometrium. We considered the diffuse heterogeneous 
echo pattern as an indicator of UL being present because like focal UL, in the NIEHS UFS it 
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is associated with enlargement of the uterus (Baird et al. 2003) and excess bleeding 
(Wegienka et al. 2003). Adenomyosis also can present as a diffuse heterogeneous echo 
pattern, but adenomyosis is usually accompanied by UL in uteri > 280g and occurs alone in 
only a minority of smaller uteri (LevGur 1996). For the 87 women who had a diffuse 
heterogeneous echopattern and no detectable focal UL we assigned a UL size based on their 
uterine volume. 
SUI Determination: Data collected at the follow-up during the computer-assisted 
telephone interview included self-reported history of SUI, which was classified as positive if 
women reported that they ever had urine leak when they coughed or sneezed during the 12 
month interval prior to a reference date determined by UL treatment and menstrual history. 
The reference date for women who had had UL treated by myomectomy, hystereoscopic 
resection, uterine artery embolization, or hysterectomy was the date of the procedure if they 
were still menstruating, or was the date of their last period if they had stopped menstruating 
prior to the treatment procedure. The reference date for women who did not undergo any of 
the procedures listed above was the date of their follow-up interview if they were still 
menstruating, or the date of their last period if they did not report a period in the last two 
months. 
Data Analysis: Potential confounders selected based on a review of the literature 
regarding risk factors for UL and SUI included age at the reference date (continuous or 
categorized as <40, [40,45), [45,50), 50+), ethnicity (African-American, Caucasian), BMI at 
baseline (kg/m2, categorized as <25, [25,30), [30,35), 35+), and the number of deliveries 
prior to the reference date (categorical, 0, 1, 2, 3+). A composite variable involving the 
number and the type of deliveries (none, only C-section deliveries, 1 vaginal delivery, 2 
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vaginal deliveries, 3+ vaginal deliveries) was also evaluated as a potential confounder, but 
was not used since results were comparable with those adjusted for the number of deliveries. 
Univariate analyses were performed to describe the distributions of exposures and 
outcomes, and assess missing data. Given the prevalence of the outcome under study (about 
50% of the participants have reported SUI), odds ratios are an overestimate for the relative 
risk. Therefore, we used linear risk models to estimate prevalence differences (PD) and 
corresponding 95% confidence intervals (CI) (Spiegelman and Hertzmark, 2005). Separate 
linear risk models were used to evaluate the association between each of the five variables of 
interest and self-reported SUI. We estimated crude, ethnicity-adjusted, and fully-adjusted 
PDs with 95% CIs, with the fully-adjusted estimates from linear risk models that included 
age at reference (continuous), ethnicity, BMI, and number of deliveries. All model estimates 
were evaluated to confirm that predicted prevalences were between 0 and 1. 
Ethnicity was evaluated as a potential effect modifier since African American women 
are at increased risk of UL but at decreased risk of SUI compared with Caucasians. In 
addition we evaluated effect modification by parity (nulliparous vs. parous) as pregnancy 
loosens the pelvic floor. Formal evaluation of effect modification by ethnicity and parity was 
performed using likelihood ratio tests (α = 0.10). All analyses were performed using the SAS 
software package (SAS v.9.1; SAS Institute, Inc., Cary, North Carolina).  
 
Results 
Over half of study participants were African-American, and about a third reported 
being nulliparous (Table 5.1). Most women were age 40-49 on the reference date (mean 
(±SD) 45.8 (±4.0) years), and 60% were overweight or obese (mean (±SD) 28.4 (±7.5) 
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km/m2). The average time from the ultrasound examination to the reference data was about 4 
years (mean (±SD) 3.9 (±2.0) years). Overall, 393 of 798 (51%) of study participants 
reported SUI during the reference period. Consistent with the literature, African-American 
women reported less SUI than Caucasian women (43% versus 57%), and there was a general 
tendency for the prevalence of SUI to increase with age, BMI, and number of deliveries. 
Sixty-three % of participants had at least one UL (499 of 798), and the prevalence of SUI 
was increased among women with UL (51%) relative to women without UL (47%). The 
adjusted prevalence difference (aPD) associated with UL was 6.7 with 95% CI: -0.5, 13.7. 
Forty-five % of participants had had at least one UL that was 2cm or larger (Table 
5.2). Relatively few women had an anterior UL in a non-retroverted uterus that was ≥ 4cm or 
≥ 2cm (4% and 15% respectively). The prevalence of SUI was similar for women with no 
UL and for those with UL < 2cm, but was increased among women with UL 2-4 cm 
(aPD=9.0 95% CI: 0.3, 17.4) and UL 4cm or larger (aPD=8.6 95% CI: -1.4, 18.6). Contrary 
to expectations, the association between UL and SUI appeared to be weaker for large (≥ 4cm) 
anterior UL in a non-retroverted uterus (aPD=2.8 95% CI: -13.4, 19.2) then for other UL 
(aPD=7.0 95% CI: -0.3, 14.1); however, estimates were imprecise due to the small number of 
observations in the former group. The association between the presence of anterior UL 2cm 
or larger in a non-retroverted uterus and SUI (aPD=8.6 95% CI: -1.6, 18.6) was similar to the 
association estimated for other UL and SUI (aPD=6.1 95% CI: -1.5, 13.5).  
The prevalence of SUI among women with a very large uterine volume (> 206.5 cm3) 
was increased relative to women with a small uterine volume (≤ 91.4 cm3) (aPD=9.1 95% CI: 
-1.5, 19.5); however, SUI was not positively associated with “medium” or “large” uterine 
volume.  
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The increase in SUI prevalence associated with medium size (2-4 cm) UL was the 
only statistically significant finding. Because ethnicity is a very strong risk factor for both 
SUI and UL, Table 5.1 and Table 5.2 contain crude, ethnicity-adjusted, as well as fully-
adjusted PDs with and 95% CIs. There was no evidence that the association between UL 
presence and SUI differed by race (p = 0.637) or parity (p = 0.999). For example the race-
specific associations between UL presence and SUI were similar, aPD=8.3 95% CI: -1.4, 
18.0 for African-Americans and aPD=4.9 95% CI: -5.3, 15.1 for Caucasians. In addition, 
there was no evidence of PD modification by ethnicity or parity when UL was classified 
according to size or position, or of modification of the association between uterine volume 
and SUI (all likelihood ratio test p-values > 0.10). The results did not change qualitatively 
when the 87 women who had a diffuse heterogeneous echopattern and no detectable focal UL 
were excluded. 
 
Discussion 
Although several papers have hypothesized that UL may be associated with SUI 
(Stovall 2001, Altman et al. 2003, Sampselle et al. 2002, Nygaard and Heit 2004), this is the 
first population-based epidemiological study to systematically evaluate the association 
between UL characteristics and presence of self-reported SUI. In addition to the presence or 
absence of any UL, we evaluated the size of the largest UL, UL location, and overall uterine 
volume, since these characteristics may affect SUI by increasing pressure exerted on the 
bladder.  
Almost half of the study population reported symptoms of SUI during the reference 
interval, but the prevalence of SUI was about 7% higher among women with UL compared 
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with women without UL after adjusting for age, ethnicity, BMI, and number of deliveries. 
Relative to women without UL, the prevalence of SUI was about 9% higher among women 
with UL that were 2cm or larger, and among women with a very large uterine volume. 
However, an anterior UL of at least 4 cm in a non-retroverted uterus, which we hypothesized 
would be most likely to exert pressure on the bladder, was not more strongly associated with 
SUI than other UL. In addition, we did not see evidence that associations between UL and 
SUI were modified by race or parity. 
The association between the presence of UL and urinary incontinence has been only 
indirectly investigated in previous studies. A cross–sectional study involving 1,293 women 
scheduled for hysterectomy evaluated the association between self-reported SUI during the 
previous month and UL as the primary indication for hysterectomy (versus other indications 
for hysterectomy) (Handa et al. 2004). Women with UL as the primary indication were no 
more likely to report SUI as women with other indications for hysterectomy (such as 
noninfectious conditions, cancer and premalignant conditions, adnexal conditions, and 
infections). However for the reasons provided in the introduction part this study cannot be 
used as evidence against an association between UL and SUI. 
Sampselle et al. (2002) studied 3,302 women aged 42 to 52 years old that were 
enrolled in the Study of Women’s Health Across the Nation cohort, a multiethnic 
longitudinal study of the natural history of menopausal transition (47% Caucasian, 28% 
African-American). Women were classified as having UL if they reported that a health care 
provider had ever told them that they had the condition. The authors estimated associations 
between ethnicity and incontinence according to UL status, but did not estimate the 
association between UL and incontinence specifically. Among women without UL, African-
  98  
American women were less likely than Caucasian women to report urinary incontinence 
(aOR = 0.31 95% CI: 0.23, 0.40 adjusted for age, menopausal status, BMI, diabetes, and 
parity). However, among women with UL, African-American women were more likely than 
Caucasian women to report urinary incontinence (aOR = 1.81 95% CI: 1.22, 2.71). To 
explain their finding the authors speculated that the propensity of African-American women 
to develop larger UL resulted in an increased prevalence of SUI, and subsequently an 
increased prevalence of urinary incontinence. 
There have been few studies that have looked on the effect of hysterectomy on SUI 
symptoms. In a prospective study the SUI prevalence dropped from 36% before surgery to 
19% six months after surgery (El-Toukhy et al. 2004). Two randomized clinical trials have 
also found reductions in SUI after hysterectomy (Thakar et al. 2002, Gimbel et al. 2005). In 
the first clinical trial the reduction in SUI was not associated with UL presence, while in the 
second the SUI reduction was attributed to the removal of uteri with large UL. We found no 
literature on the effect of myomectomy or uterine artery embolization on SUI, studies that 
would more directly address the efficacy of removal of UL for treating SUI. 
A strength of our study is that UL status was based on screening a randomly selected 
sample, so women with both symptomatic and asymptomatic UL could be accurately 
classified. The ultrasound data also allowed us to characterize the size and location of UL. In 
addition, our outcome measure was restricted to SUI, versus self-reported urinary 
incontinence of any type as in Sampselle et al. (2002). However, we could not confirm that 
UL preceded the onset of SUI, and the number of women with large (≥ 4cm) anterior UL in a 
non-retroverted uterus was small (n=34).  
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In summary, we found an increase in SUI prevalence of about 7% associated with the 
presence of UL, with slightly larger increases in prevalence associated with larger UL and 
large uterine volume. These findings are consistent with expectations regarding associations 
between UL and SUI, and suggest that the effective treatment of SUI may require treatment 
for larger UL in some cases. 
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CHAPTER VI 
CONCLUSIONS 
Introduction 
 
The common idea behind the two epidemiological studies described in this 
dissertation was to move research forward from studies of uterine leiomyomata (UL) as a 
single entity to a more detailed characterization of UL (involving position within the 
myometrium, size of the largest UL, etc.). In the first study we compared associations with 
six putative risk factors among three UL subtypes defined by location within the 
myometrium (submucosal UL, intramural/subserosal UL, and diffuse only). In the second 
study we investigated UL characteristics as risk factors for self-reported stress urinary 
incontinence (SUI). It should be noted that in the first paper UL subtype was the outcome, 
and in the second paper the UL characteristics were the risk factors of interest.  
Although UL are the most prevalent tumors among women in the United States 
(Flake et al. 2003) and there is evidence of histopathologic differences among UL subtypes 
(Marugo et al. 1989, Brosens et al. 1998), no study to date has systematically investigated 
risk factor profiles of individual UL subtypes. Similarly, although it has been hypothesized 
that uterine enlargement due to large anterior UL may cause SUI (Stovall 2001, Sampselle et 
al. 2002) no population-based epidemiological studies have assessed the association between 
UL characteristics and SUI. 
Both studies used data from the National Institute of Environmental Health Sciences 
(NIEHS) Uterine Fibroid Study (UFS), a study designed to measure the prevalence of UL,
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 identify risk factors for UL, and evaluate UL-related symptoms among African-American 
and Caucasian women. The first study used baseline data (collected between 1996 and 1999), 
while the second study used UFS baseline and follow-up data (collected between 2001 and 
2002). Both studies took full advantage of the detailed data obtained from ultrasound 
examinations (both transabdominal and transvaginal) performed as part of the baseline 
assessment. The follow-up data examination included self-reported history of SUI during the 
12-month period prior to a reference date determined by UL treatment or change in 
menopausal status. 
 
Summary of Results 
For both African-American and Caucasian premenopausal women we found similar 
associations of four of the risk factors considered (age at ultrasound examination, age at 
menarche, body mass index, and current physical activity) with the three UL subtypes. For 
both ethnic groups the inverse association of having any full-term pregnancies after age 24 
with the submucosal UL subtype seemed to be stronger than its associations with the 
intramural/subserosal UL subtype and the diffuse only subtype. There was also a positive 
association of current smoking with the diffuse UL subtype, in contrast to no associations of 
current smoking with the two focal UL subtypes, for both African-Americans and 
Caucasians. 
Compared with women with no UL, we found an estimated increase in the prevalence 
of SUI of 7% associated with any UL, with slightly larger increases (about 9%) among 
women with medium (2-4 cm) or large (4+ cm) UL. We also found an increase in SUI of 
about 9% when we compared women with a very large uterus to those with small uterine 
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size. However, contrary to what we hypothesized, we did not find a stronger association 
between the presence of an anterior UL and SUI than UL in other locations. 
  
Significance 
The findings of the first paper suggest that future studies of the etiology of UL should 
distinguish focal UL subtypes (such as submucosal UL and intramural/subserosal UL) from 
the diffuse only subtype because of possible different etiologic mechanisms. In particular the 
different association seen between current smoking and the diffuse only subtype provide 
motivation for the study of this subtype as a separate entity, to better understand the 
biological cause of the diffuse heterogeneous echopattern seen on sonograms. 
Very little is known about the pathophysiology of the diffuse only subtype. The 
diffuse heterogeneous echo pattern associated with this subtype may result from multiple 
small focal UL, or from larger UL that lack the usual distinct histological demarcation from 
the surrounding myometrium. Although many radiologists/sonographers may not include the 
presence of a diffuse heterogeneous echopattern as part of the definition of UL, we 
considered the diffuse heterogeneous echo pattern as a UL subtype because like focal UL, in 
the NIEHS UFS it is associated with enlargement of the uterus (Baird et al. 2003) and excess 
bleeding (Wegienka et al. 2003). Adenomyosis also can present as a diffuse heterogeneous 
echo pattern, but adenomyosis is usually accompanied by UL in uteri > 280g and occurs 
alone in only a minority of smaller uteri (LevGur 1996). 
One important finding from the first paper is the absence of major differences between the 
risk factor profile of the two focal UL subtypes, despite documented histopathologic 
evidence that there are differences between the submucosal UL and the intramural or 
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subserosal UL beyond their anatomic position within the myometrium. Another very 
interesting finding is the strong inverse association of full-term pregnancies after age 24 with 
submucosal UL (stronger than the association with intramural/subserosal UL). One possible 
explanation may be the expulsion of submucosal UL with birth and postpartum remodeling 
of the uterus. 
The findings from the second paper suggest that treatment for larger UL might 
enhance SUI treatment in some women. Similar to five previous epidemiological studies 
(Brown et al. 1999, Jackson et al. 2004, Handa et al. 2004, Hendrix et al. 2005, and Thom et 
al. 2006), the present study is investigating SUI in both African-American and Caucasian 
women, and provides further information on the association between ethnicity and SUI, in 
addition to information on the association of SUI with age, BMI, and parity.  
 
Strengths and Limitations 
NIEHS Uterine Fibroid Study participants, both African-American and Caucasian, 
were screened to identify UL among randomly selected premenopausal women irrespective 
of clinical symptoms. Consequently, women with both symptomatic and asymptomatic UL 
could be accurately classified according to UL presence and characteristics. This is important 
because UL may cause symptoms even when undiagnosed, and studying only symptomatic 
UL may be more likely to identify risk factors associated with growth than with incidence. 
Another important strength of the study is the detailed sonogram data that includes data on 
uterine size, uterine shape, the presence of diffuse heterogeneous echo pattern, number of 
focal UL, the size and location of the two largest UL, and the size of the three largest 
submucosal UL. 
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Limitations include the cross-sectional nature of the studies, which does not allow us 
to establish the temporality of the relationships under investigation. In particular we cannot 
evaluate risk factors for incident (versus prevalent) UL, and cannot confirm that UL preceded 
the onset of SUI symptoms. There are also limitations related to looking only at the size of 
the largest UL, and not being able to look at the number of UL. Considering the uterine size 
may have partly offset these limitations by providing a measure of the overall burden of UL. 
Also, the Caucasian women included in our study populations tended to be of low parity and 
high socioeconomic status, which may make the findings not generalizable to US Caucasian 
women of high parity and/or low socioeconomic status.  
 
Direction for Future Research 
The results of the first paper suggest treating the diffuse only subtype as a separate 
entity from the focal UL subtypes in future etiologic investigations. Although there is 
histopathologic evidence that the two focal UL subtypes are different from each other, more 
work also needs to be done to investigate potential differences between the two focal UL 
subtypes and the diffuse only subtype. An interesting related question would be to see if 
women can self-report the type of UL they have been diagnosed with.  
Although we have investigated the association with risk factors consistently 
associated with focal UL, it is possible that other risk factors that have shown inconsistent 
results with respect to their association with focal UL may have different associations with 
the focal UL subtypes (submucosal UL and intramural/subserosal UL). Data on other 
potential risk factors were collected in the NIEHS Uterine Fibroid Study, such as oral 
contraceptives and reproductive tract infections, that do not show strong overall relationships 
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with UL, but could be investigated in relation to UL subtypes in the future. As more research 
is done to characterize the biological variation in UL, there may be alternative ways to 
examine this potentially heterogeneous outcome than by the three subtypes examined here. It 
should be noted that larger studies would be needed to be able to examine risk factors for UL 
subtypes than for UL presence (all subtypes combined). 
The second paper provided preliminary evidence supporting a role of UL in the 
etiology of SUI, though contrary to expectations, location in the anterior uterus was not 
clearly associated with SUI. Although those findings suggest that treatment for larger UL 
might enhance SUI treatment in some women, they do not shade any light on what needs to 
be known in order to determine whether or when treatment of UL in order to treat SUI is 
appropriate to recommend. The later issue is very important from a public health point of 
view, and one possibility to deal with that will be for more studies to collect data specifically 
on self-reported SUI before and after UL treatment, and look at changes in the prevalence of 
SUI.  
The NIEHS Uterine Fibroid Study includes data regarding “how much of a problem” 
SUI was, with the options given as: “not a problem”, “a small problem”, “a medium 
problem”, and “a big problem”, therefore future analyses may investigate UL characteristics 
in association with severity of self-reported SUI. Another possibility would be to examine 
associations between UL characteristics and urinary urgency, which was assessed in relation 
to the same reference period as SUI by the following question: “Have you felt the need to 
urinate urgently, even though you have had little or no warning?” Although this question 
does not directly assess urge urinary incontinence, which requires urine leakage in addition to 
urgency, it would add additional information regarding potentially relevant symptoms. 
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Therefore, the consideration of severity of self-reported SUI and of the presence of self-
reported urgency would provide more insight into the relationship between UL 
characteristics and urinary symptoms that may substantially impact quality of life.  
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